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  IN	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Pelvic	  organ	  prolapse	  (POP)	  is	  a	  life	  changing	  condition	  affecting	  over	  50%	  of	  women	  aged	  50	   and	   older.	   Women	   with	   POP	   typically	   suffer	   from	   sexual,	   defecatory	   and	   urinary	  dysfunction,	  resulting	  from	  the	  descent	  of	  their	  unsupported	  pelvic	  organs	  into	  the	  vaginal	  canal.	  Over	  one	  billion	  dollars	  in	  annual	  costs	  are	  associated	  with	  surgery	  to	  repair	  POP.	  In	  general,	  surgical	  repair	  strategies	  merely	  provide	  an	  anatomical	  repair	  and	  fail	  to	  address	  the	  underlying	   cause	  of	  POP,	   thus	   increasing	   the	   risk	  of	   reoccurrence	  and	   complications.	  Vaginal	  birth	  injury	  (VaBI)	  has	  been	  identified	  as	  a	  major	  risk	  factor	  for	  POP.	  As	  such,	  the	  study	  of	  VaBI	  provides	  an	  opportunity	  to	  better	  understand	  how	  POP	  develops	  in	  order	  to	  provide	  improved	  remedies.	  To	  date,	  the	  exact	  mechanism	  by	  which	  vaginal	  delivery	  leads	  to	  POP	  remains	  elusive,	  as	  the	  time	  lapse	  between	  childbirth	  and	  POP	  symptoms	  (usually	  20-­‐30	   years)	   creates	   multiple	   confounders	   that	   limit	   the	   ability	   to	   prove	   causality.	  Therefore,	  the	  goal	  of	  this	  thesis	  work	  was	  to	  utilize	  controlled	  animal	  models	  to	  assess	  the	  impact	  of	  VaBI	  on	  vaginal	  smooth	  muscle	  (VaSM),	  as	  a	  possible	  mechanism	  of	  VaBI	  in	  the	  pathogenesis	   of	   POP.	   In	   addition,	   we	   wished	   to	   examine	   the	   impact	   of	   current	   surgical	  mesh	  repair	  on	  VaSM	  functional	  outcomes.	  Specially,	  this	  work	  1)	  investigated	  the	  impact	  of	  a	  simulated	  vaginal	  birth	  injury	  on	  VaSM	  2)	  characterized	  the	  impact	  of	  a	  potential	  loss	  of	   smooth	  muscle	   function	   on	   vaginal	   biaxial	  mechanics,	   and	   3)	   evaluated	   the	   ability	   of	  surgical	  mesh,	  designed	  to	  restore	  the	  unsupported	  organs	  to	  their	  anatomical	  position,	  on	  
	   	   v	  
VaSM	   function.	  Our	   findings	   indicate	   that	  VaBI	   can	  cause	  non-­‐recoverable	   loss	   in	  vaginal	  function,	   and	   that	   a	   loss	   of	   function	   alters	   vaginal	   mechanics,	   with	   the	   potential	   to	  compromise	  support	  of	   the	  pelvic	  organs.	  Additionally,	   the	  results	  showed	  that	  surgically	  implanted	  meshes	   have	  mechanical	   and	   textile	   properties	   that	   further	   promote	   a	   loss	   of	  VaSM	   function.	   Ultimately,	   we	   hope	   that	   these	   findings	   motivate	   the	   need	   for	   more	  measures	  to	  prevent	  VaSM	  injury	  during	  delivery,	  and	  serve	  as	  a	  guide	  for	  the	  design	  of	  de	  
novo	  meshes	  aiming	  to	  improve	  VaSM	  function.	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Figure	  1.	  Schematic	  Representation	  of	   the	  Pelvic	  Organs.	  The	  role	  of	   the	  pelvic	   floor	   is	   to	  support	   the	  pelvic	  organs.	  Failure	  to	  support	   the	  pelvic	  organs	  can	  result	   in	  pelvic	  organ	  prolapse	  (POP),	  a	  condition	  characterized	  by	  the	  decent	  of	  the	  pelvic	  organs	  into	  the	  vaginal	  canal.	  ...............................................................................................................................	  3	  Figure	   2.	   Fibromuscular	   Supportive	   Structures.	   The	   vagina	   is	   supported	   by	   connective	  tissues	   and	   ligamentous	   attachments	   through	   anchoring	   to	   muscle	   or	   bony	  structures.	   Women	   with	   POP	   exhibit	   a	   weakening	   of	   these	   structures,	   for	   which	  synthetic	  mesh	  may	  be	  surgically	  implanted,	  as	  a	  means	  to	  augment	  support.	  .............	  4	  Figure	   3.	   Pelvic	   Organ	   Prolapse	   (POP)	   Mesh	   for	   Pelvic	   Reconstruction.	   One	   of	   common	  treatment	  methods	  of	   for	  POP	   symptom	  management	   involves	   the	  placement	  of	   a	  graft,	  similar	  to	  one	  in	  this	  figure,	  to	  replace	  the	  weakened	  supportive	  tissues.	  The	  use	  of	  native	   tissues	  grafts	  or	  biologics	   is	  associated	  with	  high	   failure	   rates,	  while	  synthetic	   grafts	   or	  meshes	  which	  provide	  more	   long-­‐term	  anatomical	   support	   are	  associated	  with	  complications	  including	  erosion.	  .......................................................................	  5	  Figure	   4.	   Risk	   Factors	   of	   POP.	   Obesity,	   a	   predisposition	   to	   connective	   tissue	   disorders,	  family	  history	  of	  POP,	  increasing	  parity,	  and	  increasing	  age	  have	  been	  identified	  as	  factors	  predisposing	  women	  to	  developing	  POP.	  Of	  the	  risk	  factors,	  parity	  is	  known	  to	  have	  the	  greatest	  association	  with	  the	  development	  of	  POP.	  ............................................	  7	  Figure	  5.	  Innervation	  of	  the	  Pelvic	  Organs.	  Innervation	  of	  the	  pelvic	  organs	  is	  provided	  by	  the	   hypogastric,	   pelvic,	   and	   pudendal	   nerves.	   The	   pudendal	   nerve	   innervates	   the	  striated	  muscle	  sphincters	  of	  the	  bladder,	  vagina,	  and	  rectum,	  while	  the	  hypogastric	  and	  pelvic	  nerve	  provides	  region-­‐specific	   innervation	  to	  the	  smooth	  muscle	  within	  these	  organs.	  .............................................................................................................................................	  10	  Figure	   6.	   Schematic	   Representation	   of	   the	   Pelvic	   Floor	   Musculature.	   The	   levator	   ani	  muscles	  are	  the	  major	  muscle	  supports	  for	  the	  pelvic	  organs.	  They	  provide	  support	  in	   response	   to	   downward	   forces,	   and	   are	   subjected	   to	   large	   magnitudes	   of	   force	  during	  parturition.	  ..................................................................................................................................	  11	  Figure	   7.	   Cross	   Section	   through	   the	   Vagina.	   Shown	   are	   the	   layers	   of	   the	   vagina,	   which	  include	  the	  epithelium,	  subepithelium,	  muscularis,	  and	  the	  adventitia.	  ........................	  16	  Figure	  8.	  Mechanical	  Constituents	  of	  the	  Vagina.	  The	  vaginal	  layers	  contain	  collagen	  (red),	  elastin	   (green	   dots),	   and	   smooth	   muscle	   (green	   lines	   –	   actinin	   striations),	   which	  collectively,	  are	  the	  main	  contributors	  to	  the	  mechanical	  properties	  of	  the	  vagina.	  17	  
x	  
Figure	  9.	  Thesis	  Paradigm.	  	  The	  goal	  of	  the	  thesis	  is	  to	  provide	  insight	  into	  the	  association	  between	   VaBI,	   and	   the	   development	   of	   POP.	   The	   focus	   of	   which,	   is	   on	   vaginal	  smooth	  muscle	  as	  a	  pathogenic	  factor	  of	  POP.	  Specially,	  the	  goal	  of	  this	  thesis	  is	  to	  1)	  investigate	   the	   impact	  of	  a	  simulated	  vaginal	  birth	   injury	  on	  VaSM	  2)	  characterize	  the	   impact	   of	   a	   potential	   loss	   of	   smooth	   muscle	   function	   on	   vaginal	   biaxial	  mechanics,	   and	   3)	   evaluate	   the	   ability	   of	   surgical	   mesh,	   designed	   to	   restore	   the	  unsupported	  organs	  to	  their	  anatomical	  position,	  on	  VaSM	  function.	  ............................	  35	  Figure	  10.	  Histological	  Results of Vaginal Cross-Sections.	  (I)	                Representative	  outlines	  of	            the     
  mid vaginal	   lumen	   of	   hematoxylin - and	   eosin stained	   cross sections	   from cont 	                
rl	  (A),                   4	  WEEK	  INJ(B),	  and	  8	  WEEK	  INJ(C)	  groups.	  Vaginal	  injury	  was	  associated	  with	  an	     increase          	  in	  the	  vaginal	  lumen,	  observed	  in	  the	  4	  WEEK	  INJ	  group	  (P=	  0.007),	  with	  minimal	                recovery	   in	   the	   8	   WEEK	   INJ	   group	   (P	   =0.041).	   (II)	   Evaluation	   of	   morphology	         of	  the	  corresponding	  crossF sections	  from	  control	  (A),	  4	  WEEK	  INJ	  (B),	  and 8	   WEEK	   INJ	   groups	   showed	   gross	   disorganization	   in	   the	   4	   WEEK	   INJ	   group	  (arrows),	   and	   increased	   fibrosis	   (short	   arrows)	   in	   the	   8	   WEEK	   INJ	   group.	  (u	   =	  
 urethra,	  v	  =	  vagina,	  f	  =	  fascia)	  bar	  =	  100	  um	  ...............................................................................	  45	  Figure	  11.	  Representative	  Tracings	  of	  EFS	  and	  KCl	  Responses.	  Recordings	  of	  the	  contractile	  response	  of	  mid-­‐vaginal	   segments	   to	  KCl	   (120	  mM)	  and	  EFS	   (1-­‐	  64Hz),	   in	   control	  (A),	  4	  WEEK	  INJ	   (B),	  and	  8	  WEEK	  INJ	   (C)	  groups	  showed	   increased	  contraction	   in	  the	   control	   group,	   relative	   to	   the	   injured	   groups,	   with	   decreasing	   contractile	  magnitude	  with	  time	  post	  injury.	  There	  was	  also	  evidence	  of	  increased	  fatigue	  in	  the	  injured	  group	  as	  evidence	  by	  the	  oscillations	  following	  KCl	  administration.	  ..............	  47	  Figure	  12.	  Functional	  Response	  Curves.	  Evaluation	  of	  the	  4	  WEEK	  INJ	  vs	  8	  WEEK	  INJ	  group	  showed	   an	   increase	   in	   EC50	   (P	   =	   0.001,	   P	   =	   0.069)	   in	   response	   to	   KCl	   (n=7),	   a	  decrease	  in	  Emax	  (P	  =	  0.002,	  P	  =	  0.005)	  in	  response	  to	  CCh	  (n=7),	  a	  decline	  in	  the	  EC50	  in	  the	  distal	  vagina	  (P	  =	  0.011)	  in	  response	  to	  PE	  (n=7),	  and	  no	  further	  decline	  in	  EFS	  response	  following	  a	  decline	  in	  the	  4	  WEEK	  INJ	  group	  (P	  =	  0.758).	  ...................	  48	  Figure	  13.	  Peripheral	  Nerve	  Labeling.	  	  Evaluation	  of	  peripheral	  innervations	  (A)	  in	  addition	  to	  more	  specific	  evaluations	  of	  the	  cholinergic	  (B),	  and	  adrenergic	  innervations	  (C)	  of	  mid-­‐vaginal	  segments	  from	  control	  4	  WEEK	  INJ	  and	  8	  WEEK	  INJ	  middle	  groups,	  showed	  a	  increased	  paucity	  of	  adrenergic	  nerve	  innervations	  with	  injury.	  .................	  55	  Figure	  14.	  Schematic	  Representation	  of	  the	  Stretch-­‐Stress	  Curves.	  Loading	  of	  the	  axial	  (A),	  and	   the	   circumferential	   (B)	   direction	   of	   the	   vagina	   resulted	   in	   distinct	   loading	  patterns	  when	  the	  muscle	  was	  at	  baseline,	  contracted,	  or	  relaxed.	  Of	  note,	  was	  the	  observation	   that	   contraction	   of	   the	   muscle	   resulted	   in	   a	   curve	   synonymous	   of	   a	  more	  gradual	  recruitment	  of	  collagen	  fibers	  in	  the	  axial	  direction.	  .................................	  70	  Figure	   15.	   Axial	   and	   Circumferential	   Tensile	   Modulus.	   At	   the	   low-­‐stiffness	   region,	   the	  vagina	   was	   significantly	   less	   stiff	   in	   the	   circumferential	   direction	   when	   smooth	  muscle	  was	   at	   baseline,	   contacted,	   and	   relaxed	   (P	   =	   0.012,	   P	   =	   0.023,	   P	   =	   0.005).	  (Panel	  2)	  Smooth	  muscle	  contraction	  was	  associated	  with	  a	  trend	  toward	  a	  decrease	  in	  the	  tensile	  modulus	  in	  the	  high-­‐stiffness	  region	  of	  the	  curve	  (P	  =	  0.10).	  ..................	  71	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Figure	   16.	   Collagen,	   Elastin	   and	   Smooth	   Muscle	   Imaging.	   Multiphoton	   imaging	   revealed	  resident	  collagen	  (red),	  elastin	  (green),	  and	  smooth	  muscle	  (green	  bundles)	  within	  the	  vaginal	  muscularis	  (16–A).	  These	  structures	  are	  intricately	  connected,	  and	  may	  function	   synergistically	   to	   regulate	   collagen	   recruitment	   in	   response	   to	   applied	  loads	  (16-­‐B).	  ..............................................................................................................................................	  74	  Figure	  17.	  Collagen,	  Elastin,	  and	  Smooth	  Muscle	  Imaging	  of	  the	  Injured	  Vagina.	  Multiphoton	  imaging	  of	  8-­‐weeks	  after	  VaBi	  in	  the	  rat	  revealed	  less	  visible	  smooth	  muscle	  (green	  bundles)	  within	   the	  vaginal	  muscularis,	  evidenced	  by	  the	  absence	  of	  α-­‐actinin,(	  an	  actin	  binding	  protein).	  ..........................................................................................................................	  75	  Figure	   18.	   Vaginal	   Explants.	   3	   months	   post	   implantation	   explants	   from	   Gynemesh™	   PS,	  Restorelle®,	  UltraPro™	  perpendicular	  and	  UltraPro™	  parallel	  (A-­‐D).	  The	  half	  closest	  to	  the	  cervix,	  underlying	  the	  mesh	  was	  defined	  as	  the	  grafted	  region,	  and	  the	  lower	  portion	  adjacent	   to	   the	  mesh	  was	  defined	  as	   the	  non-­‐grafted	   region.	  At	   the	  mesh-­‐tissue	   interface	   of	   each	   mesh,	   there	   was	   evidence	   of	   host	   tissue	   ingrowth,	   with	  varying	   degree	   of	   incorporation	   as	   a	   function	   of	   mesh-­‐type.	   Less	   stiff	   meshes,	  UltraPro™	  perpendicular	  and	  Restorelle®,	  had	  better	   incorporation	   into	   the	   tissue,	  while	  the	  stiffer	  Gynemesh™	  PS	  appeared	  buckled	  and	  surrounded	  by	  a	  connective	  tissue	  capsule	  (A).	  ...................................................................................................................................	  92	  Figure	   19.	   Morphological	   Results.	   Representative	   images	   showing	   gross	   smooth	   muscle	   morphology	   following	   Massons	   trichrome	   staining	   of	   cross-­‐sections	   of	   (A)	   sham-­‐operated;	   (B)	   Gynemesh	   PS,	   (C)	   Restorelle,	   (D)	   Ultrapro™	   perpendicular,	   and	   (E)	  UltraPro™	  parallel	   tissue	  biopsies	   from	  the	  grafted	  region.	  Compared	  to	  Sham	  and	  UltraPro™	  perpendicular,	  implantation	  with	  the	  higher	  stiffness	  meshes	  appeared	  to	  have	  more	  disorganized	  smooth	  muscle	  fibers.	  Additionally,	  following	  implantation	  with	  Gynemesh	  (B),	  there	  was	  increased	  thinning	  of	  the	  muscle	  layer	  relative	  to	  all	  the	  other	  meshes.	  Scale	  bar	  =	  250	  µm.	  ..........................................................................................	  93	  Figure	   20.	   Functional	   Response	   (Maximum	   Response).	   Muscle	   mediated	   contraction	  significantly	  declined	  following	  implantation	  with	  Gynemesh	  PS,	  UltraPro™	  parallel,	  and	   Restorelle®	   in	   the	   grafted	   region	   (P	   <	   0.001,	   P	   <	   0.001,	   P	   =	   0.015)	   (A),	   and	  UltraPro	  ™	  perpendicular	  was	  greater	  than	  UltraPro	  parallel	  (P	  =	  0.052)	  in	  the	  non-­‐grafted	   region	   (B).	   Nerve	   mediated	   contractions	   significantly	   declined	   following	  Gynemesh™	   PS	   	   (P	   =	   0.008)	   implantation	   in	   the	   grafted	   region	   (C).	   Cholinergic	  receptor	  mediated	  contractions	  significantly	  also	  declined	  following	  Gynemesh™	  PS	  (P	  =	  0.007)	  in	  the	  grafted	  region	  (E).	  ..............................................................................................	  96	  Figure	  21.	  Peripheral	  Nerve	  Labeling.	  (Panel	  1)	  PGP	  9.5	  immunolabeling	  (arrows:	  positive	  labeling)	  of	  cross-­‐sections	  of	  tissue	  explants	  for	  the	  sham	  group,	  showed	  high	  levels	  of	   immunoreactivity	   (IR),	   indicative	  of	   the	  maintenance	  of	  peripheral	  nerve	   fibers	  following	  sham	  operation,	  localized	  immediately	  below	  the	  epithelial	  layer	  (ep)	  and	  within	   the	  smooth	  muscle	  (sm)	  bundles.	  Arrows:	  nerve	   fibers.	  Scale	  bar	  =	  250	  µm	  (Panel	   2)	   correspoinding	   analysis	   of	   the	   smooth	   muscle	   layer	   following	   (A)	  Gynemesh™	   PS,	   (B)	   Restorelle,	   (C)	   Ultrapro™	   perpendicular,	   and	   (D)	   UltraPro™	  parallel	  showed	  decrease	  innervation	  density	  and	  altered	  innervation	  morphology,	  which	   was	   significantly	   different	   relative	   to	   Restorelle®,	   and	   UltraPro™	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perpendicular	   (P	  <	  0.001,	  P	  <	  0.001,	  P	  <	  0.001),	   but	  not	  UltraPro™	  H	   (P	  =	  0.260).	  Scale	  bar	  =	  100	  µm.	  ................................................................................................................................	  98	  Figure	   22.	   Theoretical	   Framework.	   VaBI	   can	   lead	   to	   a	   degenerative	   remodeling	   process,	  due	  to	  changes	  in	  the	  loading	  environment	  following	  the	  compromise	  of	  the	  active	  mechanics	  (smooth	  muscle)	  (I).	  The	  underlying	  mechanism,	  of	  which	  is	  governed	  by	  the	   potential	   for	   changes	   in	   the	   active	  mechanics	   to	   alter	   changes	   in	   the	   passive	  mechanics	  (II).	  .......................................................................................................................................	  118	  Figure	  23.	  Load-­‐distension	  curves.	  Typical	  curves	  generated	  from	  mechanically	  evaluating	  the	  VSTC	  in	  normal	  and	  LOX	  deficient	  mice	  (adapted	  from	  Alperin	  et	  al.),	  illustrating	  the	  potential	  of	  the	  mechanical	  tests	  to	  characterize	  differences	  in	  tissues	  resulting	  from	  pathologic	   conditions.	  Highlighted	   in	   the	   figure	   are	   the	  parameters	   obtained	  from	  each	  curve	   including	  maximum	  load	  (A),	  maximum	  distension	  (B),	  maximum	  stiffness	  (slope)	  (C),	  the	  energy	  absorbed	  (area	  under	  the	  curve).	  Also	  highlighted	  is	  the	  yield	  point	  or	  point	  of	  permanent	  deformation	  (boxed	  region)	  occurring	  in	  the	  tissues	   of	   LOX	   deficient	   mice	   at	   a	   lower	   load,	   as	   LOX	   deficient	   mice	   exhibit	  mechanically	  inferior	  tissues.	  .........................................................................................................	  133	  Figure	  24.	  Schematic	  of	  the	  Average	  Load-­‐distension	  Curves.	  The	  VSTC	  from	  Virgin	  (A),	  4-­‐week	  postpartum	  (B),	  and	  8-­‐week	  postpartum	  (C)	  control	  (solid	  lines)	  and	  injured	  groups	  (dotted	  lines).	  Distinct	  differences	  in	  the	  impact	  of	  injury	  on	  the	  virgin	  group	  vs	   the	  PP	  group	  can	  be	  observed.	  The	  curves	  also	  show	  increased	  stiffening	  of	   the	  VSTC	  with	  times	  PP	  in	  the	  absence	  of	  injury,	  but	  a	  lack	  of	  the	  recovery	  mechanism	  is	  observed	   in	   the	   presence	   of	   an	   injury.	   There	   was	   evidence	   of	   permanent	  deformation	   of	   the	   tissue	   occurring	   at	   31%	   less	   load	   than	   controls	   in	   the	   4-­‐week	  postpartum	  injured	  group,	  and	  at	  22%	  in	  the	  8-­‐week	  postpartum.	  This	  permanent	  deformation	  was	  appeared	   to	  be	  unique	   to	  VSTC	   in	   the	  postpartum	  group,	   as	   this	  did	  not	  occur	  in	  the	  virgin	  group.	  ..................................................................................................	  136	  Figure	  25.	  Pelvic	  Cross-­‐Sections.	  Masson’s	  trichome	  staining	  of	  paraffin	  embedded	  sections	  of	  the	  rat	  pelvic	  showing	  level	  I	  (A),	  level	  II	  (B)	  and	  level	  III	  (C)	  support.	  The	  vagina	  supportive	  tissue-­‐complex	  (VSTC)	  in	  the	  rat	  are	  indeed	  contiguous	  with	  the	  vagina,	  and	  appears	  to	  be	  most	  dense.	  .......................................................................................................	  139	  Figure	   26.	   Maximum	   Axial	   	   (E11)	   &	   Circumferential	   (E22)	   Strain.	   Strains	   in	   the	  circumferential	   direction	   were,	   on	   average,	   greater	   than	   strains	   in	   the	   axial	  direction.	  Strains	  in	  the	  axial	  direction	  did	  not	  appear	  to	  be	  a	  function	  of	  the	  stress,	  but	   a	   function	   of	   circumferential	   strains.	   Increased	   strain	   in	   the	   circumferential	  direction	   was	   associated	   with	   decreased	   strain	   (or	   a	   shortening)	   in	   the	   axial	  direction	  (Poisson	  effect).	  Smooth	  muscle	  contraction	  enables	  the	  axial	  direction	  to	  maintain	   its	   geometry,	   thus	   limiting	   the	   Poisson	   effect	   (observed	   at	   .75:1	   &	   .5:1	  loading	  regimens).	  ...............................................................................................................................	  144	  Figure	  27.	  Areal	  Strain.	  Areal	  strain	  exhibited	  an	  increasing	  trend	  following	  smooth	  muscle	  contraction,	   relative	   to	   baseline	   and	   relaxed	   conditions.	   This	   trend	   is	   even	   more	  evident	  during	   .75:1	  and	   .5:1	   loading	   regimens,	  where	   smooth	  muscle	   contraction	  resulted	   in	  a	  greater	   increase	   in	  areal	  strain,	   likely	  due	  to	  the	   increase	   in	  the	  axial	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strain	  (Figure	  26).	  	  As	  noted	  above,	  the	  observed	  increase	  in	  strain	  following	  smooth	  muscle	  contraction	  is	  likely	  associated	  with	  increased	  compliance	  and	  likely	  confers	  protection	  from	  vaginal	  injury.	  ......................................................................................................	  145	  28.	   Anisotropic	   Index.	   Smooth	   muscle	   appeared	   to	   influence	   the	   anisotropic	   index,	   as	  previously	   noted.	   There	   was	   a	   trend	   toward	   decreased	   anisotropy	   with	   smooth	  muscle	   contraction,	   relative	   to	   when	   smooth	   muscle	   was	   at	   baseline	   or	   when	  relaxed.	  This	  decrease	  in	  anisotropy	  was	  even	  more	  evident	  when	  there	  is	  increased	  discrepancy	   between	   the	   magnitudes	   of	   the	   load	   applied	   to	   each	   axes	   (evident	  during	  .75:1	  and	  .5:1	  loading	  regimens).	  This	  finding	  further	  supports	  the	  theory	  of	  smooth	  muscles	  role	  in	  stress	  distribution	  [149].	  .................................................................	  146	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NOMENCLATURE	  
	   AI	   	   anisotropic	  index	  ATFP	   	   arcus	  tendenius	  fascia	  pelvis	  AR	   	   alpha	  adreno-­‐receptor	  Ca2+	   	  	  	   calcium	  CCh	   	   (2-­‐[(Aminocarbonyl)oxy]-­‐N,N,N-­‐trimethylethanaminium	  chloride	  ECM	  	   	   extracellular	  matrix	  	  EC50	   	   half	  maximum	  effective	  concentration	  EFS	   	   electrical	  field	  stimulation	  EGTA	   	   ethylene	  glycol-­‐bis(2-­‐aminoethylether)-­‐N,N,N’,N’-­‐tetraacetic	  acid	  EMAX	   	   maximum	  effective	  response	  FDA	   	   Food	  and	  Drug	  Administration	  (US)	  GAGS	   	   glycoaminoglycans	   	  K+	   	   potassium	  KCl	   	   potassium	  chloride	  	   NaCl	   	   	  sodium	  chloride	  MgC12	  	   magnesium	  chloride	  hexahydrate	  MR	   	   muscarinic	  receptor	  MTM	  	   	   maximum	  tensile	  modulus	  KH2PO4	   potassium	  dihydrogen	  phosphate	  NaHCO3	   sodium	  bicarbonate	  NANC	   	   non-­‐adrenergic	  non-­‐cholinergic	  NHP	   	   non-­‐human	  primate	  IR	   	   immunoreactive	  	  LOX	   	   lysyl	  oxidase	  LOXL1	  	   lysyl	  oxidase	  like-­‐1	  MMPs	   	   matrix	  metalloproteinases	  PE	   	   phenylephrine	  PFDs	   	   pelvic	  floor	  dysfunctions	  PGs	   	   proteoglycans	  PGP	  9.5	   protein	  gene	  product	  9.5	  POP	   	   pelvic	  organ	  prolapse	  POP-­‐Q	  	   pelvic	  organ	  prolapse	  quantification	  	  QOL	   	   quality	  of	  life	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SM	   	   smooth	  muscle	  SMCs	   	   smooth	  muscle	  cells	  TH	   	   tyrosine	  hydroxylase	  TNF-­‐α	  	   tissue	  necrosis	  factor	  alpha	  USL	   	   uterosacral	  ligament	  VaBI	   	   vaginal	  birth	  injury	  VAChT	  	   vesicular	  acetylcholine	  transporter	  VD	   	   vaginal	  delivery	  VaSM	   	   vaginal	  smooth	  muscle	  VSTC	  	   	   vaginal	  supportive	  tissue	  complex	  	  	  	  	  	  	  	  	  	  	  	  
1.0	   INTRODUCTION	  
This	   introduction	   begins	   with	   a	   general	   overview	   of	   a	   condition	   known	   as	   pelvic	   organ	  prolapse	   (POP),	   including	   its	   symptoms,	   risk	   factors,	   and	   treatment	   methods,	   which	  conveys	  the	  severity	  and	  prevalence	  of	  this	  condition.	  Also	  highlighted	  are	  the	  limitations	  associated	  with	  current	  methods	  for	  symptom	  management	  of	  POP	  that	  has	  prompted	  the	  need	   for	   studies	   aimed	   at	   elucidating	   its	   etiology	   in	   order	   to	   develop	   better	   treatment	  options.	  Following	  is	  a	  discussion	  of	  vaginal	  birth	  injury	  (VaBI),	  shown	  recently	  to	  have	  the	  greatest	   association	   with	   the	   development	   of	   POP.	   Specifically	   discussed,	   are	   the	  inconclusive	   associations,	   to	   date,	   of	   how	   VaBI	   promotes	   long-­‐term	   degeneration	   of	   key	  pelvic	   supportive	   structures.	   The	   vagina,	   which	   has	   recently	   emerged	   as	   a	   key	   pelvic	  supportive	  structure,	  is	  therefore	  introduced,	  with	  a	  description	  of	  its	  anatomy,	  in	  addition	  to	  arguments	  supporting	  the	  need	  for	  studies	  evaluating	  how	  VaBI	  may	  affect	   the	  vagina,	  and	   in	   turn,	   pelvic	   organ	   support.	   Further	   support	   to	   these	   assertions	   is	   provided	   as	  summaries	   of	   experimental	  methods	   and	   evidence	   of	   changes	   in	   the	   anatomy,	   structure	  and	  constituents	  of	  the	  vagina,	  in	  women	  with	  POP,	  relative	  to	  the	  possible	  onset	  of	  these	  changes	  occurring	  as	  a	  result	  of	  VaBI.	  However,	  to	  date,	  very	  few	  studies	  have	  investigated,	  if	   and	  how,	  VaBI	   impairs	  vaginal	   smooth	  muscle	   (VaSM),	  as	   it	   is	  a	   common	  phenomenon	  that	   has	   the	   potential	   to	   alter	   vaginal	   supportive	   function.	   Hence,	   this	   introduction	  concludes	  with	   the	  motivation	  and	   specific	   aims	  of	   this	  work,	  which	   is	   to	   investigate	   the	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impact	  of	  VaBI	  on	  VaSM,	  and	  the	  ability	  of	  current	  treatment	  methods	  (specifically,	  surgical	  mesh	  repair)	  to	  aid	  in	  reversing	  those	  changes.	  
1.1 PELVIC	  ORGAN	  PROLAPSE	  (POP)	  
1.1.1 Symptoms	  and	  Incidence	  
Pelvic	  organ	  prolapse	   (POP)	   is	  a	  pelvic	   floor	  dysfunction	  characterized	  by	   the	  protrusion	  and-­‐or	  eversion	  of	   the	  pelvic	  organs	   (bladder,	  uterus,	  and	  rectum)	   from	  their	  anatomical	  position,	   into	   the	   vaginal	   canal	   (Figure	   1).	   Women	   presenting	   with	   POP	   commonly	  experience	   difficulty	   defecating	   and	   urinating,	   in	   addition	   to	   varying	   levels	   of	   sexual	  dysfunction	   based	   on	   the	   anatomical	   site	   of	   the	   prolapse	   [1]–[3].	   This	   pelvic	   floor	  condition,	  which	  is	  highly	  associated	  with	  decreased	  quality	  of	   life	  (QOL)	  and	  depression,	  affects	  millions	  of	  women	  in	  the	  United	  States	  and	  worldwide	  [4],	  [5].	  Up	  to	  50%	  of	  women,	  over	  age	  50	  are	  understood	  to	  exhibit	  some	  degree	  of	  POP,	  the	  degree	  of	  which,	  is	  rated	  in	  stages	   that	   are	   defined	   by	   the	   POP	   Quantification	   Score	   (POP-­‐Q	   Score)	   [6].	   The	   scoring	  begins	   at	   stage	   zero,	   and	   increases	   with	   increasing	   level	   of	   decent	   of	   the	   anterior	   wall,	  posterior	  wall,	  or	  the	  vaginal	  apex,	  in	  relation	  to	  the	  hymen.	  Approximately	  40%	  of	  women	  with	   POP	   are	   asymptomatic	   and	   experience	  minimal	   progression,	   but	   women	  with	   POP	  beyond	  stage	  II	  typically	  require	  intervention	  [7],	  [8].	  As	  reported	  by	  Wu	  et	  al.,	  the	  lifetime	  risk	  of	  a	  woman	  undergoing	  a	  single	  operation	  for	  POP,	  by	  the	  age	  of	  80	  years,	  is	  12.6%	  [9],	  [10].	   This	   cohort	   of	  woman	  with	   symptomatic	   POP	   requiring	   intervention	   is	   expected	   to	  increase	   to	   56%	   within	   the	   next	   40	   years	   due	   to	   the	   rise	   in	   the	   population	   of	   elderly	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women,	   which	   is	   the	   fastest	   growing	   population	   segment	   in	   the	   United	   States	   [9].	   This	  increase	   is	   expected	   to	   pose	   a	   substantial	   health	   and	   economic	   burden	   due	   to	   increased	  hospitalization,	   a	   factor	  which	  accounts	   for	  over	  70%	  of	   the	  direct	   annual,	   and	   currently	  exceeds	  $1	  billion	  in	  the	  United	  States	  [11].	  
Figure	  1.	  Schematic	  Representation	  of	  the	  Pelvic	  Organs.	  The	  role	  of	  the	  pelvic	  floor	  is	  to	  support	  the	  pelvic	  organs.	  Failure	  to	  support	  the	  pelvic	  organs	  can	  result	  in	  pelvic	  organ	  prolapse	   (POP),	   a	   condition	   characterized	   by	   the	   decent	   of	   the	   pelvic	   organs	   into	   the	  vaginal	  canal.	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1.1.2 Treatment	  Methods	  
Surgical	   procedures	   performed	   for	   symptomatic	   management,	   generally	   involve	  replacement	   or	   reinforcement	   of	   weakened	   fibromuscular	   supports	   to	   restore	   the	  structural	   anatomy	   of	   the	   supported	   pelvic	   organs,	   commonly	   referred	   to	   as	   ligaments	  
(Figure	  2).	  
	  
Figure	  2.	  Fibromuscular	  Supportive	  Structures.	  The	  vagina	  is	  supported	  by	  connective	  tissues	   and	   ligamentous	   attachments	   through	   anchoring	   to	   muscle	   or	   bony	   structures.	  Women	  with	  POP	  exhibit	  a	  weakening	  of	  these	  structures,	  for	  which	  synthetic	  mesh	  may	  be	  surgically	  implanted,	  as	  a	  means	  to	  augment	  support.	  	  With	  the	  focus	  being	  anatomical	  outcomes,	  non-­‐absorbable	  synthetic	  polypropylene	  mesh	  use	   for	   surgical	   repair	   was	   widely	   adopted	   by	   clinicians	   because	   of	   the	   long-­‐term	  anatomical	   support	   that	   it	   provides	   to	   the	   vagina	   following	   failure	   of	   its	   fibromuscular	  supports	  [12].	  Additionally,	  with	  patients	  presenting	  with	  less	  symptoms	  during	  follow-­‐up	  visits,	  synthetic	  mesh	  use	  gradually	   increased	  relative	  to	  other	  treatment	  modalities	  [13].	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Synthetic	   propylene	   mesh	   use	   has	   continued	   to	   be	   widely	   used	   due	   to	   the	   ease	   of	  acquisition	   relative	   to	   biologic	   grafts.	   In	   2010,	   over	   100,000	   prolapse	   surgeries	   were	  performed	  which	   involved	   the	   use	   of	   polypropylene	  mesh,	   accounting	   for	   30%	   of	   cases	  [14].	  With	  increasing	  mesh	  use,	  the	  incidence	  of	  complications	  including	  exposure	  (Figure	  
3),	   erosion,	   rejection,	   pain,	   and	   infection	   became	   highly	   evident,	   but	   the	   etiology	   of	  complications	  eludes	  many	  clinicians	  [15]–[17].	  
Figure	  3.	  Pelvic	  Organ	  Prolapse	  (POP)	  Mesh	  for	  Pelvic	  Reconstruction.	  One	  of	  common	  treatment	  methods	   of	   for	   POP	   symptom	  management	   involves	   the	   placement	   of	   a	   graft,	  similar	  to	  one	  in	  this	  figure,	  to	  replace	  the	  weakened	  supportive	  tissues.	  The	  use	  of	  native	  tissues	   grafts	   or	   biologics	   is	   associated	  with	   high	   failure	   rates,	   while	   synthetic	   grafts	   or	  meshes	   which	   provide	   more	   long-­‐term	   anatomical	   support	   are	   associated	   with	  complications	  including	  erosion.	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Possible	  factors	  reported	  to	  contribute	  to	  complications	  include	  the	  host	  immune	  response,	  surgical	   technique,	   and	  mesh	   properties	   [18],	   [19].	   Route	   of	   surgical	   procedure	   can	   also	  influence	   outcomes,	   with	   abdominal	   procedures	   proving	   to	   be	   associated	   with	   less	  complications	  relative	  to	  transvaginal	  procedures	  [17],	  [20].	  However,	  rigorous	  pre-­‐market	  evaluation	   of	   these	   factors	   only	   began	   following	   a	   new	  mandate	   by	   the	   Food	   and	   Drug	  Administration	   (FDA),	   as	   these	  meshes	  were	   previously	   approved	   using	   a	   510K	   process	  	  [21],	  [22].	  Longitudinal	  studies	  estimate	  that	  30%	  of	  surgery	  for	  POP	  will	  result	  in	  failure,	  which	   will	   require	   a	   repeat	   surgery,	   and	   that	   10	   -­‐	   25%	   of	   surgeries	   will	   result	   in	  complications	  with	  a	  majority	  requiring	  mesh	  excision	  [6],	  [23]–[25].	  In	  order	  to	  improve	  these	   outcomes	   and	   develop	   improved	   treatment	   and	   preventative	   strategies,	   studies	  aimed	   at	   further	   understanding	   key	   pathologic	   factors	   of	   POP	   are	   necessary.	   The	  development	   of	   therapeutics	   directed	   toward	   those	   factors	   could	   potentially	   obviate	   the	  need	  for	  surgery	  and	  also	  significantly	  improve	  surgical	  outcomes.	  
1.1.3 Risk	  Factors	  
	  In	  an	  effort	  to	  develop	  preventative	  and	  improved	  treatment	  strategies	  for	  POP,	  genetics,	  obesity,	   age,	   race,	   and	   parity	   have	   been	   identified	   as	   important	   risk	   factors	   for	   the	  development	  of	  POP	  (Figure	   4)	   [26],	   [27].	  Parity,	  which	   refers	   to	   the	  number	  of	   times	  a	  woman	   has	   given	   birth,	   has	   been	   independently	   shown	   to	   have	   the	   greatest	   association	  with	  the	  development	  of	  POP	  [6],	  [28][29].	  In	  a	  study	  evaluating	  siblings,	  Buchsbaum	  et	  al.	  reported	  no	   indication	  of	   prolapse	   in	  82%	  of	  nulliparous	  women,	   compared	   to	  42.6%	  of	  parous	  women	  [30].	  Subsequent	  studies	  have	  shown	  that	  parity	  capable	  of	  increasing	  one’s	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risk	  by	  over	  25%,	  and	  doubling	  with	  each	  subsequent	  delivery.	  This	   is	  not	   surprising,	  as	  vaginal	  delivery	   is	   considered	  one	  of	   the	  most	  mechanically	   taxing	  events	   that	   the	  pelvic	  floor	  undergoes.	  As	  the	  fetus	  passes	  through	  the	  vaginal	  canal,	  which	  must	  typically	  expand	  to	  4	  to	  5	  times	  its	  original	  diameter,	  this	  increases	  the	  risk	  of	  injury	  to	  the	  pelvic	  supportive	  structures.	  More	  detailed	  studies	  show	  that	  women	  undergoing	  operative	  vaginal	  delivery	  with	  perineal	  lacerations	  are	  at	  an	  even	  greater	  risk	  of	  developing	  POP	  [31]–[33].	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However,	  what	  has	  been	  proven	  to	  be	  a	  major	  factor	  for	  the	  development	  of	  POP	  is	  the	  duration	  of	  the	  second	  stage	  of	  labor,	  an	  approximately	  90	  minute	  period.	  This	  period	  begins	  when	  the	  fetal	  head	  enters	  the	  vaginal	  canal,	  and	  ends	  when	  it	  passes	  the	  introitus	  [34],	  [35].	  A	  prolong	  second	  stage	  of	  labor,	  which	  results	  in	  an	  extended	  period	  of	  elevated	  pressure,	  is	  usually	  positively	  correlated	  with	  the	  use	  of	  operative	  devices	  used	  to	  expedite	  the	  process,	  but	  their	  use	  has	  also	  been	  associated	  with	  the	  development	  of	  POP	  [36],	  [37].	  Interestingly,	  studies	  of	  home	  labors,	  which	  typically	  exclude	  the	  use	  of	  operative	  devices	  also	  show	  an	  association	  between	  a	  prolong	  second	  stage	  of	  labor	  and	  the	  development	  of	  POP	   suggesting	   that	   inadequate	  maternal	   adaptation	   to	   accommodate	   the	  passage	  of	   the	  fetus	  may	  be	   the	  driving	   the	  association	  [38][39].	  The	  resulting	  extended	  duration	  of	   the	  fetus	   in	  the	  vaginal	  canal	  has	  been	  proposed	  to	   lead	  to	   injury	  to	  the	  nerves,	  muscles,	  and	  connective	  tissue	  attachments,	  which	  may	  in	  turn	  lead	  to	  the	  development	  of	  POP	  decades	  later.	  As	  discussed	  below,	  the	  impact	  of	  vaginal	  birth	  injury	  (VaBI)	  on	  these	  structures	  has	  been	   inconclusive,	  but	  nevertheless,	  essential,	  as	  they	  have	  provided	  a	   foundation	  for	  the	  studies	  outlined	  in	  this	  work.	  	  	  
1.2 IMPACT	  OF	  VAGINAL	  DELIVERY	  ON	  THE	  PELVIC	  FLOOR	  STRUCTURES	  
1.2.1 Pudendal	  Nerves	  
The	  pudendal	  nerves	  supplies	  most	  of	  the	  anatomic	  structures	  responsible	  for	  maintaining	  pelvic	   support	   and	   continence	   –	   including	   the	   striated	  muscles	   in	   the	   vagina,	   perineum,	  anus,	   and	   the	   levator	   ani	   muscles	   (Figure	   5).	   	   Injury	   to	   the	   pudendal	   nerves	   has	   been	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linked	   to	   many	   PFDs	   including	   POP[40]–[42].	   Rates	   of	   nerve	   injury	   are	   known	   to	   be	  increased	   with	   forceps	   delivery,	   multiparity,	   longer	   second-­‐stage	   labor,	   third-­‐degree	  perineal	  tear,	  and	  large	  fetal	  size.	  These	  findings	  were	  supported	  by	  a	  study	  by	  Allen	  et	  al.,	  who	   showed	   pudendal	   nerve	   denervation	   in	   80%	  of	  women	   following	   their	   first	   vaginal	  delivery	  [32].	  In	  the	  study,	  the	  risk	  factors	  also	  included	  a	  prolonged	  active	  second	  stage	  of	  labor	   and	   heavier	   babies.	   Early	   studies	   by	   Snooks	   et	   al.	   reported	   partially	   reversible	  pudendal	  nerve	  injury	  occurring	  commonly	  with	  vaginal	  birth	  [43].	  Partial	  reinnervation	  of	  surrounding	   nerves	   can	   indeed	   occur,	   but	   muscle	   function	   is	   usually	   permanently	   lost.	  They	   subsequently	   showed	   that	   partial	   denervation	   in	   some	   structures	   do	   persist	   and	  worsens	  with	   the	   passage	   of	   time	   from	   delivery,	   suggesting	   a	   higher	   risk	   of	   pelvic	   floor	  dysfunctions	   (PFDs)	   [44].	   Clinical	   studies	   have	   corroborated	   these	   results,	   showing	  denervation,	  following	  a	  prolong	  second	  stage	  of	  labor,	  which	  has	  been	  associated	  with	  the	  development	   of	   many	   PFDs,	   a	   finding	   that	   is	   not	   surprising	   as	   evidence	   of	   neuropathy	  leading	  to	  PFDs	  has	  also	  been	  shown	  in	  women	  with	  chronic	  constipation	  associated	  with	  increased	  pressure	  on	  the	  pelvic	  floor	  [32],	  [45],	  [46].	  Elective	  cesarean	  but	  not	  caesarean	  performed	   after	   the	   onset	   of	   labor	   appears	   to	   be	   protective	   against	   denervation,	   which	  would	   suggest	   that	   the	  presence	  of	   the	   fetus	   in	   the	  vaginal	   canal	   for	   an	   extended	  period	  may	  be	  inducing	  the	  reported	  nerve	  compression	  and	  transection	  [47][48].	  These	  studies	  also	   suggest	   that	   inadequate	   maternal	   adaptation	   during	   pregnancy	   may,	   therefore	  increase	   the	   risk	   of	   partial	   denervation	   of	   the	   supporting	   pelvic	   structures.	   To	   date,	  denervation	  in	  the	  key	  pelvic	  supportive	  structures	  does	  not	  appear	  to	  be	  predictive	  of	  all	  cases	  of	  POP	  development.	  More	  studies	  looking	  at	  the	  impact	  to	  the	  hypogastric	  and	  pelvic	  nerves	  are	  also	  warranted,	  as	  innervation	  integrity	  of	  the	  pudendal	  nerves	  may	  be	  a	  poor	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indicator	  of	   the	   integrity	  of	   the	  hypogastric	  and	  pelvic	  nerves.	  The	   impact	  of	  VaBI	  on	   the	  pudendal	   nerves,	   but	   not	   the	   hypogastric	   or	   pelvic	   nerves	   that	   carry	   autonomic	   nerves	  (sympathetic	   and	   parasympathetic)	   innervating	   the	   vagina	   has	   been	   more	   rigorously	  evaluated	   due	   to	   the	   ease	   of	   in-­‐vivo	   analysis	   of	   striated	   vs	   smooth	   muscle	   innervation	  function.	  	  It	  is	  also	  likely	  that	  a	  loss	  of	  pudendal	  nerve	  innervation	  to	  the	  striated	  muscles,	  as	  well	  as	  hypogastric	  and	  pelvic	  nerve	  innervation	  of	  the	  smooth	  muscle	  may	  prove	  more	  predictive	  of	  the	  onset	  of	  POP.	  Additionally,	  due	  to	  most	  studies’	  use	  of	  retrospective	  data,	  it	  remains	  to	  be	  clearly	  proven	  whether	  the	  changes	  in	  innervation	  are	  pathogenic	  factors	  or	  the	  result	  of	  POP.	  
	  
Figure	  5.	  Innervation	  of	  the	  Pelvic	  Organs.	  Innervation	  of	  the	  pelvic	  organs	  is	  provided	  by	   the	   hypogastric,	   pelvic,	   and	   pudendal	   nerves.	   The	   pudendal	   nerve	   innervates	   the	  striated	  muscle	   sphincters	   of	   the	  bladder,	   vagina,	   and	   rectum,	  while	   the	  hypogastric	   and	  pelvic	   nerve	   provides	   region-­‐specific	   innervation	   to	   the	   smooth	   muscle	   within	   these	  organs.	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1.2.2 	  Levator	  Ani	  Muscles	  
Of	   the	   key	   pelvic	   supportive	   structures,	   the	   levator	   ani	  muscles	   have	   received	   the	  most	  focus	  due	  to	  their	  major	  role	   in	  pelvic	  organ	  support,	  and	  their	  high	  risk	  of	   injury	  during	  vaginal	  delivery	  [18],	  [33],	  [49]–[51].	  	  




LAVATOR ANI MUSCLES 
-  PUBOCOCCYGEUS 
-  PUBORECTALIS 
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Trauma	  to	  the	  levator	  ani	  may	  include	  detachment	  of	  individual	  muscle	  components	  from	  their	   insertion	   points	   along	   the	   pelvic	   sidewalls,	   avulsion,	   or	   denervation	   resulting	   in	  generalized	  atrophy.	  Peschers’	  et	  al.	   evaluation	  of	   levator	  ani	  muscle	   function	  before	  and	  after	  childbirth	  showed	  evidence	  of	  muscle	  strength	  reduction	  3-­‐8	  days	   following	  vaginal	  birth,	  but	  muscle	  strength	  returned	  to	  normal	  values	  within	  two	  months	  for	  most	  women	  [52].	   To	   determine	   if	   impaired	   levator	   ani	   muscle	   strength	   was	   associated	   with	   POP,	  DeLancey	   et	   al	   in	   a	   case	   control	   study,	   compared	  women	  with	   prolapse	   to	  women	  with	  normal	  pelvic	  support	  [53].	  Women	  with	  prolapse	  were	  more	  likely	  (55%	  vs	  16%)	  to	  have	  levator	   ani	   defects	   and	   to	   generate	   less	   force	   during	   maximum	   levator	   ani	   contraction.	  However,	  Diezt	   et	   al.	   showed	  no	  evidence	  of	   levator	  ani	   avulsion	   in	  76%	  of	  women	  with	  POP	  [54].	  The	  authors	  concluded	  that	  while	  childbirth	  is	  associated	  with	  POP,	  it	  is	  unclear	  whether	  it	  is	  due	  to	  delivery-­‐related	  direct	  levator	  ani	  trauma.	  These	  findings	  support	  the	  idea	  that	  although	  a	  levator	  ani	  defect	  is	  characteristic	  of	  some	  cases	  of	  POP,	  ultimate	  onset	  may	  be	  a	  result	  of	  a	  levator	  ani	  defect	  in	  combination	  with	  another	  phenomenon	  perhaps	  occurring	   during	   childbirth.	   This	   theory	   is	   further	   supported	   by	   a	  more	   recent	   study	   by	  Berger	  et	  al.,	  under	  the	  guidance	  of	  DeLancey,	  which	  showed	  the	  capability	  of	   levator	  ani	  defect	   (LAD)	   scores	   to	   be	   predictive	   of	   POP	   occurrence	   in	   as	   many	   as	   70%	   of	   women	  presenting	  with	  symptoms,	  but	   it	  not	  predictive	  of	  the	  stage	  of	  POP	  [55].	  The	  pelvic	  floor	  may	  have	  some	  degree	  of	  redundancy	   in	   its	  support	  system,	  which	  would	  allow	  a	  partial	  loss	  of	  function	  in	  the	  levator	  ani	  muscles	  to	  be	  compensated	  for	  by	  other	  pelvic	  supportive	  structures.	   VaBI	   induced	   levator	   trauma,	   in	   addition	   to	   defects	   in	   the	   vagina	   supportive	  tissue	   complex	   (VSTC),	   may	   prove	   to	   be	   more	   predictive	   of	   the	   eventual	   eversion	   and	  protrusion	  of	  the	  pelvic	  organs	  into	  the	  vaginal	  canal.	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1.2.3 	  Vaginal	  Supportive	  Tissue	  Complex	  (VSTC)	  
However,	  to	  date,	  there	  has	  been	  a	  paucity	  of	  studies	  evaluating	  the	  impact	  of	  VaBI	  on	  the	  VSTC	  (endopelvic	  fascia	  (pubocervical	  and	  rectovaginal	  fascia),	  the	  cardinal	  ligaments	  (CL),	  uterosacral	   ligaments	  (USL),	  and	  arcus	   tendineus	   fascia	  pelvis	  (ATFP))	  (Figure	   2).	  These	  supportive	  structures	  have	  been	  formerly	  defined	  by	  DeLancey	  based	  on	  level	  of	  regional	  vaginal	  support	  [56].	  As	  defined,	  the	  uterosacral	  and	  cardinal	  ligaments,	  which	  are	  attached	  to	  the	  apical	  portion	  of	  the	  vagina,	  encompasses	  Level	  I	  support.	  The	  uterosacral	  ligament	  bridges	   the	  upper	  vagina	  and	   the	   sacrum,	  providing	  vertical	   support	   to	   the	  vaginal	  apex,	  while	   the	   cardinal	   ligaments	   attaches	   the	  upper	  vagina	   to	   the	  pelvic	   sidewalls,	   providing	  lateral	  support.	  The	  endopelvic	  fascia	  and	  ATFP,	  which	  are	  attached	  to	  the	  middle	  vagina,	  provide	   level	   II	   support.	   The	   endopelvic	   fascia	   is	   laterally	   attached	   to	   the	   vagina	   and	  condenses	   into	   the	   ATFP,	   which	   is	   composed	   of	   dense	   connective	   tissues.	   The	   ATFP	  functions	   to	   laterally	   anchor	   the	   endopelvic	   fascia	   to	   the	   levator	   ani	  muscles,	   which	   are	  attached	  to	  the	  pelvic	  sidewalls.	  With	  lateral	  support	  provided	  by	  the	  endopelvic	  fascia	  and	  the	  ATFP,	  this	  aids	  in	  maintaining	  the	  vagina	  in	  a	  suspended	  position,	  which	  in	  turn	  allows	  it	   to	   provide	   anterior	   support	   to	   the	   bladder	   and	   posterior	   support	   to	   the	   rectum.	   The	  endopelvic	  fascia,	  which	  is	  also	  attached	  to	  the	  lower	  one	  third	  of	  the	  vagina,	  provides	  level	  III	   support.	  However,	   at	   this	   level,	   the	   rectovaginal	   fascia,	  which	   is	   fused	   to	   the	   perineal	  body,	   inserts	   at	   the	   pelvic	   sidewall,	   hence	   also	   aiding	   in	   vaginal	   suspension.	   The	  uteorosacral	   ligament,	   which	   comprises	   level	   I	   or	   apical	   support,	   decreased	   resilience	  following	  vaginal	  delivery	   in	  women,	  has	  been	  associated	  with	  apical	  decent.	  Site-­‐specific	  breaks,	   weakening,	   and	   detachment	   of	   endopelvic	   fascia	   from	   the	   ATFP	   have	   been	   well	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documented	   in	   patients	   with	   POP,	   and	   are	   the	   main	   restorative	   targets	   of	   pelvic	  reconstructive	   surgeries	   [57]–[60].	   However,	   it	   remains	   to	   be	   shown	   how	   these	   site-­‐specific	  defects	  in	  the	  VSTC	  occur,	  and	  if	  they	  are	  indeed	  a	  result	  of	  VaBI.	  It	  has	  been	  well	  established	  that	  these	  structures	  undergo	  significant	  remodeling	  during	  pregnancy,	  to	  limit	  injury	   during	   delivery	   [61]–[63].	   Evidence	   of	   these	   adaptations	   suggests	   that	   they	   are	  essential	   for	   a	   successful	   delivery,	   and	   that	   prevention	   of	   injury	   to	   these	   structures	   are	  necessary	   for	   full	   restoration	   of	   vaginal	   support,	   postpartum.	   Hence,	   there	   is	   a	   need	   to	  further	   investigate	   the	   impact	   of	   VaBI	   on	   the	   vagina,	   as	   the	   vagina	   is	   likely	   subjected	   to	  large	   magnitudes	   of	   force,	   prior	   to	   transmission	   of	   those	   forces	   to	   the	   paravaginal	  attachments.	  Highly	  understudied,	  as	  shown,	  the	  vagina	  serves	  as	  a	  supportive	  structure	  in	  the	  pelvic	  floor.	  Hence	  impaired	  functionality	  could	  potentially	  lead	  to	  the	  development	  of	  POP.	  	  
1.3 VAGINAL	  STRUCTURAL	  ANATOMY	  
1.3.1 Anatomical	  Layers	  
The	   vagina	   is	  made	   up	   of	   several	   distinct	   layers	   (epithelium,	   subepithelium,	  muscularis,	  and	   adventitia),	   which	   contribute	   to	   its	   ability	   to	   serve	   as	   a	   pelvic	   supportive	   structure	  
(Figure	   7).	   The	   inner	   lumen	   of	   the	   vagina	   is	   a	   non-­‐cornified	   stratified	   squamous	  epithelium.	  This	  structure	  is	  layers	  of	  cells	  deep	  with	  an	  abundance	  of	  estrogen	  receptors	  which	   undergo	   cyclical	   changes	   in	   response	   to	   the	   level	   of	   circulating	   hormones,	   for	  example,	   thinning	  when	  estrogen	   levels	   are	   low	  and	   thickening	  when	  baseline	   levels	   are	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restored	  [64],	   [65].	  The	  thickness	  of	   the	  epithelium	  also	  naturally	  varies,	  along	  its	   length,	  with	   increasing	   thickness	   from	   proximal	   to	   distal.	   This	   results	   in	   the	   presence	   of	  longitudinal	  rugae	  that	  run	  the	  entire	  length	  of	  the	  vagina,	  becoming	  more	  prominent	  at	  the	  narrow	   introitus.	   Another	   possible	   source	   of	   the	   rugae	   is	   from	   underlying	   connective	  tissues	  in	  the	  subepithelium,	  and	  hence	  the	  presence	  or	  lack	  of	  can	  serve	  as	  an	  indicator	  of	  vaginal	   structural	   integrity.	   This	   dense	   connective	   tissue	   layer	   is	   the	  major	   resistance	   to	  forces	  applied	  to	  the	  vaginal	  wall.	  As	  alluded	  to	  in	  the	  preceding	  paragraphs,	  changes	  along	  the	  vertical	  axis	  also	  includes	  the	  thickness	  of	  the	  subepithelial	  layer,	  which	  is	  much	  thicker	  in	  the	  proximal	  vagina	  than	  it	  is	  in	  the	  distal	  vagina.	  Also	  embedded	  within	  this	  layer,	  are	  nerve	   plexuses	   as	   well	   as	   blood	   vessels.	   Immediately	   beneath	   the	   subepithelium	   is	   the	  vaginal	   muscularis,	   a	   fibromuscular	   layer,	   which	   contains	   inner	   circular	   and	   outer	  longitudinal	   smooth	   muscles	   interspersed	   with	   fibrous	   connective	   tissue,	   particularly	  elastin.	  Smooth	  muscle	  plays	  an	  essential	  role	  in	  active	  vaginal	  mechanics,	  and	  also	  aids	  in	  restoring	   the	  vaginal	  muscularis	   and	   the	   folding	   rugae.	  The	  adventitia,	   the	  most	   external	  elastic	  layer	  of	  the	  vagina,	  is	  shared	  with	  the	  bladder	  anteriorly,	  and	  the	  rectum	  posteriorly.	  The	   adventitia	   consists	   of	   smooth	   muscle	   bundles	   interspersed	   with	   loose	   connective	  tissues,	   nerves,	   and	   blood	   vessels.	   Overall,	   the	   thickness	   of	   these	   layers	   and	   the	  maintenance	   of	   their	   constituents	   are	   essential	   for	   maintaining	   vaginal	   mechanical	  integrity,	  as	  each	  layer	  unique	  mechanics	  is	  essential	  for	  vaginal	  function	  [66].	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Figure	  7.	  Cross	  Section	  through	  the	  Vagina.	  Shown	  are	  the	  layers	  of	  the	  vagina,	  which	  include	  the	  epithelium,	  subepithelium,	  muscularis,	  and	  the	  adventitia.	  
1.3.2 Mechanical	  Constituents	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Figure	   8.	   Mechanical	   Constituents	   of	   the	   Vagina.	   The	   vaginal	   layers	   contain	   collagen	  (red),	   elastin	   (green	   dots),	   and	   smooth	   muscle	   (green	   lines	   –	   actinin	   striations),	   which	  collectively,	  are	  the	  main	  contributors	  to	  the	  mechanical	  properties	  of	  the	  vagina.	  
	  Collagen	   provides	   the	   tensile	   strength	   and	   its	   type,	   ratio,	   density,	   and	   degree	   of	  crosslinking	   are	   important	   for	   the	   maintenance	   of	   the	   mechanical	   properties	   of	   the	  extracellular	  matrix,	   which	   is	   tissue-­‐specific.	   The	   vagina	   is	   comprised	   of	   mostly	   fibrillar	  collagens	   (I:	   III:	   V),	   with	   a	   small	   amount	   of	   non-­‐collagenous	   glycoproteins,	   elastin,	  hyaluronan	  and	  proteoglycans	  [67]–[69].	  Collagen	  III	  is	  the	  predominant	  fibrillar	  collagen	  in	  the	  vagina,	  relative	  to	  stiffer	  organs	  like	  the	  aorta,	  which	  have	  a	  greater	  ratio	  of	  collagen	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I:III	  [67].	  The	  association	  of	  collagen	  I	  and	  collagen	  III	  with	  collagen	  V,	  is	  known	  to	  result	  in	  fibrils	  with	  controlled	  diameters,	  the	  level	  of	  which	  is	  important	  for	  the	  maintenance	  of	  the	  characteristic	  mechanics	  of	  the	  organ	  [70]–[72].	  As	  demonstrated	  by	  Niyibzi	  and	  others,	  an	  increase	  in	  collagen	  III	  and	  V	  decreases	  the	  mechanical	  strength	  of	  the	  tissue	  by	  decreasing	  fiber	  size	  [73].	  The	  degree	  of	  crosslinking	  of	  the	  collagen	  fibers	  following	  secretion	  into	  the	  extracellular	   space,	   also	   influences	   the	   mechanical	   properties	   of	   the	   resulting	   organ.	  Another	  important	  mechanical	  component	  of	  the	  vagina	  is	  elastin,	  which	  affords	  resiliency	  through	   its	   ability	   to	   recoil,	   returning	   the	   collagen	   fibers	   to	   their	   original	   configuration	  post-­‐loading.	   Similar	   to	   collagen,	   elastin	   is	   present	   in	   the	   extracellular	   space	   in	   both	   an	  immature	  and	  mature	  form,	  with	  maturity	  and	  mechanical	  integrity	  typically	  defined	  by	  the	  degree	  of	  crosslinking.	  The	  length	  and	  amount	  of	  elastin	  could	  also	  change	  the	  mechanics	  of	  the	   vagina,	   and	   is	   associated	   with	   changes	   in	   the	   phenotype	   of	   smooth	   muscle,	   which	  synthesizes	  elastin	  [74],	  [75].	  A	  lost	  of	  vaginal	  elastin	  can	  result	  in	  widening	  of	  the	  vaginal	  opening,	   which	   in	   turn,	   could	   alter	   the	   loading	   conditions	   of	   the	   attached	   connective	  tissues,	  and	   in	   turn	  pelvic	  organ	  support.	  The	  vaginal	  wall	  also	  contains	  smooth	  muscles,	  which	  provide	  active	  mechanics	  to	  the	  vaginal	  wall,	  allowing	  the	  vagina	  to	  rapidly	  change	  its	  diameter	  via	  contraction	  and	  relaxation,	  and	  maintain	  vaginal	  tone.	  The	  thickness	  of	  the	  inner	  circular	  and	  outer	  longitudinal	  smooth	  muscle	  layers	  vary	  along	  its	  length,	  with	  the	  proximal	  vagina	  containing	  denser	  and	  thicker	  muscle	  structures	  relative	  to	  the	  distal	  end,	  although	   the	   functional	   significance	   remains	   uncertain.	   As	  mentioned,	   these	   components	  are	  essential	  and	  their	  alteration	  are	  associated	  with	  pathologic	  conditions	  in	  many	  organs	  including	  the	  vagina.	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1.3.3 Innervations	  
Embryologically,	  the	  vagina	  originates	  from	  the	  vertical	  fusion	  of	  the	  ascending	  sinovaginal	  bulb	  and	  the	  descending	  mullerian	  system,	  thus	  exhibiting	  gross	  structural	  and	  functional	  differences	   between	   the	   upper	   two-­‐thirds	   and	   the	   lower	   one-­‐third.	   As	   an	   example,	  innervation	   of	   the	   upper	   two-­‐thirds	   of	   the	   vagina	   is	   supplied	   by	   autonomic	   nerve	   fibers	  from	  the	   inferior	  hypogastric	  plexus	  (uterovaginal	  plexus)	  while	   innervation	  of	   the	   lower	  one-­‐third	   is	   supplied	   by	   both	   autonomic	   and	   somatic	   nerve	   fibers	   from	   the	   pelvic	   and	  pudendal	   nerve,	   as	   illustrated	   in	   Figure	   4	   [76].	   The	   presence	   of	   these	   nerve	   plexuses	  results	   in	   a	   rich	   supply	   of	   parasympathetic	   and	   sympathetic	   nerve	   innervations	   to	   all	  regions	  of	  the	  vagina,	  but	  with	  the	  parasympathetic	  innervation	  predominant	  in	  the	  upper-­‐two-­‐thirds	  region	  and	  the	  sympathetic	  innervation	  dominant	  in	  the	  lower	  one-­‐third	  region	  [40].	   Innervation	  density	  also	  differs	  along	  the	  vertical	  axis,	  with	   increasing	  density	   from	  proximal	  to	  distal,	  resulting	  in	  low	  sensitivity	  at	  the	  vault	  and	  high	  sensitivity	  at	  the	  vaginal	  introitus	   [77].	   	  These	  nerves	  fibers	  have	  been	  detected	  in	  the	  subepithelium,	  immediately	  below	   the	   muscularis	   and	   within	   thick-­‐walled	   blood	   vessels.	   Intraepithelial	   varicosities	  have	   also	   been	   detected	   in	   the	   distal	   vagina	   (introitus)	   [77].	   The	  muscularis	   region	   also	  contains	  nerve	  fibers,	  which	  innervate	  the	  smooth	  muscle	  within	  that	  layer.	  Smooth	  muscle	  within	   the	   upper	   two-­‐thirds	   of	   the	   vagina	   is	   predominantly	   under	   parasympathetic	   and	  sympathetic	  control,	  with	  the	  exception	  of	  the	  1-­‐2	  cm	  region	  encompassing	  the	  distal	  two-­‐thirds	   of	   the	   vagina,	   which	   is	   partially	   innervated	   by	   somatic	   nerves,	   as	   discussed	  previously.	   The	   somatic	   innervations	   control	   the	   sphincter	   like	   circumferential	   striated	  muscle	  structure	  surrounding	  the	  distal	  end	  of	  the	  vagina	  [78].	  These	  muscles	  are	  essential	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for	  maintaining	  vaginal	  contraction,	  and	  have	  been	  shown	  to	  be	  essential	  for	  reproduction	  and	   parturition	   although	   as	   alluded	   to,	   they	   play	   a	   major	   role	   in	   maintaining	   vaginal	  support.	  Hence,	  their	  dysfunction	  has	  been	  linked	  to	  multiple	  pathologies,	  which	  could	  be	  due	  to	  alternation	  in	  their	   innervation	  [79]–[81].	  As	  mentioned,	  VaBI	  has	  the	  potential	   to	  alter	   pudendal	   nerve	   innervation,	   and	   in	   turn,	   vaginal	   innervations.	   In	   addition,	   these	  muscles	   also	   contain	   receptors	   for	   cholinergic,	   adrenergic	   (α1),	   and	   non-­‐cholinergic	   and	  adrenergic	   (NANC)	  neurotransmitters	   released	  by	   the	   localized	  nerves,	  of	  which	  changes	  could	   also	   alter	   muscle	   function.	   The	   level	   of	   circulating	   hormones	   or	   changes	   in	   the	  loading	   environment	   resulting	   from	   changes	   in	   age,	   pregnancy	   status,	   and	   disease	   may	  subsequently	   influence	   innervation	   density	   due	   to	   the	   nervous	   system’s	   role	   in	  organogenesis	   and	   tissue	   remodeling.	   However,	  more	   investigation	   into	   the	   influence	   of	  these	   factors	  on	  muscle	   innervation	  within	  the	  vagina,	  and	   its	  role	   in	  the	  pathogenesis	  of	  POP	  is	  highly	  warranted.	  
1.4 MARKERS	  OF	  VAGINAL	  REMODELING	  
1.4.1 	  Biochemical	  and	  Immunohistochemical	  Markers	  
To	  date,	  much	  effort	  has	  been	  directed	  towards	  understanding	  the	  remodeling	  of	  the	  major	  mechanical	  constituents	  (collagen	  and	  elastin)	  of	   the	  vagina	  during	  POP	  progression,	  and	  how	   their	   turnover	   may	   play	   a	   role	   in	   the	   pathogenesis	   of	   POP.	   Since	   smooth	   muscle	  synthesizes	   both	   elastin	   and	   collagen	   and	  maintains	   the	   active	  mechanics	   of	   the	   vagina,	  smooth	  muscle	  and	   its	   innervation	  have	  also	  begun	   to	   receive	  attention,	  albeit	   limited.	   If	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the	  causative	  factors	  are	  not	  fully	  understood,	  preventative	  measures	  cannot	  be	  designed.	  This	   also	  means	   that	   despite	   excellent	   anatomical	   restoration	   following	  mesh	   repair	   for	  POP,	   remodeling	   of	   these	   major	   mechanical	   constituents	   may	   continue	   to	   ensue,	   likely	  leading	  to	  reported	  complications	  and	  mesh	  failure.	  	  	  
Collagen	  
	   Studies	  investigating	  changes	  in	  vaginal	  tissue	  collagen	  content	  in	  women	  with	  POP	  relative	  to	  non-­‐POP	  controls	  have	  shown	  higher	  collagen	  type	  III,	  a	  collagen	  type	  which	  is	  significantly	   less	   stiff	   than	   the	   also	   present,	   collagen	   type	   I	   [57],	   [82].	   Changes	   in	   these	  ratios	  can	  have	  a	  significant	  impact	  on	  the	  resulting	  mechanics	  of	  the	  vagina,	  promoting	  a	  further	  loss	  of	  vaginal	  support,	  as	  these	  fibers	  have	  varying	  degrees	  of	  stiffness.	  There	  has	  also	   been	   evidence	   of	   a	   concomitant	   increase	   in	   the	   expression	   of	   matrix	  metalloproteinases	   (MMPS)	   associated	   with	   the	   proteolysis	   of	   these	   fibrillar	   collagens	  (MMP-­‐1	  &	  MMP-­‐13)	  in	  the	  vagina	  supporting	  the	  loss	  of	  overall	  collagen	  content,	  which	  can	  alter	   vaginal	   mechanics	   [83],	   [84].	   MMPs,	   which	   are	   produced	   by	   smooth	   muscle	   and	  fibroblasts,	  are	  synthesized	  intracellularly	  in	  their	   latent	  form,	  and	  then	  excreted	  into	  the	  extracellular	   space,	   where	   they	   become	   activated.	   Upon	   activation,	   MMPs	   can	   cleave	  various	  elements	  of	  the	  matrix,	  altering	  the	  balance	  of	  its	  composition	  [85][86].	  In	  an	  effort	  to	   determine	   if	   the	   collagen	   fibers	   being	   synthesized	   are	   mechanically	   similar	   to	   those	  produced	  by	  women	  without	  POP,	  studies	  have	  attempted	  to	  evaluate	  the	  expression	  levels	  of	  lysyl	  oxidases	  (LOX),	  the	  crosslinking	  family	  of	  proteins.	  Increased	  crosslinking	  renders	  increased	   stiffness	   to	   the	   collagen	   fibers	   following	   synthesis	   and	   excretion	   into	   the	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extracellular	   space,	   a	   process	   after	   which	   the	   fiber	   is	   referred	   to	   as	   mature.	   Of	   the	   few	  studies	   that	   have	   evaluated	   LOX	   expression	   in	   women	   with	   POP,	   the	   results	   showed	   a	  decline	  in	  lysyl	  oxidase	  like-­‐1	  (LOXL1)	  expression	  in	  women	  with	  POP	  [87],	  [88].	  LOXL1	  is	  associated	  with	  the	  crosslinking	  of	  collagen	  fibers,	  hence	  a	  decline	  would	  result	  in	  less	  stiff	  collagen	   fibers,	  however	   it	   remains	  uncertain	  as	   to	   the	   influence	  on	   the	   resulting	  vaginal	  mechanics.	  It	  is	  likely	  that	  parity	  and	  aging,	  which	  are	  major	  drivers	  for	  the	  manifestation	  of	  POP	   leads	   to	  destabilization	  of	   collagen	   synthesis,	   crosslinking,	   and	  degradation.	  Even	  more	   interesting	   are	   findings	   that	   this	   rapid	   remodeling	   process	   following	   childbirth	   is	  subdued	   in	   advanced	   stages	   of	   prolapse	   in	   post-­‐menopausal	   women,	   without	   the	  amelioration	  of	  symptoms.	  These	  changes	  in	  collagen	  content	  may	  also	  be	  accompanied	  by	  changes	  in	  other	  tissue	  components,	  however	  how	  these	  factors	  collectively	  influences	  the	  pathogenesis	  of	  POP	  is	  unclear.	  	  
	  
Elastin	  
	   As	   noted,	   changes	   in	   other	   tissue	   components,	   including	   elastin	   expression	   in	   the	  vagina,	  has	  provided	  much	   insight	   into	   the	  pathogenesis	  of	  POP,	   and	  has	  prompted	  even	  more	  questions.	  Similar	  to	  collagen,	  both	  immature	  and	  mature	  elastin	  is	  found	  in	  vaginal	  tissue,	   and	   similar	   to	   collagen,	   mature	   elastin	   or	   crosslinked	   elastin	   exhibits	   increased	  stiffness	  relative	  to	  the	  immature	  or	  non-­‐crosslinked	  elastin.	  In	  women	  with	  POP,	  both	  the	  expression	  of	  immature	  (tropoelastin)	  and	  mature	  elastin	  is	  down-­‐regulated	  in	  the	  vagina	  and	   adjacent	   connective	   tissues	   [89]–[92].	   MMP-­‐9,	   a	   known	   gelatinase	   which	   degrades	  elastin	   was	   also	   unregulated,	   supporting	   the	   idea	   of	   a	   rapid	   remodeling	   process	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characterized	  by	   increase	  degradation	  of	   elastin	   [69],	   [93].	   Lysyl	   oxidase	   like-­‐2	   (LOXL2),	  which	  aids	  in	  the	  crosslinking	  of	  elastin	  is	  also	  known	  to	  be	  down	  regulated	  in	  women	  with	  POP,	  relative	  to	  controls,	  which	  again	  may	  result	  in	  inferior	  vaginal	  mechanics	  [87].	  Fibulin	  5,	  an	  extracellular	  matrix	  protein	  known	   to	  play	  a	  major	   role	   in	  elastin	  organization,	  has	  also	   been	   evaluated	   in	   women	   with	   POP,	   and	   the	   results	   showed	   a	   positive	   correlation	  between	   elastin	   and	   Fibulin	   5	   expression	   in	   the	   ECM	   [90].	   The	   results	   also	   showed	   a	  correlation	  between	  the	  stage	  of	  prolapse	  and	  the	  degree	  of	  Fibulin	  5	  expression,	   further	  supporting	   their	   role	   in	   the	  pathogenesis	   of	  POP.	  However,	   similar	   to	   the	   changes	   in	   the	  expression	  of	  collagen,	  it	  remains	  unclear	  as	  to	  why	  these	  changes	  occur,	  and	  if	  they	  are	  the	  cause,	   or	   the	   effect	   of	   POP.	   This	   is	   indeed	   the	   case	   as	   the	   study	   showed	   no	   difference	  following	  vaginal	  birth	  or	  menopause,	  which	  as	  mentioned,	  are	  major	  risk	  factors	  of	  POP.	  Nevertheless,	  a	  more	  specific	  risk	  factor	  like	  VaBI	  may	  have	  the	  potential	  to	  increase	  elastin	  expression	   eventually	   leading	   to	   the	   development	   of	   POP,	   similar	   to	   the	   increased	  expression	  during	  pregnancy.	  However,	  a	  more	  direct	  association	  of	  these	  changes	  to	  VaBI	  is	  warranted.	  	  
Smooth	  Muscle	  	  Recent	  studies	  characterizing	  smooth	  muscles(SM)	  in	  women	  with	  POP	  have	  shown	  higher	   apoptotic	   rate	  of	   smooth	  muscle	   cells	   (SMCs),	   loss	  of	   innervation,	  as	  well	  as	  an	  overall	   disorganization	   and	   smaller	   fractional	   area	   of	   muscle	   fibers	   in	   the	   vaginal	   wall	  [94]–[97].	  As	  confirmed	  by	  Northington	  et	  al,	   these	  histological	  changes	  are	  accompanied	  by	   functional	  changes.	  These	  changes	  can	  manifest	  as	  a	   loss	  of	   innervation	   to	   the	  muscle	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bundles,	  a	  loss	  of	  receptors	  on	  the	  muscles,	  or	  a	  loss	  of	  the	  contractile	  components	  (actin	  fibers)	   within	   the	   muscles	   [98].	   Following	   these	   changes,	   alterations	   in	   the	   forces	  generated	   by	   the	   muscle	   bundles	   can	   ensue,	   with	   the	   potential	   to	   alter	   tension	   on	  connective	  tissues	  and	  ligamentous	  attachments.	  This	  is	  due	  to	  the	  ability	  of	  smooth	  muscle	  to	   dynamically	   sense	   and	   respond	   to	   changes	   in	   force,	   as	   exhibited	   in	   other	  mechanical	  organs	  like	  the	  bladder,	  and	  arteries	  [80],	  [99],	  [100].	  However,	  as	  expected,	  in	  the	  case	  of	  the	  vagina,	  these	  auto	  regulated	  muscles	  can	  respond	  to	  perturbations	  only	  after	  receiving	  the	   appropriate	   stimulation	   from	   their	   parasympathetic	   (M2,3-­‐cholinergic)	   and	  sympathetic	   (α1-­‐adrenergic)	   innervations.	   	   It	   can	   then	   be	   assumed	   that	   in	   women	  with	  POP,	   the	   vagina	   may	   lack	   this	   delicate	   balance	   of	   innervation	   or	   tensional	   stimulation,	  resulting	  in	  a	  negative	  remodeling	  response	  and	  the	  manifestation	  of	  POP.	  However,	  there	  has	  also	  been	  a	   lack	  of	  consensus	   in	  smooth	  muscle	   findings,	  particularly	  with	  regards	  to	  whether	   smooth	   muscle	   dysfunction	   is	   the	   cause	   or	   the	   effect	   of	   POP.	   The	   study	   by	  Boreham	  et	  al	  showed	  no	  correlation	  between	  changes	  in	  smooth	  muscle	  volume	  and	  POP	  stage	  of	  cycle,	  unlike	  with	  elastin	  and	  collagen	  [101].	  The	  authors	   therefore	   inferred	   that	  these	  changes	  in	  smooth	  muscle	  must	  occur	  very	  early	  and	  may	  be	  influencing	  changes	  in	  elastin	   and	   collagen	   synthesis	   during	   POP	   progression.	   However,	   there	   has	   been	   no	  association	   to	  date	  between	  the	  onset	  of	  POP	  changes	  and	  any	  of	   the	  risk	   factors	  of	  POP,	  including	  VaBI.	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1.4.2 	  Mechanical	  Parameters	  
Changes	  in	  the	  above	  mentioned	  mechanical	  constituents	  have	  the	  ability	  to	  alter	  both	  the	  structural	  and	  mechanical	  properties	  of	  the	  vagina.	  This	  can	  result	  from	  either	  a	  loss	  in	  the	  active	  mechanical	  properties,	  the	  passive	  mechanical	  properties,	  or	  from	  both.	  The	  passive	  tissue	   mechanics,	   in	   general,	   reflect	   the	   properties	   of	   the	   acellular	   matrix	   components,	  including	   elastin	   and	   collagen,	   while	   active	   mechanics	   reflect	   the	   properties	   of	   smooth	  muscle.	  The	  passive	  and	  active	  mechanical	  properties	  hence	  represent	  distinct	  aspects	  of	  tissue	  function;	  and	  in	  order	  to	  fully	  understand	  remodeling	  of	  the	  vaginal	  mechanics,	  it	  is	  essential	  to	  evaluate	  both	  the	  active	  and	  passive	  mechanical	  properties.	  To	  date,	  however,	  studies	   evaluating	   changes	   in	   vaginal	   mechanics	   have	   predominantly	   focused	   on	  characterizing	   changes	   in	   the	   passive	  mechanics	   of	   the	   vagina,	   as	   changes	   in	   elastin	   and	  collagen	  content	  were	  assumed	  to	  be	  the	  only	  key	  pathogenic	   factors	  of	  POP	  [67],	   [102]–[104].	  Rubod	  et	  al,	  after	  elongating	  tissues	  at	  varying	  deformation	  rates,	  revealed	  that	  the	  vagina	   normally	   exhibits	   a	   viscoelastic	   and	   a	   viscoplastic	   response	   [102].	   The	  characterization	  of	  the	  mechanical	  properties	  of	  the	  vagina	  is	  essential,	  as	  these	  properties	  are	  normalized	  expression	  of	  a	  specimen’s	  reaction	  to	  external	  forces.	  Therefore,	  they	  are	  excellent	   indicators	  of	  the	  bonds	  and	  state	  of	  the	  constituents	  of	  the	  tissues,	  making	  it	  an	  appropriate	  measure	  of	  tissue	  remodeling.	  Results	  from	  these	  studies	  have	  shown	  that	  the	  vagina	   of	   menopausal	   women	   with	   POP	   is	   stiffer	   than	   tissues	   from	  menopausal	   control	  women	  [103].	  A	  very	  recent	  study,	  using	  tactile	  imaging,	  also	  showed	  that	  the	  vagina	  is	  less	  elastic	   in	  women	  with	   POP,	   a	   finding	  which	   could	   certainly	   influence	   the	   progression	   of	  POP,	   as	   well	   as	   how	   the	   vagina	   responds	   to	   surgical	   augmentation	   [67].	   The	   increased	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stiffness	   and	   loss	   of	   elasticity	   has	   been	   attributed	   to	   a	   decline	   in	   the	   ratio	   of	   collagen	  I/collagen	   III,	   however	   these	   changes	   could	  be	  a	   result	   of	   changes	   in	   elastin	   and	   smooth	  muscle.	   As	   previously	   stated,	   the	   possibility	   of	   this	   phenomenon	   has	   not	   been	   widely	  studied	   in	   the	   vagina,	   but	   findings	   from	   the	   cardiovascular	   literature	   support	   these	  assertions.	  Early	  studies	  suggest	  that	  a	  decrease	  in	  elastin	  with	  a	  corresponding	  decrease	  in	  smooth	  muscle,	  as	  found	  to	  be	  the	  case	  for	  women	  with	  POP,	  can	  lead	  to	  increased	  tissue	  stiffness.	  This	  conclusion	  is	  based	  on	  the	  intricate	  interaction	  between	  elastin	  and	  smooth	  muscle,	   and	   their	   ability	   to	   confer	   elasticity	   to	   resident	   structures	   through	   a	   delayed	  recruitment	  of	  collagen	  [105],	  [106].	  However,	  more	  research	  is	  needed	  to	  understand	  how	  they	  are	  associated	  to	  risk	  factors	  for	  POP.	  Additionally,	  it	  needs	  to	  be	  specially	  determined	  how	  VaBI	  may	  lead	  to	  an	  alteration	  in	  these	  structures,	  and	  subsequently	  predisposes	  one	  to	  developing	  POP.	  
1.4.3 Animal	  Models	  
As	  evidenced,	  human	  studies	  have	  provided	  much	  insight,	  but	   limitations	  associated	  with	  tissue	  acquisition	  and	  ethical	  limitations	  has	  left	  several	  gaps	  within	  our	  knowledge	  of	  the	  pathogenesis	   of	   POP.	   To	   improve	   our	   understanding,	   many	   investigators	   have	  experimented	   with	   animal	   models	   including	   primates,	   rodents,	   and	   sheep	   especially	   for	  mechanistic	   studies	   [107],	   [108].	   Validation	   for	   use	   of	   these	   models	   generally	   involves	  investigation	  of	  the	  potential	  of	  the	  model	  to	  replicate	  the	  pathology	  as	  it	  occurs	  in	  humans,	  similarity	  of	  structure	  and	  function	  of	  the	  organ	  (s)	  involved	  relative	  to	  humans,	  the	  size	  of	  the	  organ	  (s)	  (which	  is	  influenced	  by	  the	  animal	  size),	  as	  well	  as	  tolerance	  to	  agents	  being	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injected	  (eg.	  drugs,	  cells,	  etc,	   if	  applicable).	  For	  POP,	  the	  anatomical	  structures	  that	  are	  of	  major	   interest	   are	   the	  pelvic	   supportive	   structures,	  which	  have	  been	  associated	  with	   the	  development	   of	   POP.	   These	   structures	   include	   the	   lavator	   ani	  muscles,	   connective	   tissue	  attachments,	   the	   vagina,	   and	   innervations	   of	   these	   structures.	   The	   cost	   of	   purchase,	  housing	  and	  surgical	  intervention	  can	  also	  influence	  ultimate	  use	  of	  a	  model,	  when	  several	  models	  meet	  the	  validation	  criteria	  for	  a	  study.	  
	  
Rodents	  	  Rodent	  models	  (rats	  and	  mice),	  which	  are	  widely	  used	  for	  pelvic	  floor	  studies,	  have	  been	  reported	  by	  Moalli	  et	  al.	  to	  be	  an	  appropriate	  model	  for	  POP,	  due	  to	  analogous	  pelvic	  supportive	  structures	  to	  that	  of	  humans	  including	  the	  uterosacral	  ligament	  which	  attaches	  the	  upper	  vagina	  to	  the	  spine,	  at	   level	  I	  [109].	  In	  rodents,	  the	  vagina	  is	  also	  supported	  by	  the	  endopelvic	  fascia	  and	  ATFP	  at	  level	  II,	  and	  is	  seen	  as	  a	  dense	  band	  of	  connective	  tissue	  extending	   from	   the	  pubic	   symphysis	   to	   the	   lateral	   bony	  pelvis.	  At	   level	   III	   in	   the	   rat,	   the	  connective	   tissue	   attachments	   at	   the	   distal	   vagina	   can	   also	   be	   observed.	  Observations	   of	  major	  lateral	  supports	  including	  the	  cardinal	  ligaments	  at	  level	  I	  have	  not	  been	  reported	  in	  the	   literature.	   Also,	   Moalli	   et	   al	   have	   also	   shown	   that	   the	   levator	   ani	   muscles,	   although	  present	   in	   rodents,	   primarily	   function	   to	   support	   the	   tail.	   Interestingly,	   these	   minor	  discrepancies	  can	  be	  advantageous	  for	  studies	  aiming	  to	  investigate	  the	  effects	  of	  the	  VSTC	  independent	  of	  the	  contribution	  of	  the	  levator	  ani	  muscles	  and	  cardinal	  ligaments.	  To	  date,	  the	   rodent	  model	  has	  also	  been	  successfully	  used	   to	  evaluate	   the	   impact	  of	   the	  effects	  of	  various	  risk	  factors	  of	  POP	  including	  simulated	  birth	  trauma,	  and	  molecular	  deficiencies	  on	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the	  mechanical	   and	   biomechanical	   properties	   of	   pelvic	   structures,	   and	   their	   innervation	  [107][108].	  However,	  the	  model	  is	  not	  without	  limitations.	  The	  shorter	  reproductive	  cycle	  and	  gestation	  period,	  multiple	   fetuses,	  quadrupedal	  posture,	  and	  small	   size	   limits	   its	  use.	  Additionally,	  the	  significantly	  shorter	  lifespan,	  variable	  healing	  response,	  and	  the	  absence	  of	   the	   manifestation	   of	   POP	   in	   rodents,	   renders	   other	   models	   more	   attractive	   for	   some	  studies.	  
	  
Non-­‐Human	  Primates	  
	   Non-­‐human	   primates’	   (NHP)	   (particularly	   the	   Rhesus	   Macaques	   and	   Squirrel	  Monkeys)	   similar	   reproductive	   cycles	   and	   gestation	   periods	   to	   humans,	   single	   fetuses,	  occasional	  bipedal	  posture,	  and	  large	  size	  indeed	  have	  made	  them	  a	  more	  attractive	  model	  for	   pelvic	   floor	   studies.	   Additionally,	   the	   primate	  model	   has	   also	   been	   shown	   to	   contain	  analogous	  level	  I,	   level	  II,	  and	  III	  support	  to	  that	  of	  humans	  [110]–[114].	  At	  level	  II	   in	  the	  primate,	   the	   levator	   ani	   muscles	   consisting	   of	   the	   iliocaudalis,	   pubocaudalis,	   and	  puborectalis	  muscles,	   functions	   to	   support	   the	  pelvic	   organs	   similar	   to	   the	   iliococcygeus,	  puboccygeus,	   and	   puborectalis	   muscles	   in	   humans	   [112].	   The	   primate	   model	   (Rhesus	  Macaques)	  has	  also	  been	  shown	  to	  contain	  the	  cardinal	  ligament,	  forming	  the	  uterosacral-­‐cardinal	   ligament	   complex,	   a	   structure	   not	   found	   in	   rodents	   [114].	   This	  model	   is	   highly	  preferred,	  as	  non-­‐human	  primates	  also	  develop	  spontaneous	  prolapse	  related	  to	  childbirth	  [110].	   Hence,	   this	   model	   has	   been	   successfully	   used	   to	   evaluate	   the	   effects	   of	   parity,	  hormone,	  and	  levator	  ani	  muscle	  integrity	  on	  the	  development	  of	  POP	  [107].	  The	  effect	  of	  upright	  posture	  allows	  researchers	  to	  account	  for	  the	  effect	  of	  gravity	  on	  the	  pelvic	   floor,	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making	   it	   ideal	   for	   studying	   the	   effects	   of	   strategies	   to	   improve	  pelvic	   organ	   support.	  Of	  recent,	   the	   primate	  model	   has	   also	   been	   successfully	   used	   for	   the	   evaluation	   of	   surgical	  prolapse	  mesh	   for	   pelvic	   organ	   support,	   as	   reported	   in	   this	  work.	   The	   primate	  model	   is	  considered	  the	  goal	  standard	  for	  pelvic	  floor	  studies,	  with	  Rhesus	  macaques	  proving	  more	  advantageous	  due	  to	  their	  larger	  size	  relative	  to	  squirrel	  monkeys.	  However	  the	  high	  cost,	  and	  inaccessibility	  of	  the	  animals	  limits	  widespread	  use.	  	  	  
Sheep	   	  The	  sheep	  (Ewe)	  model	  is	  a	  more	  cost-­‐effective	  alternative	  to	  NHP	  models,	  as	  they	  also	   develop	   spontaneous	   prolapse.	   The	   manifestation	   of	   prolapse	   in	   the	   sheep	   is	   also	  known	   to	   be	   associated	   with	   increased	   intra	   abdominal	   pressure	   similar	   to	   what	   is	  clinically	   observed	   in	   humans.	   However,	   in	   contrast	   to	   humans,	   the	   presentation	   of	  symptoms	  of	  POP	  occurs	  closer	  to	  the	  time	  of	  delivery,	  making	  its	  manifestation	  different	  [115].	  Nevertheless,	   it	   is	   adequate	   for	  evaluating	   changes	  associated	  with	  pregnancy	  and	  vaginal	   delivery	   independent	   of	   hormonal	   withdrawal	   that	   may	   predispose	   one	   to	  developing	  POP.	  Their	  unique	  and	  highly	  elevated	  intra-­‐abdominal	  pressure	  may	  also	  lead	  to	  an	  altered	  loading	  environment	  within	  the	  pelvic	  floor	  that	  is	  absent	  in	  women,	  however,	  one	   could	   propose	   that	   the	   effects	   of	   the	   increased	   pressure	   may	   be	   negligible,	   as	   the	  supportive	  structures	  may	  be	  adequately	  designed	  to	  maintain	  support	  in	  the	  presence	  of	  this	   increased	  pressure.	  Additionally,	  being	  quadrapeds,	   the	   loading	  of	   the	  pelvic	   floor	   in	  the	  sheep	  differs	  from	  humans	  although	  similar	  pelvic	  supportive	  structures	  to	  humans,	  at	  level	  I,	  level	  II	  and	  level	  III	  of	  the	  vagina,	  have	  been	  observed.	  To	  date,	  the	  use	  of	  the	  sheep	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model	  for	  POP	  is	  still	  relatively	  novel	  and	  highly	  limited	  relative	  to	  other	  models.	  However,	  it	  has	  been	  successfully	  used	  to	  evaluate	  the	  impact	  of	  parity	  on	  the	  development	  of	  POP,	  and	  the	   impact	  of	  prolapse	  mesh	   implantation	  for	  pelvic	  support	  [107].	  Their	   limited	  use	  may	  be	  more	  a	  result	  of	  the	  cost-­‐benefit	  relative	  to	  rodents,	  and	  the	  housing	  requirements	  needed	  for	  large	  studies.	  
1.5 MOTIVATION	  AND	  SPECIFIC	  AIMS	  
1.5.1 Motivation	  
The	  extended	  period	  of	  time	  period	  between	  childbirth,	  or	  more	  specifically	  VaBI,	  and	  the	  manifestation	  of	  POP	  symptoms	  (usually	  20-­‐30	  years),	  makes	   it	  rather	  difficult	   to	  draw	  a	  direct	  causal	   relationship.	   If	   birth	   injury	   is	   indeed	   an	   inciting	   factor	   for	   developing	   POP,	  it	   must	   have	   the	   potential	   to	   induce	   a	   mechanically	   perturbed	   state	   in	   the	   pelvic	   floor,	  to	   continually	   induce	   a	   remodeling	   response	   that	   will	   manifest	   with	   time.	   However,	   to	  date,	   there	   is	   a	   paucity	   of	   studies	   that	   have	   investigated	   the	   potential	   of	   vaginal	   injury	  during	  delivery,	  to	  incite	  a	  degenerative	  remodeling	  response.	  Additionally,	  during	  delivery	  multiple	   structures	   can	   be	   impacted	   simultaneously,	   and	   as	   previously	   alluded	   to,	   the	  pelvic	  floor	  is	  a	  complex	  mechanical	  structure,	  and	  an	  injury	  impairing	  one	  structure,	  can	  disrupt	  the	  delicate	  balance	  of	  forces,	   leading	  to	  failure	  of	  the	  entire	  support	  system	  over	  time,	  making	  it	  difficult	  to	  determine	  the	  exact	  inciting	  factor.	  	  The	  vagina	   is	  anchored	  to	  pelvic	   floor	  musculature	   to	  create	  a	  bridge	  of	  support	   for	  the	  bladder	  and	  urethra	  to	  sit	  upon,	  alteration	  in	  mechanical	  properties	  could	  in	  turn,	  alter	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tension	   on	   its	   ligamentous	   supports,	   as	   well	   as	   its	   ability	   to	   support	   the	   pelvic	   organs.	  	  Hence,	  the	  vagina	  and	  its	  attachments	  have	  recently	  emerged	  as	  key	  supporting	  structures	  within	  the	  pelvic	  floor,	  and	  have	  also	  been	  identified	  as	  structures	  with	  a	  high	  likelihood	  of	  injury	   during	   delivery.	   The	   vagina	   and	   its	   attachments	   consist	   of	   collagen,	   elastin	   and	  smooth	  muscle	  cells	  (SMCs),	  work	  synergistically	  to	  maintain	  vaginal	  mechanical	  integrity,	  including	  tone	  and	  compliance.	  The	  literature	  suggests	  that	  changes	  in	  the	  mechanics	  of	  the	  vagina,	  i.e	  stiffness	  and	  elasticity,	  as	  seen	  with	  POP,	  are	  governed	  by	  the	  reported	  change	  in	  elastin	   and	   smooth	  muscle.	   However,	   there	   is	   no	   literature	   to	   support	   the	   timing	   of	   the	  onset	  of	  these	  changes	  and	  how	  they	  may	  be	  related	  to	  known	  risk	  factors	  of	  POP.	  	  However,	  our	  previous	  characterization	  of	  an	  ideal	  adaptive	  remodeling	  process	  in	  rodents,	  which	  do	  not	  sustain	  vaginal	   injuries	  during	  delivery	  due	  to	  the	  small	  size	  of	  the	  fetal	  head	  relative	  to	  the	  vaginal	  opening,	  support	  an	  injury	  mechanism.	  The	  study	  results	  showed	  major	  adaptive	  changes	  in	  the	  active	  vaginal	  mechanics	  (smooth	  muscles)	  during	  pregnancy,	  but	  full	  postpartum	  recovery,	  suggesting	  that	  this	  recovery	  mechanism	  may	  be	  a	  key	  factor	  differentiating	  women	  that	  go	  on	  to	  develop	  prolapse,	  and	  those	  that	  do	  not.	  We	  therefore	  hypothesize	  that	  maternal	  birth	  injury	  causes	  a	  direct	  insult	  to	  vaginal	  SMCs,	  leading	   to	   a	   decline	   in	   vaginal	   tone.	   The	   rationale	   of	   which,	   is	   that	   the	   impairment	   of	  smooth	  muscle	   function	   (and	   indirectly	   elastin)	  will	   alter	   the	   load	   seen	   by	   the	   collagen,	  leading	   to	   mechanical	   stimulation	   of	   the	   resident	   fibroblasts,	   in	   favor	   of	   a	   degenerative	  remodeling	  process,	  perhaps	  manifesting	  as	  prolapse	  with	  time	  and	  age.	  	  As	   noted,	   supporting	   studies	   have	   shown	   that	   women	   with	   POP	   have	   a	   higher	  apoptotic	   rate	  of	  SMCs,	   thus,	   contributing	   to	  a	  smaller	   fraction	  of	  smooth	  muscle	   in	   their	  vaginal	   wall,	   and	   a	   widened	   genital	   hiatus.	   The	   absence	   of	   adequate	   smooth	   muscle	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support,	  paralleled	  with	  a	  widened	  genital	  haitus	  in	  the	  vaginal	  walls	  of	  women	  with	  POP,	  further	  suggests	  a	  central	  role	  of	  SMCs	  in	  maintaining	  vaginal	  integrity.	  Hence,	  the	  goal	  of	  this	   thesis	   work	   was	   to	   evaluate	   the	   impact	   of	   VaBI	   on	   vaginal	   smooth	   muscle	   (VaSM)	  function,	  as	  this	  may	  play	  a	  key	  role	  in	  the	  pathogenesis	  of	  POP.	  More	  specially,	  this	  work	  i)	  evaluated	   the	   impact	   of	   a	   simulated	   vaginal	   injury	   on	   VaSM	   morphology,	   innervation,	  contraction,	  and	  receptor	  function	  ii)	  characterized	  the	  impact	  of	  a	  potential	  loss	  of	  smooth	  muscle	   function	  on	  vaginal	  mechanics,	   and	   iii)	   evaluated	   the	   ability	  of	   current	   treatment	  methods	  for	  POP	  to	  restore	  VaSM	  function	  (Figure	  9).	  	  
1.5.2 Specific	  Aims	  
Specific	  Aim	  1:	  Evaluate	  the	  impact	  of	  a	  simulated	  injury	  in	  the	  rat	  on	  vaginal	  smooth	  muscle	  	  	  	  Rationale:	  As	  noted,	  VaBI	  has	  greatest	  association	  with	  the	  development	  of	  POP,	  and	  has	  been	  shown	  to	  negatively	  impact	  several	  pelvic	  floor	  structures.	  It	  is	  likely	  then	  that	   vaginal	   injury	   can	   directly	   impact	   the	   smooth	   muscle	   layers,	   as	   well	   as	   its	  innervation	  through	  the	  hypogastric	  and	  pelvic	  nerves.	  	  
	  Hypothesis:	  At	  4	  weeks	  post-­‐injury,	  we	  expect	  to	  see	  less	  sensitivity,	  lower	  tension,	  and	   less	   force	  generation	  of	  VaSM	   in	  response	   to	  each	  of	   the	  receptor	  agonists,	  or	  nerve	  and	  muscle	  stimulants.	  These	  changes	  are	  expected	  to	  be	  evident	  to	  a	  greater	  degree,	  at	  8	  weeks,	  and	  would	  be	  indicative	  of	  degeneration	  of	  muscle	  innervation,	  contraction,	  and	  receptor	  function.	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  Significance:	   This	   aim	   provides	   a	   framework	   for	   the	   subsequent	   aims,	   due	   to	   its	  potential	   to	   show	   if	   smooth	   muscle	   is	   indeed	   impacted	   by	   birth	   injury,	   and	   if	  degeneration	  worsens	  with	  time.	  Evidence	  of	  recovery	  would,	  however,	  suggest	  that	  smooth	  muscle	  may	  not	  be	  an	  inciting	  factor	  and	  not	  be	  orchestrating	  the	  lingering	  effects	  of	  injury.	  This	  evidence	  of	  smooth	  muscle	  injury	  as	  well	  as	  a	  lack	  of	  recovery,	  but	  not	  necessarily	  evidence	  of	  POP	  is	  warranted	  in	  order	  to	  show	  the	  potential	  of	  VaBI	  to	  induce	  a	  degenerative	  remodeling	  response	  that	  may	  manifests	  as	  POP,	  with	  time.	  	  	  
Specific	  Aim	  2:	  Evaluate	  the	  impact	  of	  changes	  in	  smooth	  muscle	  function	  on	  vaginal	  biaxial	  
mechanics	  	  	  Rationale:	   Based	   on	   the	   premise	   that	   smooth	   muscle	   acts	   as	   a	   dynamic	   shock	  absorber,	   and	   as	   a	   regulator	   of	   collagen	   fiber	   recruitment,	   a	   loss	   of	   its	   function,	  would	  lead	  to	  an	  alternation	  in	  tissue	  stiffness.	  	   Hypothesis:	  Smooth	  muscle	  plays	  a	  protective	  role,	  thus	  after	  rendering	  the	  vagina	  passive,	  we	   expect	   to	   observe	   an	   increase	   in	   stiffness,	   and	  decreased	   areal	   strain,	  resulting	  from	  a	  more	  abrupt	  recruitment	  of	  collagen	  fibers.	  	   Significance:	  Evidence	  of	  changes	   in	  smooth	  muscle	   function	  on	  vaginal	  mechanics	  would	   validate	   its	   role	   in	   inducing	   vaginal	   remodeling	   following	   injury	   during	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delivery,	  as	  resident	  fibroblasts	  will	  be	  exposed	  to	  greater	  physiologic	  strains,	  which	  has	  the	  potential	   to	   induce	   increased	  production	  of	  matrix-­‐degrading	  proteins	  and	  alteration	   in	   collagen	   production.	   These	   findings	   could	   have	   major	   clinical	  implications	  for	  both	  the	  evaluation	  and	  treatment	  of	  prolapse.	  	  
Specific	  Aim	  3:	  Assess	  the	  impact	  of	  surgical	  mesh	  implantation	  for	  POP	  on	  vaginal	  smooth	  
muscle	  	  Rationale:	   Surgical	   mesh	   implantation	   for	   POP	   symptomatic	   management	   is	  associated	  with	  numerous	  complications	  including	  erosion	  through	  the	  vaginal	  wall.	  It	   is	   highly	   likely	   that	   with	   the	  migration	   of	   the	  mesh	   from	   the	   adventitia	   to	   the	  epithelium,	   the	   vaginal	   layers	   would	   be	   impacted,	   especially	   the	   smooth	   muscle	  layer.	  	  	   Hypothesis:	   Mesh	   implantation	   will	   impair	   smooth	   muscle	   function	   contraction,	  innervation,	  and	  receptor	  function.	  	  	   Significance:	   With	   the	   increased	   incidence	   of	   mesh	   complications	   and	  reoccurrences,	   if	   the	  study	  shows	  that	  smooth	  muscle	   is	   indeed	  impacted	  by	  mesh	  implantation,	   then	   efforts	   could	  be	  directed	   to	   redesign	   these	  meshes,	   in	   order	   to	  improve	  clinical	  outcomes.	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Figure	  9.	  Thesis	  Paradigm.	  	  The	  goal	  of	  the	  thesis	  is	  to	  provide	  insight	  into	  the	  association	  between	   VaBI,	   and	   the	   development	   of	   POP.	   The	   focus	   of	   which,	   is	   on	   vaginal	   smooth	  muscle	  as	  a	  pathogenic	  factor	  of	  POP.	  Specially,	  the	  goal	  of	  this	  thesis	  is	  to	  1)	  investigate	  the	  impact	  of	  a	  simulated	  vaginal	  birth	  injury	  on	  VaSM	  2)	  characterize	  the	  impact	  of	  a	  potential	  loss	  of	  smooth	  muscle	  function	  on	  vaginal	  biaxial	  mechanics,	  and	  3)	  evaluate	  the	  ability	  of	  surgical	  mesh,	  designed	  to	  restore	  the	  unsupported	  organs	  to	  their	  anatomical	  position,	  on	  VaSM	  function.	  
2.0	   VAGINAL	  DELIVERY	  WITH	  INJURY	  ALTERS	  VaSM	  FUNCTION	  
2.1 BACKGROUND	  
Vaginal	   delivery	   is	   one	   of	   the	   most	   mechanically	   taxing	   events	   that	   the	   pelvic	   floor	  undergoes.	   Hence,	   the	   vagina	   and	   its	   supportive	   connective	   tissues	   undergo	   adaptive	  remodeling	  prior	   to	  delivery	   to	  minimize	   risk	  of	   injury,	   and	   to	  ensure	  a	   speedy	  recovery	  postpartum.	   Remodeling	  mechanisms	   that	   allow	   the	   tissue	   to	  withstand	   high	   degrees	   of	  deformation	  without	   damage	   and	   reduce	   pain	   include	   decreased	   number	   of	   cross-­‐linked	  fibers	  of	  elastin	  and	  collagen,	  increase	  in	  smooth	  muscle	  volume,	  and	  a	  significant	  decline	  in	   local	   nerve	   terminals	   and	   nociceptors	   [116],	   [117].	   These	   changes	   are	   usually	  accompanied	   by	   increased	   interstitial	   edema,	   and	   an	   increase	   in	   tissue	   water	   content,	  promoting	  tissue	  compliance	  and	  pliability	  [118].	  However,	  the	  extent	  of	  remodeling	  varies	  by	  individual	  characteristics,	  and	  as	  such,	  some	  women	  would	  be	  more	  at	  risk	  of	  incurring	  more	  severe	  injuries	  than	  others.	  Approximately	  78%	  of	  vaginal	  deliveries	  are	  known	  to	  be	  associated	   with	   injuries,	   and	   in	   some	   cases	   the	   post-­‐partum	   recovery	   is	   far	   from	   ideal	  [119].	  Despite	   the	  clear	   implications	  of	  VaBI	  as	  a	   risk	   factor,	   the	  exact	  mechanism	  remains	  elusive	   as	   the	   time	   lapse	   between	   childbirth	   and	   the	   manifestation	   of	   POP	   symptoms	  (usually	  20-­‐30	  years)	  creates	  multiple	  confounders	  that	  limit	  the	  ability	  to	  prove	  causality.	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Increased	   vaginal	   wall	   mobility,	   a	   condition	   usually	   associated	   with	   pregnancy,	  evident	   in	   women	   with	   POP	   has	   recently	   prompted	   conclusions	   that	   injuries	   during	  delivery	  may	  prevent	  the	  adaptive	  changes	  occurring	  during	  pregnancy	  from	  reverting	  to	  pre-­‐pregnancy	   levels	  [117],	   [118].	  As	  the	  degree	  of	  adaptive	  remodeling	  to	  accommodate	  passage	  of	  the	  fetus	  is	  usually	  indicative	  of	  the	  degree	  of	  successful	  postpartum	  recovery,	  our	   previously	   published	   study	   attempted	   to	   characterize	   an	   ideal	   adaptive	   remodeling	  process	   in	   rodents,	   as	   they	   do	   not	   sustain	   injuries	   during	   delivery.	   The	   results	   showed	  significant	   changes	   in	   the	   active	   mechanics	   (provided	   by	   smooth	   muscle)	   of	   the	   vagina	  during	   the	   course	   of	   pregnancy,	   while	   significant	   changes	   in	   the	   passive	   mechanics	  (provided	   by	   collagen,	   elastin,	   glycosaminoglycans,	   preoteoglycans	   etc.)	   were	   observed	  post	   partum[22].	   Additionally,	   the	   results	   also	   showed	   full	   post	   partum	   recovery	   of	   the	  active	  mechanics,	   but	   not	   the	   passive	  mechanics.	   Taken	   together,	   the	   results	   suggest	   an	  important	  role	  of	  smooth	  muscle	  remodeling	  in	  maternal	  adaptations,	  as	  well	  as	  their	  need	  for	   full	   recovery	   post	   partum.	   It	   could	   then	   be	   inferred	   that	   smooth	   muscle	   adaptive	  remodeling	   and	   full	   recovery	   post	   partum,	   as	   is	   seen	   in	   rodents,	   may	   be	   the	   key	   factor	  differentiating	  women	  that	  go	  on	  to	  develop	  prolapse,	  and	  those	  that	  do	  not.	  	  Therefore,	   the	   objective	   of	   this	   study	   was	   to	   utilize	   both	   pharmacologic	   and	  immunohistochemical	   techniques	   to	   functionally	   and	   histologically	   assess	   the	   degree	   of	  smooth	   muscle	   recovery	   following	   a	   simulated	   vaginal	   birth	   injury	   in	   the	   rodent.	   The	  rodent	  model	  of	   simulated	  birth	   trauma	  has	  been	  widely	  used	   for	  mechanistic	   studies	  of	  stress	   urinary	   incontinence	   (SUI),	   and	   replicates	   many	   of	   the	   characteristics	   of	   SUI	  conditions	   in	   women,	   including	   impaired	   urethral	   smooth	   muscle	   function.	   Following	  injury,	   responses	   of	   the	   vaginal	   tissue	   strips	   to	  KCl	   and	   electrical	   field	   stimulation	   (EFS)	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will	   serve	   as	   our	   general	   indicators	   of	   changes	   to	   the	   muscle	   myofiber	   and	   nerve	  innervations,	   while	   responses	   to	   agonists	   of	   muscarinic-­‐	   and	   α1-­‐adrenergic	   receptors,	  known	   to	   be	   dominant	   within	   the	   vagina,	   will	   serve	   as	   our	   indicators	   of	   adrenergic	   or	  cholinergic	   receptor	   changes.	  Histological	   analysis	  will	   be	   used	   to	   evaluate	   gross	  muscle	  morphology	  and	  nerve	  innervations,	  offering	  more	  rigorous	  characterization,	  as	  functional	  changes	  may	  precede	  histological	  changes	  or	  vice-­‐versa.	  	   Evidence	   of	   a	   lack	   of	   full	   recovery	   and	   a	   persistent	   decline	   in	   smooth	   muscle	  innervation	  and	  contraction	  would	  begin	  to	  illustrate	  how	  maternal	  birth	  injury,	  occurring	  in	  a	   subset	  of	  women,	  may	  potentially	   limit	   the	  ability	  of	   smooth	  muscle	   to	   fully	   recover	  post	  partum.	  More	   generally,	   this	   study	  has	   the	  potential	   to	  provide	  data	   that	   can	   aid	   in	  elucidating	  the	  association	  between	  vaginal	  delivery	  and	  the	  development	  of	  POP,	  as	  a	  loss	  of	  vaginal	  smooth	  muscle	  function	  could	  compromise	  vaginal	  support	  of	  the	  pelvic	  organs.	  Ultimately,	   studies	   like	   these	   could	   serve	   as	   guidelines	   for	   the	   design	   of	   more	   feasible	  clinical	   studies	   needed	   to	   equip	   clinicians	   with	   relevant	   information	   to	   develop	   more	  preventative	  treatment	  measures	  for	  POP,	  and	  other	  related	  pelvic	  floor	  dysfunctions.	  	  
2.2 PROTOCOLS	  
2.2.1 Birth	  Injury	  Model	  
3-­‐month	   old	   virgin,	   female	   rats	   (Long	   Evans,	   230-­‐280	   g,	   Hilltop	   Lab	   Animals,	   Inc.,	  Scottsdale,	  PA)	  were	  randomly	  assigned	  to	  4-­‐week	  injured	  (n=30),	  8-­‐week	  injured	  (n=30),	  and	  control	   (n	  =	  30)	  groups.	  Following	   the	   Institutional	  Animal	  Care	  and	  Use	  Committee	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(IACUC)	  guidelines,	   the	  rats	  underwent	  a	  simulated	  birth	   injury	  to	  mimic	  vaginal	  distress	  occurring	  commonly	  during	  a	  prolonged	  second	  stage	  of	  delivery.	  To	  induce	  the	  injury,	  a	  16	  Fr	  catheter	  was	  inserted	  into	  the	  vagina	  of	  the	  anesthetized	  rats,	  and	  inflated	  with	  5ccs	  of	  water.	  This	  volume	  has	  been	  shown	  previously	  by	  our	  group	  to	  induce	  a	  grossly	  observable	  vaginal	  laceration	  [4].	  	  While	  maintaining	  the	  volume,	  the	  rats	  were	  placed	  with	  their	  pubic	  symphysis	  at	  the	  edge	  of	  the	  table,	  and	  the	  catheter	  was	  then	  weighted	  with	  130gm,	  which	  was	  allowed	  to	  hang	  freely	  for	  3	  hours	  (Figure	  10).	  Rats	  were	  housed	  in	  a	  temperature	  and	  light-­‐controlled	   room	  with	   free	  access	   to	   food,	  and	  at	  4-­‐and	  8-­‐weeks	  post-­‐injury	   the	   rats	  were	  sacrificed.	  
2.2.2 	  Functional	  Analysis	  (Organ	  Bath)	  
Immediately	   after	   sacrifice	   at	   4-­‐weeks	   and	   8	   weeks	   post	   injury,	   the	   vagina	   was	   excised	  from	  each	  rat,	  and	  placed	  into	  Krebs’-­‐bicarbonate	  buffer	  (in	  mM/L:	  NaCl	  118,	  NaHCO3	  25,	  KCl	   4.7,	   MgSO4	   1.2,	   CaCl2	   2.5,	   KH2PO4	   1.2,	   and	   D-­‐glucose	   11).	   Approximately	   5	   x	   7	   mm	  circumferential	  vaginal	  strips	  were	  obtained	  from	  the	  proximal,	  middle	  and	  distal	  vagina,	  and	  suspended	  between	  two	  stationary	  clips	   in	  20	  ml	  tissue	  baths	  containing	  oxygenated	  Krebs’-­‐bicarbonate	  buffer	  	  (95%	  O25%	  CO2	  at	  37°C).	  Contractile	  responses	  were	  monitored	  with	   a	   pressure	   transducer	   (Transbridge	   4M,	   World	   Precision	   Instruments),	   and	  recordings	  were	  obtained,	  with	  Chart	  5	  software	  on	  a	  PowerLab	  system	  (sampling	  at	  40	  Hz,	  AD	   Instruments).	   Each	   tissue	   strip	   was	   adjusted	   to	   a	   tension	   of	   0.5	  g	   and	   allowed	   to	  equilibrate	   for	   at	   least	   60	  min,	   while	   changing	   the	   buffer	   solution	   every	   20	   min.	   	   To	  evaluate	   muscle-­‐mediated	   contractions,	   the	   contractile	   response	   to	   increasing	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concentrations	  of	  KCl	  (10,	  20,	  30,	  40,	  60,	  80,	  and	  120	  mM)	  was	  then	  measured	  (n=7).	  These	  concentrations	  were	   chosen	   based	   on	   results	   from	   dose	   response	   curves	   in	   preliminary	  experiments,	  in	  which	  we	  found	  the	  greatest	  change	  in	  force	  between	  10-­‐40	  mMKCl,	  with	  a	  plateau	  generally	  reached	  by	  120	  mMKCl.	  Once	  the	  response	  to	  a	  dose	  of	  KCl	  plateaued,	  the	  tissue	   was	   washed	   with	   Krebs	   solution	   3	   times	   (10	   minutes	   for	   each	   wash),	   prior	   to	  application	   of	   the	   next	   KCl	   dose.	   Contractile	   responses	   were	   normalized	   to	   tissue	   dry	  weight	   and	   volume,	   and	   EC50	   values	   (the	   concentration	   required	   to	   produce	   50%	   of	   the	  maximal	   contractile	   response)	   were	   calculated.	   The	   tissue	   exposed	   to	   KCl	   was	  subsequently	   used	   to	   evaluate	   nerve	   mediated	   contractile	   response.	   Electrical	   field	  stimulation	  (EFS)	  at	  frequencies	  of	  1-­‐64	  Hz,	  intensity	  of	  20	  volts,	  and	  duration	  of	  2	  seconds	  (n=6)	  was	  applied	  using	  a	  S88,	  Grass	  Telefactor	  stimulator.	  Tissue	  samples	  were	  washed	  with	   Krebs	   solution	   2	   times	   (5	   minutes	   for	   each	   wash)	   between	   trials.	   Contractile	  responses	   were	   again	   recorded,	   and	   normalized	   to	   tissue	   dry	   weight	   and	   volume.	   For	  analysis	  of	  receptor-­‐mediated	  contractions,	  the	  vaginas	  (n=14)	  were	  prepared	  in	  the	  same	  manner	   as	   those	   used	   for	   the	   KCl/EFS	   trials.	   Prior	   to	   stimulation	  with	   each	   agonist,	   the	  tissue	   was	   exposed	   to	   120	   mM	   KCl,	   which	   was	   used	   for	   evaluating	   muscle	   myofiber	  integrity	  and	   for	  normalizing	   for	  variability	   in	  muscle	   contractility.	  After	   the	   response	   to	  the	  120mM	  dose	  of	  KCl	  plateaued,	  the	  tissue	  was	  washed	  with	  Krebs	  solution	  3	  times	  (10	  minutes	   for	   each	   wash).	   Carbachol	   (n=7),	   a	   mixed	   muscarinic-­‐nicotinic	   acetylcholine	  receptor	  (MR)	  agonist	  or	  phenlyephrine	  (n=7),	  an	  α1-­‐adrenoceptor	  (AR)	  agonist,	  was	  then	  added	   to	   the	  organ	  bath	   in	   increasing	  concentrations	  (10−8	   to	  10−4	  M);	  non-­‐cumulatively.	  After	  the	  response	  to	  a	  concentration	  plateaued,	  the	  tissue	  was	  washed	  with	  Krebs	  solution	  3	  times	  (10	  minutes	  for	  each	  wash),	  prior	  to	  the	  application	  of	  the	  next	  dose.	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2.2.3 Histochemical	  and	  Immunohistochemical	  Analysis	  (Nerve	  Labeling)	  
Histological	   and	   immunohistochemical	   assays	   were	   also	   performed	   on	   fresh	  circumferential	   segments	   (proximal,	   middle,	   and	   distal),	   obtained	   from	   each	   rat.	   Each	  segment	   was	   fixed	   in	   4%	   paraformaldehyde	   overnight,	   and	   then	   exposed	   to	   graded	  concentrations	   of	   sucrose	   (cryoprotectant)	   before	   embedding	   into	   optimal	   cooling	  temperature	   (OCT)	   medium	   (Tissue-­‐Tek,	   Miles	   Inc.,	   Elkhart,	   USA).	   For	   histochemical	  analysis	  of	  gross	  morphology,	  and	  to	  measure	  vaginal	  perimeter,	  10-­‐20	  μm	  serial	  cryostat-­‐sections	   of	   the	   vaginal	   wall	   were	   obtained.	   The	   sections	   were	   then	   processed	   for	  hematoxylin	   and	   eosin	   staining	   according	   to	   the	   methods	   of	   the	   Center	   for	   Biological	  Imaging	   (CBI,	   University	   of	   Pittsburgh).	   For	   immunohistochemistry,	   the	   10um	   sections	  were	   air-­‐dried	   for	   1	   hour,	   permeabilized	   in	   .2%	   Triton	   X-­‐100	   for	   10	   min,	   and	   then	  incubated	   for	   1.5	   hours	   in	   2%	   Bovine	   Serum	   Albumin(BSA).	   Using	   the	   indirect	   probing	  method,	   the	   sections	  were	   first	   incubated	   for	  1	  hour	  at	   room	   temperature,	  with	  primary	  antibody	  diluted	   in	  PBDT	  (1xPBS,	   .2%	  BSA,	  2%	  Donkey	  Serum	  (Jackson	  Laboratories;	  no.	  017-­‐000-­‐00),	   and	   .03%	   Triton)	   against	   PGP	   9.5	   (1:10000;	   rabbit	   polyclonal	   antibody:	  Accurate	  Chemical,	  Westbury,	  NY	  YBG78630507),	  TH	  (1:1000;	  rabbit	  polyclonal	  antibody:	  Sigma	  T8700),	  and	  VAChT	  (1:5000	  rabbit	  monoclonal	  antibody:	  Sigma	  V5387).	  Following	  primary	  incubation,	  the	  sections	  were	  rinsed	  with	  PBS,	  and	  incubated	  for	  1	  hour	  at	  room	  temperature	   with	   Cy3-­‐conjugated	   f(ab)	   donkey	   anti-­‐rabbit	   IgG	   (1:100;	   Jackson	  Laboratories	  no.	  711	  165	  152)	  diluted	  in	  PBDT.	  The	  sections	  were	  again	  washed	  in	  buffer,	  and	  mounted	  in	  Fluoro-­‐Gel	  medium	  (EMS,	  Hatfield,	  PA	  	  17985-­‐10).	  In	  control	  experiments,	  no	  immunofluorescence	  staining	  was	  observed	  when	  the	  primary	  antiserum	  was	  omitted.	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2.2.4 	  Morphometric	  Analysis	  
All	  images	  were	  captured	  using	  a	  Nikon	  microscope	  synced	  to	  a	  Nikon	  color	  digital	  camera,	  before	  being	  imported	  into	  Elements	  software	  (NIS-­‐Elements	  AR	  3.2)	  for	  quantification.	  To	  measure	  the	  length	  of	  the	  vaginal	  perimeter	  in	  the	  three	  regions	  of	  the	  vagina,	  4x	  images	  of	  hematoxylin	   and	   eosin	   stained	   cross-­‐sections	   of	   the	   vaginal	   wall	   were	   prepared,	   and	  manual	   tracings	  of	   the	  outlines	  of	   the	  muscularis	   layer	  were	  performed.	  For	  comparative	  analysis	   of	   vaginal	   thickness,	   measurements	   were	   obtained	   at	   all	   four	   quadrants	   of	   the	  wall,	   and	   an	   average	   value	   of	   the	   four	   locations	   was	   obtained	   for	   each	   section.	   All	  measurements	  were	  done	  by	  blind	  estimation	  in	  duplicate,	  resulting	  in	  a	  repeat	  variability	  ratio	   of	   .01.	   To	   evaluate	   fibers	   immunoreactive	   for	   PGP	  9.5,	   TH,	   and	  VAChT	   in	   the	   three	  regions	   of	   the	   vagina,	   images	   were	   randomly	   captured	   at	   10x	   magnification,	   in	   all	   four	  quadrants	   of	   the	   vagina.	   For	   analysis,	   all	   images	  were	   acquired,	   and	   the	   same	   threshold	  was	   applied.	   Pixels	   of	   binary	   images	  whose	   intensity	   did	   not	   exceed	   the	   threshold	   value	  were	  automatically	  removed	  and	  considered	  negative.	  The	  number	  of	  profiles	  per	  unit	  area	  of	  the	  vaginal	  wall	  for	  the	  four	  locations	  were	  measured	  (fractional	  area)	  and	  averaged	  for	  each	  section.	  Nerves	   in	  all	   layers	  of	   the	  vaginal	  wall	  were	  quantified,	  but	   to	  prevent	  bias,	  attempts	  were	  made	  to	  exclude	  vascular	  innervation.	  For	  normalization,	  the	  fractional	  area	  of	  VAChT	  and	  TH	  immonoreactive	  nerves	  were	  expressed	  as	  a	  percentage	  of	   total	  nerves	  (PGP	  9.5	  immuoreactive	  nerves).	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2.2.5 Statistical	  Analysis	  
Functional	  Assays	  
	  
	  Non-­‐linear	   regression	  was	  used	   to	   analyze	   respone	   curves	  using	  GraphPad	  prism	  6.0	  (GraphPad	  Software,	  San	  Diego,	  CA).	  The	  maximal	  effect	  (Emax),	  and	  the	  half-­‐maximal	  effective	  concentration	  values	  were	  compared	  between	  groups	  using	  one-­‐way	  analysis	  of	  variance	  Students	  t-­‐test.	  Results	  were	  reported	  as	  means	  ±	  error.	  Significance	  was	  set	  at	  P	  <	  0.05.	   	  
Histochemical	  and	  Immunohistochemical	  Assays	  
	   Statistical	   analysis	  was	   performed	  using	   SAS	   statistical	   software,	   version	  9.2	   (SAS	  Institute	   Inc.).	   The	  mean	   value	   ±	   error	   of	   all	   parameter	   for	   each	   of	   the	   three	   vaginal	  segments	  was	  calculated.	  Differences	   in	  nerve	  type,	  vaginal	  wall	   thickness,	  and	  perimeter	  of	   the	   segments,	   between	   groups	   were	   compared	   using	   one-­‐way	   analysis	   of	   variance	  Students	  t-­‐test.	  Significance	  was	  set	  at	  P	  <	  0.05.	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2.3 RESULTS	  
2.3.1 	  Histological	  Results	  
Effects	  of	  birth	  injury	  on	  gross	  tissue	  morphology	  
	  
	   Evaluation	   of	   gross	   morphological	   changes	   showed	   the	   greatest	   difference	   between	  groups,	  in	  the	  proximal-­‐	  and	  mid-­‐vagina	  (Table	  1).	  	  
	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Table	  1.	  Morphometric	  Analysis	  	   Perimeter	  (mm)	  	  	  	  	  	  	  	   Thickness	  (mm)	  
Proximal	  	  Control	  	   	  15.620	  ±	  0.088	   	  0.307	  ±	  0.008	  4	  WEEK	  INJ	  	   15.437	  ±	  0.167	   0.428	  ±	  0.013a*	  8	  WEEK	  INJ	   16.170	  ±	  0.146	   0.376	  ±	  0.010a*	  
Middle	  	  Control	  	   	  18.198	  ±	  0.336	   	  0.309	  	  ±	  0.009	  4	  WEEK	  INJ	  	   22.201	  ±	  0.309a*	   0.325	  ±	  0.005	  8	  WEEK	  INJ	  	   21.067	  ±	  0.394a*	   0.343	  ±	  0.009	  
Distal	  Control	  	   	  16.570	  ±	  0.259	   	  0.551	  ±	  0.014	  4	  WEEK	  INJ	  	   18.906	  ±	  0.390	   0.632	  ±	  0.016	  8	  WEEK	  INJ	  	   17.373	  ±	  0.235	   0.601	  ±	  0.012	  
Values	  	  presented	  as	  Mean	  ±	  	  SEM	  (	  n	  =	  6,	  per	  group)	  *indicates	  significant	  
at	  	  P<	  .05	  a	  relative	  to	  control	  b	  relative	  to	  4	  WEEK	  INJ	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Figure	   10.	  Histological Results of Vaginal Cross-Sections.	   (I)	   Representative	   outlines	   of	   the	   mid vaginal	   lumen	   of	   hematoxylinF and	   eosinF stained	   cross sections	   from	  control	  (A),	   4	  WEEK	   INJ	   (B),	   and	   8	  WEEK	   INJ	   (C)	   groups.	   Vaginal	   injury	  was	   associated	  with	   an	   increase	   in	   the	   vaginal	   lumen,	   observed	   in	   the	   4	   WEEK	   INJ	   group	   (P=	   0.007),	   with	   minimal	  recovery	  in	  the	  8	  WEEK	  INJ	  group	  (P	  =0.041).	  (II)	  Evaluation	  of	  morphology	  of	  the	  corresponding	   crossF sections	   from	   control	   (A),	   4	   WEEK	   INJ	   (B),	   and	   8	   WEEK	   INJ	   groups	   showed	   gross	   disorganization	   in	   the	   4	   WEEK	   INJ	   group	   (arrows),	   and	   increased	   fibrosis	  (arrows)	  in	  the	  8	  WEEK	  INJ	  group.	  (u	  =	  urethra,	  v	  =	  vagina,	  f	  =	  fascia)	  bar	  =	  100	  um	  
In	  the	  proximal	  vagina	  the	  thickness	  of	  the	  vaginal	  wall	  significantly	  increased	  from	  0.307	  ±	  0.024	  mm	  to	  0.428	  ±	  0.034	  mm	  (P	  =	  0.010)	  by	  4	  weeks	  post-­‐injury,	  and	  at	  8	  weeks	  post	  injury	  the	  thickness	  had	  only	  marginally	  recovered	  relative	  to	  controls	  (0.376	  ±	  0.025	  mm,	  P	   <	   0.062).	   In	   the	  mid	   vagina,	   the	   vaginal	   lumen	   increased	   from	   18.198	   ±	   0.824	  mm	   to	  
P = 0.042 
P = 0.007 
**Mean&±&SEM&
&&&Control&&&&&&&&4&Week&INJ&&&&8&Week&INJ&
A. B. C. 
A C B 
 CONTROL/sham  4 WEEK/INJ  8 WEEK/INJ 
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22.201	   ±	   1.011	  mm	   at	   4	  weeks	   post	   injury,	   as	   illustrated	   by	   the	   representative	   outlines	  
(Figure	   10	   –	   Panel	   1),	   corresponding	   to	   a	   22.2%	   increase	   (P	   =	   0.007).	   Subsequent	  evaluation	  at	  8	  weeks	  also	  showed	  that	  the	  perimeter	  of	  the	  lumen	  had	  not	  fully	  recovered	  relative	  to	  controls	  (P	  <	  0.042).	  Hemotoxylin	  and	  Eosin	  staining	  performed	  to	  histologically	  assess	   the	   impact	  of	   these	  morphometric	   changes	  on	  gross	   tissue	   structure,	   showed	  at	  4	  weeks	  post	  injury,	  disorganization	  of	  connective	  tissues	  and	  smooth	  muscle	  bundles,	  most	  extensively	   in	   the	   mid	   vagina	   (Figure	   10).	   At	   8	   weeks	   post	   injury,	   there	   was	   less	  disorganization,	  but	  with	   increasing	   fibrosis	   (Figur	   10).	  Also	  at	  8	  weeks	  post	   injury,	   the	  location	  along	  the	  vagina	  where	  gross	  laceration	  had	  occurred	  did	  not	  recover,	  as	  there	  was	  less	  dense	  connectives	  tissues	  and	  muscles	  bundles	  relative	  to	  adjacent	  locations.	  	  
	  
2.3.2 Functional	  Results	  
Effect	  of	  VaBI	  on	  Musclegenic	  Contractions	  
	  	   Our	  functional	  analysis	  began	  with	  the	  evaluation	  of	  myofiber	  function,	  as	  measured	  by	  the	  force	  generated	  following	  KCl-­‐induced	  contractions	  (n	  =	  7,	  per	  group)	  (Figure	  11).	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  Figure	   11.	   Representative	   Tracings	   of	   EFS	   and	   KCl	   Responses.	   Recordings	   of	   the	  contractile	   response	   of	   mid-­‐vaginal	   segments	   to	   KCl	   (120	   mM)	   and	   EFS	   (1-­‐	   64Hz),	   in	  control	  (A),	  4	  WEEK	  INJ	  (B),	  and	  8	  WEEK	  INJ	  (C)	  groups	  showed	  increased	  contraction	  in	  the	   control	   group,	   relative	   to	   the	   injured	   groups,	   with	   decreasing	   contractile	  magnitude	  with	  time	  post	  injury.	  There	  was	  also	  evidence	  of	  increased	  fatigue	  in	  the	  injured	  group	  as	  evidence	  by	  the	  oscillations	  following	  KCl	  administration.	  
	  The	  response	  curves	  showed	  concentration	  dependent	  contractions	  that	  were	  significantly	  different	  between	  the	  groups	  in	  the	  proximal	  and	  mid-­‐vagina	  (Figure	  12).	  In	  the	  proximal	  vagina,	  at	  4	  weeks,	  Emax	  was	  similar	  to	  controls	  but	  the	  EC50	  had	  decreased	  in	  the	  proximal	  vagina	   relative	   to	   controls	   (P	   =	   0.168,	   P	   =	   0.007)	   (Table	   2,	   Table	   3).	   At	   8-­‐weeks	   the	  contractile	  force	  generated	  had	  become	  significantly	  higher,	  as	  evidence	  by	  an	  increase	  in	  Emax	  from	  1.198	  ±	  0.213	  mN	  to	  2.618	  ±	  0.824	  mN	  (P	  =	  0.006),	  with	  a	  persistent	  decrease	  in	  EC50	   from	   -­‐2.359	   ±	   0.059	  M	   to	   -­‐2.860	   ±	   0.056M	   (P	   <	   0.001).	   In	   the	  middle	   vagina,	   at	   4	  weeks,	  the	  Emax	  also	  had	  not	  increased	  (P	  <	  0.540),	  but	  the	  EC50	  had	  decreased	  from	  -­‐2.45	  ±	  0.048	  M	   to	   -­‐2.59	   ±	   0.056	  M	   (P	   =	   0.056).	   Subsequent	   evaluations	   at	   8	  weeks	   post	   injury	  
 1 sec 
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showed	  that	  the	  Emax	  had	  not	  increased	  (P	  <	  0.540),	  but	  the	  EC50	  persistently	  declined	  -­‐2.75	  ±	  0.053	  M	  (P	  =	  0.003).	  Similar	  to	  the	  histological	  analysis,	  no	  differences	  were	  observed	  in	  the	   distal	   vagina.	   To	   determine	   if	   the	   effects	   varied	   with	   time	   post	   injury,	   comparisons	  between	  the	  4-­‐	  and	  8-­‐week	  groups	  were	  performed.	  The	  results	  showed	  no	  changes	  in	  Emax,	  but	   there	   was	   a	   significant	   increase	   in	   EC50	   between	   the	   4	   and	   8-­‐week	   groups	   in	   the	  proximal	   and	   middle	   vagina	   (P	   =	   0.001,	   P	   =	   0.069),	   indicating	   a	   persistent	   increase	   in	  muscle	  hypersensitivity.	  
	  
	  	   	  





Figure	   12.	   Functional	   Response	   Curves.	   Evaluation	  of	   the	  4	  WEEK	   INJ	   vs	  8	  WEEK	   INJ	  group	   showed	   an	   increase	   in	   EC50	   (P	   =	   0.001,	   P	   =	   0.069)	   in	   response	   to	   KCl	   (n=7),	   a	  decrease	  in	  Emax	  (P	  =	  0.002,	  P	  =	  0.005)	  in	  response	  to	  CCh	  (n=7),	  a	  decline	  in	  the	  EC50	  in	  the	   distal	   vagina	   (P	   =	   0.011)	   in	   response	   to	   PE	   (n=7),	   and	   no	   further	   decline	   in	   EFS	  response	  following	  a	  decline	  in	  the	  4	  WEEK	  INJ	  group	  (P	  =	  0.758).	  	  
  Emax: P < 0.001 
B. Nerve (EFS: 1-64Hz) 
A. Muscle Myofiber (KCl: 10-120 mM) C. Cholinergic Receptors (CCh: 10−8 to 10−4 M) 
D. α1-Adrenergic Receptors (PE: 10−8 to 10−4 M) 
**Mean ± SEM 
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Effect	  of	  VaBI	  on	  Neurogenic	  Contractions	  
	   To	  evaluate	  nerve	  function,	  the	  force	  generated	  following	  EFS-­‐induced	  contractions	  were	   measured,	   as	   shown	   in	   Figure	   1	   (n	  =	   7,	   per	   group).	   The	   response	   curves	   showed	  frequency	  dependent	  contractions	  that	  were	  significantly	  different	  between	  the	  groups	  in	  the	  proximal,	  mid-­‐	  and	  distal	  vagina	  (Figure	  12).	  In	  the	  proximal	  vagina,	  at	  4	  weeks	  post	  injury,	  Emax	  was	  similar	  to	  control	  (P	  =	  0.868),	  but	  had	  declined	  at	  8	  weeks	  to	  0.471	  ±	  0.381	  mN	  from	  0.804	  ±	  0.241	  mN,	  albeit	  non-­‐significantly	  (P	  =	  0.085)	  (Table	  2,	  Table	  3).	  In	  the	  mid-­‐vagina,	  at	  4	  weeks	  there	  was	  significant	  decline	  in	  Emax	  from	  0.822	  ±	  0.204	  mN	  to	  0.533	  ±	  0.180	  (P	  =	  0.026).	  Subsequently	  evaluation	  at	  8	  weeks	  showed	  a	  persistent	  decline	  (0.476	  ±	   0.415)	  mN	   but	  was	   variable,	   thus	  making	   differences	   undetectable	   (P	   =	   0.091).	   In	   the	  distal	   vagina,	   at	   4	   weeks	   post	   injury	   there	   was	   no	   decline	   in	   Emax	   (P	   =	   0.971),	   but	  evaluations	  at	  8	  weeks	  post	  injury	  showed	  a	  persistent	  decline	  in	  Emax	  from	  0.610	  ±	  0.100	  mN	   to	  0.278	  ±	  0.034	  mN	  (P	  =	  0.023).	  A	  more	   specific	   look	  at	   the	  Emax,	   at	  64	  Hz,	   showed	  significant	  declines	  in	  the	  proximal,	  middle	  and	  distal	  vagina	  at	  8	  weeks	  relative	  to	  controls	  (P	  =	  0.020,	  P	  =	  0.024,	  P	  =	  0.012),	   indicating	  a	  persistent	   loss	   in	  nerve	   function.	  To	  again	  determine	   if	   the	   effect	   varied	  with	   time	   post	   injury,	   comparisons	   between	   the	   4-­‐	   and	   8-­‐week	  groups	  were	  performed.	  The	  results	  showed	  evidence	  of	  a	  decreasing	  trend	  in	  Emax	  in	  the	  proximal	  and	  distal	  vagina	  (P	  =	  0.034,	  P	  =	  0.032),	  indicating	  a	  persistent	  loss	  of	  nerve	  function.	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  Table	  2.	  Maximum	  Contractile	  (Emax)	  Response	  to	  KCl	  and	  EFS	  	   	  	  KCl	  -­‐	  Emax	  (mN/mm3)	   	  	  	  	  EFS	  -­‐	  Emax	  	  	  	  	  	  (%	  KCl)	  
Proximal	  	  Control	  	   	  1.198	  ±	  0.079	   	  	  0.804	  ±	  0.035	  4	  WEEK	  INJ	  	   2.122	  ±	  0.224	   	  0.824	  ±	  0.032	  8	  WEEK	  INJ	  	   2.831	  ±	  0.200b*	   	  0.374±	  0.043ab*	  
Middle	  	  Control	  	   	  1.537	  ±	  0.149	   	  	  	  	  	  	  	  0.901	  ±	  0.054	  4	  WEEK	  INJ	  	   1.033	  ±	  0.064	   	  	  0.534	  ±	  0.030a*	  8	  WEEK	  INJ	  	   1.340	  ±	  0.091	   	  	  0.246±	  0.023ab*	  
Distal	  Control	  	   	  	  1.339	  ±	  0.084	   	  	  	  0.610±	  0.051	  4	  WEEK	  INJ	  	   	  1.451	  ±	  0.133	   	  0.489	  ±	  0.029	  8	  WEEK	  INJ	  	   	  0.988	  ±	  0.076	   	  0.278	  ±	  0.015ab*	  
Emax	   determined	   from	   non-­‐linear	   regression	   of	   the	   concentration-­‐
response	   curves	   	   -­‐	   values	   presented	   as	   Mean	   ±	   SEM	   (n	   =	   7)	  
*significant	   at	   P<	   .05	   a	   relative	   to	   control	   b	   relative	   to	   4	  WEEK	   INJ	  
abbreviations:	  KCl:	  Potassium	  Choloride,	  EFS:	  Electrical	  Field	  Stimul	  
	  
	  
Effect	  of	  VaBI	  on	  Muscarinic	  Receptor	  Mediated	  Contractions	  
	   To	  evaluate	  muscarinic	  receptor	  function,	  the	  force	  generated	  following	  carbachol-­‐induced	  contractions	  were	  measured	  (n	  =	  7,	  per	  group).	  The	  response	  curves	  showed	  dose	  dependent	   contractions	   that	   were	   significantly	   different	   between	   the	   groups	   in	   the	  proximal,	  and	  distal	  vagina	  (Figure	  12).	  In	  the	  proximal	  vagina,	  at	  4	  weeks	  post	  injury,	  Emax	  decreased	  from	  2.450	  ±	  0.390	  mN	  to	  1.443	  ±	  0.280	  mN	  (P	  =	  0.0193),	  but	  the	  EC50	  had	  was	  similar	  to	  control	  (P	  =	  0.687)	  (Table	  3,	  Table	  4).	  Evaluation	  of	  the	  8-­‐week	  group	  showed	  that	  the	  Emax	  had	  further	  decreased	  to	  1.026	  ±	  0.023	  mN	  (P	  =	  0.010),	  but	  the	  EC50	  was	  still	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similar	   to	   control	   (P	   =	   0.869).	   At	   4	   weeks	   post	   injury,	   Emax	   in	   the	   proximal	   vagina	   had	  decreased	  from	  2.450	  ±	  0.390	  mN	  to	  1.443	  ±	  0.280	  mN	  (P	  =	  0.019),	  but	  the	  EC50	  was	  similar	  to	  control	  (P	  =	  0.687).	  In	  the	  middle	  vagina,	  at	  4	  weeks	  post	  injury,	  the	  Emax	  was	  similar	  (P	  =	  0.331)	  and	   the	  EC50	  was	  also	  similar	  controls	   (P	  =	  0.240)	  and	  at	  8	  week	  Emax	  had	   further	  declined,	  but	  did	  not	  reach	  significance	  (P	  =	  0.060)	  and	  neither	  did	  the	  E50	  (P	  =	  0.682).	  In	  the	   distal	   vagina,	   at	   4	  weeks	   post	   injury,	   Emax	   had	   also	   decreased	   from	  1.611	   ±	   0.353	   to	  0.814	  ±	  0.196	  %	  (P	  =	  0.032)	  but	  the	  EC50	  had	  not	  decreased	  (P	  =	  0.962),	  and	  evaluation	  of	  the	  8-­‐week	  group	  showed	  a	  persistent	  decline	   in	  Emax	  (0.788	  ±	  0.181	  mN,	  P	  =	  0.037),	  but	  again	  there	  was	  no	  difference	  in	  the	  EC50	  (P	  =	  0.846).	  Comparison	  of	  the	  4-­‐week	  vs	  8-­‐week	  group	  showed	  evidence	  of	  a	  decreasing	  trend	  in	  Emax	  in	  the	  proximal	  and	  middle	  vagina	  (P	  =	   0.002,	   P	   =	   0.005),	   but	   with	   no	   corresponding	   change	   in	   EC50	   (P	   =	   0.772,	   P	   =	   0.804),	  indicating	  a	  persistent	  decline	  in	  receptor	  density,	  but	  not	  in	  receptor	  sensitivity.	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Table	  3.	  Half-­‐Maximum	  Concentration	  (EC50)	  for	  KCl,	  CCh,	  and	  PE	  	   KCl-­‐	  pEC50	  (M)	   CCh-­‐	  pEC50	  (M)	   PE-­‐	  pEC50	  (M)	  
Proximal	  	  Control	  (n	  =7)	   	  -­‐2.359	  ±	  0.019	   	  	  -­‐6.146	  ±	  0.021	   	  -­‐3.132	  ±	  0.275	  4	  WEEK	  INJ	  (n	  =	  7)	   	  	  	  -­‐2.595	  ±	  0.019a*	   	  -­‐6.078	  ±	  0.051	   	  -­‐4.523	  ±	  0.234	  8	  WEEK	  INJ	  (n	  =	  7)	   	  	  	  	  -­‐2.860	  ±	  0.013ab*	   	  	  	  	  -­‐6.155	  ±	  0.079	   	  -­‐3.616	  ±	  0.380	  
Middle	  	  Control	  (n	  =	  7)	   	  -­‐2.454	  ±	  0.015	   	  -­‐6.089	  ±	  0.041	   	  -­‐1.765	  ±	  0.143	  4	  WEEK	  INJ	  (n	  =	  7)	   	  -­‐2.595	  ±	  0.059a*	   	  -­‐6.084	  ±	  0.047	   	  	  	  -­‐5.972	  ±	  0.119a*	  8	  WEEK	  INJ	  (n	  =	  7)	   	  	  -­‐2.756	  ±	  0.051ab*	   	  -­‐6.033	  ±	  0.055	   	  	  	  	  -­‐5.949	  ±	  0.109a*	  
Distal	  Control	  (n	  =	  7)	   	  -­‐2.550	  ±	  0.030	   	  -­‐6.090	  ±	  0.036	   	  	  -­‐3.060	  ±	  0.460	  4	  WEEK	  INJ	  (n=7)	   	  -­‐2.515	  ±	  0.026	   	  -­‐5.969	  ±	  0.066	   	  	  	  -­‐6.034	  ±	  0.017a*	  8	  WEEK	  INJ	  (n	  =7)	   -­‐2.536	  ±	  0.013	   	  	  	  	  -­‐6.011	  ±	  0.104	   	  	  	  	  -­‐6.342	  ±	  0.052ab*	  
EC50	   determined	   from	   non-­‐linear	   regression	   of	   the	   concentration-­‐response	   curves	   -­‐	  
values	  presented	   as	  Mean	   ±	  SEM	   (n	   =	   7)	   *indicates	   significant	   at	   P<	   .05	   a	   relative	   to	  
control	   b	   relative	   to	   4	   WEEK	   INJ	   -­‐	   abbreviations:	   KCl:	   Potassium	   Choloride,	   CCh:	  
Carbachol,	  PE:	  Phenylephrine	  Note:	  No	  sensitivity	  measure	  was	  obtained	  for	  EFS	  
	  
Effect	  of	  VaBI	  on	  Adrenergic	  Receptor	  Mediated	  Contractions	  
	   To	   evaluate	   α1-­‐adrenergic	   receptor	   function,	   the	   force	   generated	   following	  phenylephrine-­‐induced	  contractions	  was	  measured	  (n	  =	  7,	  per	  group).	  The	  response	  curves	  showed	  dose	  dependent	  contractions	  that	  were	  significantly	  different	  between	  the	  groups	  in	  the	  middle,	  and	  distal	  vagina	  (Figure	  12).	  In	  the	  middle	  vagina,	  at	  4	  weeks	  post	  injury,	  Emax	  and	  EC50	  were	  similar	  to	  controls	  (P	  =	  0.187,	  P	  =	  0.609),	  but	  evaluation	  of	  the	  8-­‐week	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group	   showed	   that	   the	   Emax	   had	   decreased	   from	  1.366	   ±	   0.190	   to	   0.825	   ±	   0.420	  %	   (P	   =	  0.030),	  but	  there	  was	  no	  difference	  in	  the	  EC50	  (P	  =	  0.183)	  (Table	  3,	  Table	  4).	  In	  the	  distal	  vagina,	   at	   4	   weeks	   post	   injury,	   the	   Emax	   was	   similar	   to	   controls	   but	   the	   EC50	  decreased	  relative	  to	  controls	  (P	  =	  0.281,	  P	  =	  0.025),	  and	  evaluation	  at	  8	  weeks	  showed	  similar	  trends	  (P	  =	  0.229,	  P	  =	  0.025).	  Comparison	  of	   the	  4-­‐week	  vs	  8-­‐week	  group	  showed	  evidence	  of	  a	  decreasing	  trend	  in	  Emax,	  but	  significant	  declines	  were	  only	  evident	  in	  the	  EC50	  in	  the	  distal	  vagina	  (P	  =	  0.011),	  indicating	  a	  persistent	  increase	  in	  receptor	  hypersensitivity.
Table	  4.	  Maximum	  contractile	  (Emax)	  response	  to	  CCh	  and	  PE	  	  	  CCh	  	  -­‐	  Emax	  	  	  	  	  	  (%	  KCl)	   	  	  	  	  PE	  -­‐	  Emax	  (%	  KCl)	  
Proximal	  Control	   	  2.450	  ±	  0.147	   	  0.753	  ±	  0.044	  4	  WEEK	  INJ	   	  1.470	  ±	  0.036a*	   	  0.442	  ±	  0.087	  8	  WEEK	  INJ	   	  	  1.026	  ±	  0.093ab*	   	  0.320	  ±	  0.073a*	  
Middle	  Control	   1.706	  ±	  0.080	   	  0.777	  ±	  0.026	  4	  WEEK	  INJ	   1.805	  ±	  0.045	   	  0.896	  ±	  0.065	  8	  WEEK	  INJ	   	  1.107	  ±	  0.026ab*	   	  0.825	  ±	  0.070	  
Distal	  Control	   	  	  1.611	  ±	  0.113	   	  0.967±	  0.031	  4	  WEEK	  INJ	   	  	  0	  .851	  ±	  0.063a*	   	  1.637	  ±	  0.075a*	  8	  WEEK	  INJ	   	  	  0.788	  ±	  0.073a*	   	  2.053	  ±	  0.217a*	  
Emax	  determined	  from	  non-­‐linear	  regression	  of	  the	  concentration-­‐
response	   curves	   -­‐	   values	   presented	   as	   Mean	   ±	   SEM	   (n	   =	   7)	  
*indicates	  significant	  at	  P<	  .05	  a	  relative	  to	  control	  b	  relative	  to	  4
WEEK	  INJ	  abbreviations:	  CCh:	  Carbachol	  PPE:	  Phenylephrine	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2.3.3 	  Immunohistochemical	  Results	  
Effect	  of	  VaBI	  on	  Peripheral	  Nerve	  Density	  	  
	  PGP	  9.5,	  an	  enolase	  expressed	  in	  peripheral	  nerves,	  was	  used	  as	  a	  pan	  neuronal	  marker	  (n	  =	  5,	  per	  group).	  Follow	  labeling	  and	  quantification	  of	  the	  percent	  fractional	  area	  of	  PGP-­‐IR	  nerves,	   there	  were	  significant	  differences	   in	  the	  middle	  and	  the	  distal	  vagina	  (Figure	  13,	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Figure	   13.	   Peripheral	   Nerve	   Labeling.	   	   Evaluation	   of	   peripheral	   innervations	   (A)	   in	  addition	  to	  more	  specific	  evaluations	  of	  the	  cholinergic	  (B),	  and	  adrenergic	  innervations	  (C)	  of	  mid-­‐vaginal	  segments	  from	  control	  4	  WEEK	  INJ	  and	  8	  WEEK	  INJ	  middle	  groups,	  showed	  a	  increased	  paucity	  of	  adrenergic	  nerve	  innervations	  with	  injury.	  	  
	  
Effect	  of	  VaBI	  Cholinergic	  Nerve	  Density	  	  
	   	  Nerves	   labeling	   positive	   for	   a	   vesicular	   acetylcholine	   transporter	   (VAChT),	  which	  mediates	   acetylcholine	   storage	   by	   synaptic	   nerves	   was	   used	   as	   a	   marker	   of	   cholinergic	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nerves.	   Following	   labeling	   and	   quantification	   of	   the	   percent	   fractional	   area	   of	   VAChT-­‐IR	  nerves,	  the	  results	  showed	  significant	  differences	  in	  the	  proximal,	  middle	  and	  distal	  vagina	  
(Figure	  13,	  Table	  5).	  In	  the	  proximal	  vagina,	  at	  4	  weeks	  post	  injury,	  the	  percent	  fractional	  area	  of	  VAChT	  -­‐IR	  nerves	  had	  decreased	  relative	  to	  controls	  (0.818±	  0.115	  to	  0.203	  ±	  0.042	  %,	  P	  <	  0.001),	  and	  evaluation	  of	  the	  8-­‐week	  group	  no	  recovery	  at	  0.205	  ±	  0.030	  (P	  <	  0.001).	  In	  the	  middle	  vagina,	  at	  4	  weeks	  post	  injury,	  the	  percent	  fractional	  area	  had	  also	  declined	  relative	  to	  controls	  (0.520±	  0.043	  to	  0.195	  ±	  0.027	  %,	  P	  <	  0.001),	  and	  evaluation	  of	  the	  8-­‐week	  group	  showed	  that	  the	  percent	  fractional	  area	  had	  not	  recovered	  (0.235	  ±	  0.037,	  P	  <	  0.001).	  In	  the	  distal	  vagina,	  at	  4	  weeks	  post	  injury,	  the	  percent	  fractional	  area	  had	  declined	  relative	  to	  controls	  (0.702	  ±	  0.037	  to	  0.166	  ±	  0.044	  %,	  P	  <	  0.001),	  and	  evaluation	  of	  the	  8-­‐week	  group	  showed	  no	  recovery	  (0.104	  ±	  0.018,	  P	  <	  0.001).	  Comparison	  of	  the	  4-­‐week	  vs	  8-­‐week	   group	   showed	   no	   significant	   difference	   in	   the	   percent	   fractional	   area	   in	   the	  proximal,	  middle	  or	  distal	  vagina	  (P	  =	  0.972,	  P	  =	  0.443,	  P	  =	  0.264).	  
	  
Effect	  of	  VaBI	  on	  Adrenergic	  Nerve	  Density	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Tyrosine	   hydroxylase	   (TH),	   which	   catalyzes	   the	   conversion	   of	   the	   amino	   acid	   L-­‐tyrosine	  to	  dihydroxyphenyalanine	  (DOPA),	  was	  used	  as	  a	  marker	  for	  adrenergic	  nerves	  (n	  =	  5,	  per	  group).	  Follow	  labeling	  and	  quantification	  of	  the	  percent	  fractional	  area	  of	  TH-­‐IR	  nerves,	   the	  results	  showed	  significant	  differences	   in	  the	  middle	  and	  distal	  vagina	  (Figure	  
13	  Table	  5).	  In	  the	  middle	  vagina,	  at	  4	  weeks	  post	  injury,	  the	  percent	  fractional	  area	  of	  TH-­‐IR	  nerves	  had	  decreased	  relative	  to	  controls	  (0.407	  ±	  0.051	  to	  0.214	  ±	  0.052	  %,	  P	  =	  0.046),	  and	  evaluation	  of	  the	  8-­‐week	  group	  showed	  no	  recovery	  at	  0.156	  ±	  0.065	  (P	  =	  0.001).	  In	  the	  
	   	   57	  
distal	  vagina,	  the	  percent	  fractional	  area	  at	  4	  weeks	  had	  also	  declined	  relative	  to	  controls	  (0.492	  ±	  0.087	   to	  0.119	  ±	  0.032	  %,	  P	  =	  0.006),	   and	   evaluation	  of	   the	  8-­‐week	   group	   also	  showed	   that	   the	   percent	   fractional	   area	   had	   recovered	   (0.065	   ±	   0.016,	   P	   <	   0.001).	  Comparison	   of	   the	   4-­‐week	   vs	   8-­‐week	   group	   showed	   declining	   trends,	   but	   no	   significant	  difference	   in	   the	   percent	   fractional	   area	   in	   the	   middle	   or	   distal	   vagina	   (P	   =	   0.334,	   P	   =	  0.179).	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
	  
	  	  	  	  	  	  	  	  Table	  5.	  Innervation	  Density	  (%	  Fractional	  Area)	  	   	  	  	  	  	  	  PGP	  9.5	  	  	  (pan	  neuronal)	  	  	  	  	  	   	  	  	  	  	  	  VAChT	  	  	  (cholinergic)	   	  	  	  	  	  	  	  	  TH	  	  (adrenergic)	  
Proximal	  	  Control	   	  0.536	  ±	  0.070	   	  0.818	  ±	  0.054	   	  0.500	  ±	  0.039	  4	  WEEK	  INJ	   0.305	  ±	  0.016	   0.203	  ±	  0.017a*	   	  0.159	  ±	  0.029	  8	  WEEK	  INJ	   0.251	  ±	  0.016	   0.205	  ±	  0.012a*	   	  0.136	  ±	  0.013a*	  
	  
Middle	  	  Control	   	  0.922	  ±	  0.075	   	  0.520	  ±	  0.021	   	  0.407	  ±	  0.031	  4	  WEEK	  INJ	   0.438	  ±	  0.027a*	   0.195	  ±	  0.013a*	   	  0.214	  ±	  0.025a*	  8	  WEEK	  INJ	   0.300	  ±	  0.016a*	   0.235	  ±	  0.015a*	   	  0.156	  ±	  0.007a*	  
Distal	  Control	   	  0.428	  ±	  0.013	   	  0.702	  ±	  0.022	   	  0.492	  ±	  0.042	  4	  WEEK	  INJ	   0.258	  ±	  0.019a*	   0.166	  ±	  0.018a*	   0.119	  ±	  0.016a*	  8	  WEEK	  INJ	   	  0.206	  ±	  0.013a*	   0.104	  ±	  0.009a*	   0.065	  ±	  0.006a*	  
Values	  	  presented	  as	  Mean	  ±	  	  SEM	  (n	  =	  7)	  -­‐	  significant	  difference	  a	  relative	  to	  control	  
b	  relative	  to	  4	  WEEK	  INJ,	  significant	  at	  *P<	  .05	  ,	  abbreviations:	  PGP	  9.5:	  Protein	  Gene	  
Product	  9.5,	  VAChT:	  Vesicular	  Acetylcholine	  Transporter,	  TH:	  Tyrosine	  Hydrolase	  
	   	   58	  
2.4 DISCUSSION	  
This	   study	   was	   designed	   to	   pharmacologically	   and	   immunohistologically	   assess	   smooth	  muscle	   recovery	   following	   a	   simulated	  birth	   injury	   in	   a	   rodent	  model.	   At	   4	  weeks	   and	  8	  weeks	   post	   injury,	   evaluations	   were	   performed	   to	   assess	   time-­‐dependent	   changes	   in	  recovery,	   as	   evidence	  of	   a	   persistent	   change	   in	   smooth	  muscle	  morphology	   and	   function	  would	  illustrate	  how	  maternal	  birth	  injury,	  occurring	  in	  a	  subset	  of	  women,	  may	  potentially	  limit	  the	  ability	  of	  smooth	  muscle	  to	  fully	  recover,	  postpartum.	  The	  results	  showed	  changes	  in	   smooth	   muscle	   morphology,	   as	   well	   as	   myofiber,	   nerve	   and	   receptor	   function.	  Interestingly,	  morphological	  changes	  were	  observed	  to	  recover	  or	  stabilize	  with	  time,	  while	  changes	   in	   function	   steadily	   declined.	   More	   specifically,	   muscle	   and	   receptor	   function	  significantly	   declined	   with	   time,	   suggesting	   their	   potential	   role	   in	   modulating	   smooth	  muscle	  degeneration.	  The	  responses	  were	  also	  region	  specific,	  with	  the	  greatest	  impact	  of	  injury	   occurring	   in	   the	   proximal	   and	   middle	   vagina,	   but	   with	   the	   distal	   vagina	   rapidly	  declining	   by	   8	   weeks	   to	   the	   level	   of	   the	   proximal	   and	  middle	   vagina.	   The	   injury	   model	  utilized	  does	  not	  mimic	  the	  hormonal	  and	  mechanical	  adaptations	  that	  precede	  childbirth,	  and	  the	  regional	  differences	  may	  indeed	  be	  a	  function	  of	  the	  mode	  of	  injury,	  nevertheless	  the	   results	   show	   the	   gross	   potential	   of	  maternal	   birth	   injury	   to	   alter	   vaginal	  mechanics,	  when	  maternal	  adaptations	  are	  insufficient.	  Hence,	  the	  greatest	  contribution	  of	  this	  study	  could	  be	  the	  data	  that	  helps	  elucidate	  a	  potential	  link	  between	  birth	  injury	  and	  pelvic	  organ	  prolapse,	   as	  women	  with	   prolapse	   also	   have	   altered	   vaginal	   smooth	  muscle	  morphology	  and	  function.	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These	   alterations	   in	   function	   are	  most	   evident	   in	   the	   anterior	   vaginal	  wall,	  which	  consists	   of	   a	   dense	   layer	   of	   circular	   and	   longitudinal	   smooth	  muscle	   bundles	   interlaced	  between	   layers	   of	   connective	   tissues.	   As	   such,	   the	   anterior	   vaginal	   compartment	   has	   an	  increased	  occurrence	  of	  prolapse,	   thus	  compromising	  support	  to	  the	  bladder	  and	  urethra	  [122].	   Hence,	   much	   research	   has	   been	   geared	   toward	   the	   characterization	   of	   smooth	  muscle	  properties	  in	  vaginal	  tissues	  of	  the	  anterior	  wall	  in	  women	  with	  prolapse.	  A	  study	  by	   Boreham	   and	   el.	   analyzing	   smooth	  muscle	  morphometry	   in	   the	   anterior	   vaginal	  wall	  reported	   a	   decrease	   in	   thickness	   of	   the	   smooth	   muscle	   layer	   in	   women	   with	   prolapse	  relative	  to	  controls	  [101].	  The	  observed	  changes	  were	  not	  related	  to	  age,	  race	  or	  stage	  of	  prolapse,	   hence	   the	   authors	   concluded	   that	   these	   changes	   may	   occur	   early	   in	   the	  pathogenesis	   of	   the	   dysfunction.	   Little	   is	   known,	   however,	   with	   respect	   to	   risk	   factors	  influencing	   the	   alteration	   in	   smooth	   muscle	   structure	   and	   function	   in	   prolapse	   vaginal	  tissues.	  What	  is	  known,	  however,	  is	  that	  these	  changes,	  in	  addition	  to	  the	  observed	  loss	  of	  tone	  and	  increased	  wall	  mobility,	  are	  both	  phenomena	  typically	  associated	  with	  pregnancy	  [123].	   In	  preparation	   for	  delivery,	   smooth	  muscle	   cells	   dedifferentiate	   from	  a	   contractile	  (0.17	   N/m)	   to	   a	   more	   undifferentiated	   and	   less	   contractile	   phenotype	   (0.09	   N/m),	  characterized	  by	  increased	  migration	  and	  proliferation,	  thus	  increasing	  tissue	  growth	  and	  compliance	   [124].	   According	   to	   Dietz	   et	   al,	   women	  with	   increased	   vaginal	   wall	  mobility	  before	   delivery	   are	   at	   less	   risk	   of	   incurring	   delivery	   related	   changes,	   a	   finding	   further	  supported	   Oliphant	   et	   al	   [125],	   [126].	   These	   findings	   support	   the	   premise	   that	   smooth	  muscle	   in	   women	   with	   POP	   results	   from	   the	   disruption	   of	   the	   post	   partum	   recovery	  mechanisms	  following	  VaBI.	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Injury	   to	   the	   smooth	   muscle	   can	   modulate	   its	   phenotype,	   as	   shown	   in	   a	   study	  evaluating	   injured	   arteries,	   which	   were	   injured	   similar	   to	   the	   method	   employed	   in	   this	  study	   [127].	   The	   results	   showed	   a	   greater	   amount	   of	   synthetic	   smooth	   muscle	   cells	   in	  injured	   arteries,	   a	   phenomenon	   which	   is	   known	   to	   be	   a	   result	   of	   injury	   to	   the	   elastic	  lamellae.	  The	  injury	  induced	  increased	  matrix	  deposition	  and	  neointimal	  thickening	  of	  the	  arterial	  wall,	  but	  smooth	  muscle	  cells	  did	  eventually	  return	  to	  their	  contractile	  phenotype,	  restoring	  myofiber	  function.	  This	  study	  is	  one	  among	  several	  showing	  that	  strain	  induced	  injuries	  can	  cause	  smooth	  muscle	  modulation,	  and	  complementary	  studies	  have	  shown	  that	  these	   changes	   (i.e	   neointima	   formation)	   are	   necessary	   for	   equilibrating	   the	   stress	   field	  within	  the	  arterial	  wall	  following	  hemodynamic	  perturbations	  [128],	  [129].	  These	  findings	  clearly	   attest	   to	   the	  potential	   of	   strain	   injuries	   to	   induce	   smooth	  muscle	   remodeling,	   but	  drawing	   further	   from	   these	   studies,	   one	   could	   infer	   that	   the	   observed	   increase	   in	   the	  thickness	  of	   the	  vaginal	  wall	   in	   the	  proximal	  vagina,	  and	  the	   increase	   in	   the	  perimeter	  of	  the	   vaginal	   lumen	   in	   the	   middle	   vagina,	   may	   be	   a	   result	   of	   smooth	   muscle	   phenotypic	  modulation	   in	   response	   to	   altered	   mechanical	   loading,	   following	   injury.	   One	   could	   also	  further	  infer,	  that	  in	  the	  absence	  of	  a	  response	  needed	  to	  equilibrate	  the	  stress	  field	  within	  the	  vaginal	  wall,	  a	  continuous	  remodeling	  response	  will	  ensue.	  However,	  for	  the	  vagina,	  the	  observed	  changes	  were	  short-­‐lived,	  as	  our	  evaluations	  at	  8	  weeks	  showed	  a	  trend	  toward	  baseline.	   These	   findings	   suggest	   that	   the	   impact	   of	   mechanical	   perturbations	   may	   be	  compensated	  for,	  and	  hence	  may	  not	  be	  orchestrating	  the	  tissue	  degeneration.	  	  However,	   changes	   in	   nerve	   function	   did	   persist,	   and	   hence	   may	   potentially	  orchestrate	   tissue	  degeneration.	  The	  pudendal	  nerve,	  arising	   from	  the	  S2-­‐S4	  nerve	  roots,	  supplies	  most	   of	   the	   anatomic	   pelvic	   structures	   and	   partially	   reversible	   pudendal	   nerve	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injury	   occurs	   commonly	  with	   vaginal	   birth,	   as	  well	   as	   the	   pelvic	   and	   hypogastric	   nerves	  which	   innervates	   vaginal	   smooth	  muscle	   are	   also	   impacted	   [130].	   Nerve	   injury	   is	   more	  likely	  with	   forceps	  delivery,	  multiparity,	   longer	   second-­‐stage	   labor,	   third-­‐degree	  perineal	  tear,	   and	   macrosomia	   [131].	   Denervation	   within	   the	   pubococcygeus	   and	   anal	   sphincter	  muscles	   accompany	   42%	   to	   80%	   of	   vaginal	   deliveries,	   and	   these	   effects	   are	   likely	   also	  evident	   within	   the	   vagina.	   Snooks	   et	   al.	   also	   showed	   that	   denervation–reinnervation	  patterns	   become	   more	   pronounced	   with	   increased	   passage	   of	   time	   from	   delivery,	  supporting	  our	  functional	  and	  histological	  findings	  of	  persistent	  declines	  in	  cholinergic	  and	  adrenergic	   nerve	   function	   at	   8	   weeks	   relative	   to	   initial	   evaluations	   at	   the	   4	   weeks	   post	  injury	  [131].	  The	  findings	  are	  limited	  to	  impact	  of	  injury	  on	  smooth	  muscle	  function	  in	  the	  circumferential	  direction	  since	  the	  circumferential	  direction	  is	  known	  to	  undergo	  the	  most	  significant	   deformation,	   but	   similar	   findings	   may	   be	   likely	   found	   in	   the	   longitudinal	  direction.	  Correspondingly,	   evaluations	   of	   the	   receptors	   showed	   impact	   to	   cholinergic	   and	  adrenergic	  receptors	   in	  the	  proximal	  and	  middle	  vagina.	  Very	  few	  studies	  have	  evaluated	  the	  impact	  of	  prolapse	  on	  vaginal	  cholinergic	  and	  adrenergic	  receptor	  function,	  but	  recent	  studies	   by	  Northington	   et	   al.	   evaluating	   adrenergic	   receptor	   function;	   found	   that	   tissues	  from	   women	   with	   prolapse	   had	   a	   lower	   response	   to	   the	   adrenergic	   receptor	   agonist,	  phenylephrine	   relative	   to	   non-­‐prolapse	   controls	   [98].	   The	   difference	   was	   striking,	   and	  supports	   the	   idea	   that	  a	   loss	  of	  receptor	   function	  occurring	  after	  birth	   injury,	  may	  play	  a	  potential	   role	   in	   the	   pathogenesis	   of	   pelvic	   organ	   prolapse	   (POP).	   The	   functional	   and	  physiological	   significance	   of	   these	   receptors	   have	  not	   been	  widely	   studied	   in	   the	   vagina,	  but	   age	   related	   declines	   in	   M3	   muscarinic	   receptors	   function	   in	   the	   bladder	   results	   in	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decreased	   contractility,	   thus	   impairing	   voiding	   function	   [132].	   The	   vagina	   is,	   however	  known	   to	   undergo	   age-­‐related	   increases	   in	   cholinergic	   and	   adrenergic	   receptor	  innervation,	   perhaps	   as	   a	   compensation	   for	   a	   decline	   in	   vaginal	   receptor	   function	   [133].	  Hence,	   a	  decline	   in	   receptor	   function	   in	  addition	   to	  a	  decline	   in	  nerve	   function	  as	   shown	  here	  following	  injury,	  could	  lead	  to	  a	  loss	  of	  tone	  within	  the	  vagina,	  thus	  comprising	  pelvic	  support.	   The	   semi-­‐quantitative	   nature	   of	   immunolabeling	   techniques	   also	   renders	   it	  vulnerable	  to	  questions	  about	  reliability;	  however	  it	  suffices	  here,	  as	  only	  relative	  changes	  were	  evaluated.	  	  Overall,	  our	  results	  showed	  progressive	  changes	  in	  myofiber	  and	  receptor	  function,	  with	  time	  post	  injury,	  which	  may	  be	  attributed	  to	  the	  observed	  loss	  of	  nerve	  function..	  The	  lack	  of	  progressive	  histomorophologic	   findings	  suggests	  that	  changes	   in	  vaginal	  structure	  may	   be	   unrealiable	  markers	   for	   early	   prognosis	   of	   POP,	   and-­‐or	  may	   attest	   to	   the	   lower	  sensitivity	  of	  the	  histological	  assays	  relative,	  to	  functional	  assays.	  However,	  the	  functional	  assay	  did	  show	  a	  decline	  in	  nerve	  and	  receptor	  function	  with	  time,	  suggesting	  an	  increased	  role	  in	  orchestrating	  future	  changes	  in	  vaginal	  function.	  The	  impact	  was	  broad,	  severe,	  and	  region-­‐specific,	  with	  the	  greatest	  impact	  observed	  in	  the	  middle	  vagina	  (20	  -­‐80%	  functional	  change).	  The	  injury	  model	  utilized,	  unfortunately,	  does	  not	  mimic	  the	  hormonally	  regulated	  maternal	  adaptations	  that	  precede	  a	  birth	  injury,	  and	  the	  regional	  differences	  may	  indeed	  be	   a	   function	   of	   the	  mode	   of	   injury,	   nevertheless	   the	   results	   show	   the	   potential	   of	   birth	  injury	  to	  alter	  vaginal	  smooth	  muscle	  function,	  when	  maternal	  adaptations	  are	  insufficient.	  
3.0	   	  VaSM	  FUNCTION	  INFLUENCES	  VAGINAL	  BIAXIAL	  MECHANICS	  
3.1 BACKGROUND	  
As	  reported	   in	  Chapter	  2,	   vaginal	   smooth	  muscle	   contractile	  machinery,	   innervation,	   and	  receptor	  function	  are	  impaired	  following	  VaBI.	  Therefore,	  evidence	  of	  a	  strong	  relationship	  between	   smooth	   muscle	   function	   and	   vaginal	   mechanics	   would	   further	   validate	   the	  potential	  role	  of	  smooth	  muscle	  as	  a	  pathogenic	  factor	  of	  POP.	  It	  has	  been	  long	  established	  that	   pregnancy	   induces	   the	   differentiation	   of	   VaSM	   cells	   from	   a	   contractile	   (0.17	   N/m)	  phenotype	   to	  a	  more	   immature	  or	  synthetic	  phenotype	  (0.09	  N/m)	   [22].	  These	  synthetic	  smooth	   muscles	   cells	   have	   no	   contractile	   tone,	   are	   migratory,	   and	   highly	   proliferative,	  enabling	   the	  vagina	   to	   increase	   its	  muscle	  content	   in	  order	   to	  accommodate	  passage	  of	  a	  large	  fetus	  with	  reduced	  risk	  of	  injury.	  These	  phenotypic	  changes	  can	  indeed	  alter	  vaginal	  mechanics.	  This	  is	  of	  particular	  relevance,	  as	  full	  recovery	  of	  smooth	  muscle	  to	  a	  contractile	  phenotype	  post-­‐partum	  is	  essential	  for	  restoring	  vaginal	  tone.	  This	  is	  rather	  interesting,	  as	  after	  delivery	  in	  many	  women,	  the	  vagina	  is	  usually	  not	  fully	  restored.	  These	  changes	  can	  be	  observed	  as	  decreased	  vaginal	  tone,	  increased	  diameter,	  lower	  elasticity,	  in	  addition	  to	  other	   common	   characteristics	   of	   changes	   in	   the	   active	   muscle	   mechanics	   of	   the	   tissue	  [134].	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  The	  changes	  in	  vaginal	  properties	  following	  delivery,	  are	  interesting	  relative	  to	  the	  development	   of	   POP,	   as	   studies	   characterizing	   smooth	   muscle	   properties	   and	   density	  within	  prolapse	  and	  non-­‐prolapse	  tissues	  have	  shown	  that	  women	  with	  POP	  have	  a	  lower	  amount	  of	  contractile	  smooth	  muscle	  cells	  compared	  to	  women	  presenting	  with	  symptoms	  of	   POP	   [94].	   Additionally,	   studies	   evaluating	   vaginal	   smooth	   muscle	   protein	   at	   the	  transcriptional	   level	   showed	   alteration	   of	   SM-­‐myosin	   heavy	   chain	   and	   caldesmon	  expressions,	  which	  are	  markers	  smooth	  muscle	  contractile	  potential	  [135].	  However,	  there	  has	  been	  a	  lack	  of	  consensus	  in	  smooth	  muscle	  findings,	  especially	  with	  regards	  to	  whether	  smooth	   muscle	   dysfunction	   is	   the	   cause	   or	   the	   effect	   of	   POP.	   Limited	   sample	   sizes	   and	  challenges	  of	  human	  tissue	  acquisition	  for	  such	  studies	  contribute	  to	  the	  conflicting	  results.	  Notwithstanding,	  a	  definitive	  finding	  is	  that	  changes	  in	  smooth	  muscles	  are	  present	  within	  the	  vagina	  [136].	  	  In	  arteries,	  smooth	  muscle	  acts	  as	  a	  shock	  absorber	  during	  phasic	  stroke	  volume	  in	  systole,	  thereby	  dampening	  the	  arterial	  pressure	  wave	  [137].	  The	  active	  tension	  generated	  by	   smooth	  muscle	   also	  decreases	   compliance,	   and	   increases	  wall	   area,	  wall	   stiffness	   and	  stress.	  Smooth	  muscle	  also	  has	  a	  huge	  effect	  on	  arterial	  elasticity,	  due	  to	  its	  abundance	  in	  the	  wall,	  and	  comparable	  percentages	  (28%	  of	  wall	  area)	  have	  been	  determined	  for	  vaginal	  smooth	  muscle,	   further	  supporting	  its	  major	  role	  in	  maintaining	  vaginal	  mechanics	  [138],	  [139].	   It	  has	  also	  been	  shown	  that	  elastin	  and	  collagen	  account	  for	  a	   larger	  percentage	  of	  wall	   area,	   and	  mechanics	   of	   the	   vaginal	  wall	   is	   likely	   highly	   dependent	   on	   these	   passive	  structures.	  However,	  impairment	  of	  the	  active	  components	  may	  have	  secondary	  effects	  on	  the	  passive	   components,	  with	   the	  potential	   to	   alter	   the	   loading	   environment,	   and	   induce	  tissue	   remodeling.	   It	   is	   not	   surprising	   then,	   that	   studies	   do	   find	   a	   degree	   of	   correlation	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between	   collagen	   architecture	   and	   POP.	   If	   smooth	   muscle	   is	   in	   series	   with	   elastin	   and	  collagen	   in	   the	  vaginal	  wall,	   as	  has	  been	  postulated	  by	  Bank	  et	   al.	   (Figure	   16),	   a	   loss	  of	  smooth	   muscle	   function	   would	   cause	   more	   rapid	   recruitment,	   altering	   the	   mechanical	  properties	  of	  the	  vagina.	  These	  changes	  in	  mechanical	  properties	  could	  therefore	  promote	  a	  remodeling	  response	  that	  could	  manifests	  as	  POP.	  	  This	   finding	   is	   expected	   because	   a	   myriad	   of	   diseases	   are	   associated	   with	   an	  alternation	   in	   the	   mechanical	   properties	   of	   the	   pathologic	   organs.	   For	   abdominal	   aortic	  aneurysms,	  a	  “rupture	  potential	  index,”	  defined	  as	  the	  locally	  acting	  wall	  stress	  divided	  by	  the	  local	  wall	  strength,	  was	  suggested	  for	  predicting	  the	  risk	  of	  abdominal	  aortic	  aneurysm	  rupture,	   to	   determine	   point	   of	   intervention,	   and	   evaluate	   surgical	   outcomes	   [140].	   The	  utilization	  of	  these	  principles	  in	  the	  field	  of	  gynecology	  may	  also	  improve	  clinical	  outcomes,	  because	   POP	   does	   result	   in	   significant	   biomechanical	   changes	   in	   pelvic	   supporting	  structures.	   Currently,	   there	   is	   no	   data	   available	   that	   shows	   alterations	   in	   vaginal	  mechanics,	  resulting	  from	  a	  loss	  of	  smooth	  muscle	  function,	  and	  especially	  following	  VaBI.	  Thus,	  the	  goal	  of	  this	  work	  is	  to	  characterize	  the	  contribution	  of	  vaginal	  smooth	  muscle	  to	  parameters	  of	  vaginal	  wall	  stiffness,	  elasticity,	  and	  anisotropy;	  as	  these	  findings	  could	  have	  major	  clinical	  implications	  for	  both	  the	  evaluation	  and	  treatment	  of	  POP.	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3.2 PROTOCOL	  
3.2.1 Animals	  
The	  Institutional	  Animal	  Care	  and	  Use	  Committee	  at	  the	  University	  of	  Pittsburgh	  approved	  the	  use	  of	  animals,	   in	  accordance	  with	  the	  National	   Institute	  of	  Health	  Guide	  for	  the	  Care	  and	  Use	  of	  Laboratory	  Animals.	  For	  the	  study,	  10	  virgin	  female	  rats	  at	  3-­‐month	  old	  virgin	  were	  obtained	  (Long	  Evans,	  230-­‐280	  g,	  Hilltop	  Lab	  Animals,	   Inc.,	  Scottsdale,	  PA)	  and	  pair	  housed	  in	  a	  temperature	  and	  light-­‐controlled	  room	  with	  free	  access	  to	  food,	  until	  the	  day	  of	  sacrifice.	  
	  
3.2.2 Biaxial	  Mechanical	  Tests	  
Tissue	  Preparation	  
	   Immediately	   after	   sacrifice,	   the	   vagina	  was	   excised	   from	  each	   rat,	   and	  placed	   into	  Krebs’-­‐bicarbonate	  buffer	   (in	  mM/L:	  NaCl	  118,	  NaHCO3	  25,	  KCl	  4.7,	  MgSO4	  1.2,	  CaCl2	  2.5,	  KH2PO4	  1.2,	  and	  D-­‐glucose	  11).	  The	  vagina	  was	  then	  cut	  along	  the	  length	  of	  the	  urethra,	  the	  longitudinal	   edge	   of	   the	   specimen	   was	   then	   cut	   to	   ensure	   that	   the	   urethra	   had	   been	  completely	  dissected.	  Approximately	  10	  ±	  3.0	  x	  10	  ±	  3.00	  mm	  vaginal	  strips	  were	  obtained	  from	   the	   posterior	  wall	   of	   the	   vagina.	   Specimen	   thickness	  was	   obtained	   using	   a	   custom,	  laser	  reflection	  system,	  and	  the	  width	  and	  length	  were	  measured	  by	  digital	  calipers	  [141].	  Hooks	  with	  suture	  lines	  attached,	  were	  inserted	  with	  4	  hooks	  along	  each	  edge	  of	  the	  tissue	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as	   shown,	   five	  markers	  were	   then	   centrally	   placed	   on	   the	   tissue,	   to	   limit	   edge	   effects	   as	  shown	   in	   Figure	   1.	   The	   tissue	   was	   then	   placed	   into	   a	   400	   ml	   tissue	   bath	   containing	  oxygenated	  Krebs’-­‐bicarbonate	  buffer	  (95%	  O25%	  CO2	  at	  37°C)	  for	  the	  duration	  of	  the	  test.	  	  	  
Testing	  Regimen	  
	   The	   sample	   was	   loaded	   into	   the	   biaxial	   testing	   device	   –	   Bose	   Electroforce	   LM1	  Testbench	   system	   (Bose	   Corporation,	   Minnesota,	   USA).	   The	   sample	   was	   allowed	   to	  equilibrate	  for	  5	  minutes	  and	  then	  a	  preloaded	  (0.1N)	  using	  a	  triangular	  loading	  waveform	  at	  frequency	  of	  0.25	  Hz.	  The	  markers	  were	  tracked,	  during	  the	  test,	  using	  a	  contrast	  based	  camera	  system	  (Bose	  2-­‐D	  DVE	  software)	  to	  obtain	  tissue	  strain	  (Green	  strain).	  The	  sample	  was	  then	  subjected	  to	  10	  cycles	  of	  preconditioning	  using	  a	  sine	  wave	  displacement	  curve	  of	  equi-­‐biaxial	   Lagrangian	   stress	   (0.1	   MPa)	   along	   the	   longitudinal	   and	   circumferential	  directions.	  Additional	  cycles	  were	  performed	  at	  ratios	  of	   (.5:1,	   .75:1,	  1:1,	  1:75,	  1:.5),	  with	  1:1	   indicating	   0.1	   MPa	   of	   equibiaxial	   stress,	   and	   data	   were	   recorded	   for	   analysis.	   (For	  simplicity,	   only	   data	   from	   1:1	   regimen	   is	   discussed.	   Data	   on	   additional	   regimens	   are	  reported	  in	  Appendix	  II.)	  The	  specimen	  was	  then	  brought	  to	  the	  predefined	  zero	  position,	  and	  120	  mM	  KCl	  solution	  was	  added	  to	  the	  bath	  to	  induce	  smooth	  muscle	  tonic	  contraction.	  The	   specimen	   was	   equilibrated	   for	   5	   minutes	   and	   then	   preloaded,	   preconditioned,	   and	  tested	   as	   described	   above.	   Following	   the	   muscle	   contractile	   regimen,	   Ca2+	   free	   Krebs	  solution	  supplemented	  with	  4	  mM	  of	  the	  calcium-­‐chelating	  agent	  EGTA,	  was	  added	  to	  the	  bath	  to	  induce	  muscle	  relaxation	  and	  the	  protocol	  was	  repeated	  [142].	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Parameters	  	   For	   analysis,	   stress-­‐strain	   curves	   were	   generated	   based	   on	   the	   Green-­‐Lagrangian	  strains	  calculated	  from	  the	  marker	  displacements.	  The	  strains	  were	  calculated	  for	  both	  the	  circumferential	  (εCirc)	  and	  axial	  (εAxial)	  direction,	  each	  during	  the	  3	  experimental	  conditions	  (baseline,	  contacted	  and	  relaxed).	  The	  maximum	  strain	  and	  maximum	  tangent	  modulus	  for	  the	  toe	  stiffness	  vs	  linear	  stiffness	  region	  of	  the	  curve	  were	  obtained.	  Also	  calculated	  were	  the	  areal	  strain,	  and	  the	  anisotropic	  index	  (Eqs.1	  and	  2).	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  Areal  Strain =    ε!"#$ ∗ ε!"#$% + (ε!"#$ +   ε!"#$%)	  	  	  	  	  	  	  (1)	  
	   	  	  	  	  	  	  	  	  	  	  Anisotropic  Index = 2 ∗    !!"#$  ∗    !!"#$%(!!"#$  !  !!"#$%)	  	  	  	  	  	  	  (2)	  	  To	   separate	   the	   contribution	  of	   the	   active	   (MTMa)	   and	   (MTMp)	  passive	  properties	   to	   the	  tensile	  modus	  of	  the	  vagina,	  total	  tension	  (MTMT)	  was	  defined	  similarly	  to	  that	  previously	  reported	  by	  both	  Gao	  et	  al.	  and	  Tremblay	  et	  al	   [106],	   [143].	  Total	   tension	  for	  the	  current	  study	   was	   calculated	   following	   KCl	   application.	   Using	   this	   method,	   total	   tension	   in	   the	  tissue	   is	   defined	   as	   the	   summation	   of	   active	   and	   passive	   tension.	   Thus,	   following	   the	  application	  of	  EGTA	  all	  active	  tension	  should	  diminish,	  resulting	  in	  a	  total	  tissue	  tension	  of	  only	  the	  passive	  contributors	  ie	  collagen,	  elastin,	  GAGs	  etc.	  However,	  it	  is	  possible	  that	  not	  all	  of	  the	  active	  tension	  will	  be	  eliminated.	  Therefore	  the	  parameter	  f	  (a	  value	  representing	  
the	   percent	   change	   in	   the	   active	   mechanics	   of	   the	   tissues)	   was	   used	   to	   account	   for	   the	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functional	   contribution	   of	   smooth	  muscle	   (Eq.	   3).	   All	   Statistical	   analysis	   was	   performed	  utilizing	  a	  one-­‐way	  ANOVA,	  with	  a	  significance	  level	  of	  P	  <	  0.05.	  	   MTM! =   MTM! + 𝑓MTM!	  	  (3)	  
3.2.3 	  	  Collagen,	  Elastin,	  and	  Smooth	  Muscle	  Imaging	  
Multiphoton	   imaging	  was	  performed	   to	  visualize	   collagen,	  elastin,	   and	  smooth	  muscle,	   in	  non-­‐stretched	  specimens.	   Images	  of	   injured	  specimens	  evaluated	   in	  Chapter	  2,	  were	  also	  captured	  to	  determine	  the	  impact	  VaBI	  on	  these	  structures.	  For	  visualization,	  each	  segment	  was	   fixed	   in	   4%	   paraformaldehyde	   overnight.	   Following	   the	   methods	   of	   Hill	   et	   al.,	   the	  specimen	   was	   placed	   on	   a	   glass	   slide	   and	   imaging	   was	   performed	   using	   an	   Olympus	  FV1000	  MPE	  (Tokyo,	  Japan)	  equipped	  with	  a	  Spectra-­‐Physics	  DeepSee	  Mai	  Tai	  Ti-­‐Sapphire	  laser	   (Newport,	   Mountain	   View,	   CA)	   [144].	   The	   images	   were	   obtained	   at	   an	   excitation	  wavelength	  of	  870nm,	  numerical	  aperture	  (NA)	  of	  1.12,	  using	  a	  25x	  MPE	  water	  immersion	  objective.	  	  	  
3.2.4 	  	  Statistical	  Analysis	  
Statistical	  analysis	  was	  performed	  using	  SPSS	  statistical	  software	  (version	  17.0;	  SPSS	  Inc.,	  Chicago,	   IL).	  The	  average	  parameter	  estimates	   for	  each	  muscle	  condition	  were	  compared	  using	   non-­‐parametric	   one-­‐way	   analysis	   of	   variance	   (ANOVA).	   Significance	   was	   set	   at	  p<0.05.	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3.3 RESULTS	  
3.3.1 	  	  Functional	  Results	  
The	  results	  suggest	  that	  the	  vagina	  can	  be	  characterized	  as	  hyperelastic	  and	  anisotropic,	  as	  has	  been	  previously	  reported	  (Figure	  14).	  	  
	  





Figure	  14.	  Schematic	  Representation	  of	  the	  Stretch-­‐Stress	  Curves.	  Loading	  of	  the	  axial	  (A),	  and	  the	  circumferential	  (B)	  direction	  of	  the	  vagina	  resulted	  in	  distinct	  loading	  patterns	  when	  the	  muscle	  was	  at	  baseline,	  contracted,	  or	  relaxed.	  Of	  note,	  was	  the	  observation	  that	  contraction	  of	  the	  muscle	  resulted	  in	  a	  curve	  synonymous	  of	  a	  more	  gradual	  recruitment	  of	  collagen	  fibers	  in	  the	  axial	  direction.	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Table	  6.	  Biaxial	  Curves	  -­‐	  Parameters	  	   Baseline	  (Krebs)	   Contracted	  (KCl)	   Relaxed	  (EGTA)	  E11	  Low	  Tensile	  Modulus	  	  	  (MPa)	   1.797	  ±	  0.460	   1.678	  ±	  0.167	   1.987	  ±	  0.454	  E11	  High	  Tensile	  Modulus	  (MPa)	   1.944	  ±	  0.785	   1.943	  ±	  0.799	   2.236	  ±	  0.270	  E11	  Maximum	  Strain	  (%)	   0.035	  ±	  0.004	   0.027	  ±	  0.007	   0.031	  ±	  0.010	  E22	  Low	  Tensile	  Modulus	  (MPa)	   0.690	  ±	  0.058	   0.571	  ±	  0.044	   0.531	  ±	  0.139	  E22	  High	  Tensile	  Modulus	  (MPa)	   2.640	  ±	  0.805	   2.016	  ±	  0.581	   1.710	  ±	  0.413	  E22	  Maximum	  Strain	  (%)	   0.059	  ±	  0.004	   0.063	  ±	  0.007	   0.069	  ±	  0.017	  
Parameter	  obtained	  from	  the	  stress-­‐strain	  curves	  when	  smooth	  muscle	  was	  at	  baseline,	  
contracted,	  and	  relaxed.	  The	  data	  are	  means	  ±	  SD;	  n	  =	  5	  	  *indicates	  P	  <	  0.05	  	  	  
	  	  Specially,	  contraction	  of	  the	  VaSM	  caused	  a	  36%	  (P	  =	  0.74)	  percent	  decrease	  in	  the	  tensile	  modulus	  in	  the	  axial	  direction,	  and	  a	  9%	  (P	  =	  0.87)	  increase	  in	  the	  circumferential	  direction	  
(Figure	  15).	  Differences	  relative	  to	  the	  relaxed	  conditions	  were	  even	  more	  obscure,	  and	  no	  differences	   were	   observed	   in	   the	   maximum	   strain	   in	   the	   axial	   and	   the	   circumferential	  direction.	  As	  evident,	  from	  the	  Figure,	  the	  differences	  were	  not	  significant,	  as	  limitations	  of	  the	  testing	  system	  prevented	  the	  acquisition	  of	  data	  at	  low	  loads	  (load	  <	  0.1	  N).	  Previously,	  work	  by	  Bank	  et	  al	  et	  Gao	  et	  al	  showed	  that	  smooth	  muscle	  is	  most	  functional	  at	  low	  loads	  such	  at	   that	  used	  here	   (Figure	   16)	   [105],	   [106].	  Hence,	   the	  effect	  of	   smooth	  muscle	  was	  particularly	   evident	   by	   the	   significant	   difference	   in	   strains	   observed	   during	   our	   preload	  regimen.	  Specifically,	  following	  preloading	  of	  the	  tissue,	  the	  average	  strains	  in	  the	  baseline	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vs	  contracted	  state	  significantly	  differed	  for	  E11	  (13.6	  ±	  4.8%	  vs	  23.4	  ±	  11.5%,	  P	  =	  0.03),	  and	   for	   the	   areal	   strain	   (0.29	  ±	  0.13%	  vs	  0.58	  ±	  0.37%,	  P=	  0.06).	  The	   axial	   strains	  were	  large,	   thus	   rendering	   our	   baselines	   too	   high	   to	   observe	   any	   major	   significant	   effects	   of	  smooth	  muscle.	  	  There	  was	  also	  very	   little	  difference	  observe	   in	   the	   areal	   strain	  or	   the	  anisotropic	  index	  (Table	  7).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Table	  7.	  Biaxial	  Coupling	  -­‐	  Parameters	  	   Anisotropic	  	  Index	   Areal	  Strain	  	  Baseline	  (Krebs)	   0.78	  ±	  0.414	   0.10	  ±	  0.04	  Contracted	  (KCl)	   0.91	  ±	  0.289	   0.12	  ±	  0.06	  Relaxed	  (EGTA)	   0.99	  ±	  0.272	   0.11	  ±	  0.02	  
Parameter	  obtained	  from	  the	  high-­‐stiffness	  region	  of	  the	  
stress-­‐strain	  curves	  when	  smooth	  muscle	  was	  at	  baseline,	  
contracted,	  and	  relaxed.	  The	  data	  are	  means	  ±SD;	  n	  =	  5	  	  
*indicates	  P	  <	  0.05	  	  
	  	  	  	  	  	  	  	  	  However,	   as	   shown	   in	   Appendix	   II,	   there	   was	   a	   trend	   at	   all	   loading	   regimens,	  toward	   increased	   areal	   strain	   and	   decreasing	   anisotropy	   following	   smooth	   muscle	  contraction.	  These	  changes	  were	  most	  evident	  when	   there	  was	  a	  significant	  difference	   in	  the	   stressing	   being	   applied	   to	   each	   axis	   (Figure	   29).	   This	   supports	   the	   absence	   of	   any	  significant	  difference	  observed	  at	  the	  1:1	  loading	  regimen,	  as	  the	  ability	  of	  smooth	  muscle	  to	  distribute	   stress	  between	   the	  axes.	  The	   results	   in	  Appendix	   II	   also	   show	  a	  governing	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role	   of	   strains	   in	   the	   circumferential	   direction	   on	   strains	   observed	   in	   the	   longitudinal	  direction,	  which	  may	  be	  indicative	  of	  the	  preferred	  orientation	  of	  the	  collagen	  and	  elastin.	  
3.3.2 Histological	  Results	  
Evaluation	   of	   the	   collagen,	   elastin,	   and	   smooth	  muscle	   in	   the	   vaginal	  muscularis	   showed	  smooth	  muscle	  bundles	  intricately	  connected	  to	  the	  surrounding	  collagen	  and	  elastin	  fibers	  
(Figure	  16).	  For	  validation	  of	  this	  method,	  vaginal	  tissues	  of	  VaBI	  injured	  rats,	  at	  8	  weeks	  post-­‐injury	   were	   evaluated	   and	   showed	   less	   visible	   muscle	   bundles	   relative	   to	   controls	  
(Figure	  17).	  	  





Figure	  16.	  Collagen,	  Elastin	  and	  Smooth	  Muscle	  Imaging.	  Multiphoton	  imaging	  revealed	  resident	   collagen	   (red),	   elastin	   (green),	   and	   smooth	   muscle	   (green	   bundles)	   within	   the	  vaginal	  muscularis	   (16–A).	   These	   structures	   are	   intricately	   connected,	   and	  may	   function	  synergistically	  to	  regulate	  collagen	  recruitment	  in	  response	  to	  applied	  loads	  (16-­‐B).	  	  
	  




Figure	   17.	   Collagen,	   Elastin,	   and	   Smooth	   Muscle	   Imaging	   of	   the	   Injured	   Vagina.	  Multiphoton	  imaging	  of	  8-­‐weeks	  after	  VaBi	   in	  the	  rat	  revealed	  less	  visible	  smooth	  muscle	  (green	  bundles)	  within	  the	  vaginal	  muscularis,	  evidenced	  by	  the	  absence	  of	  α-­‐actinin,(	  an	  actin	  binding	  protein).	  	  
3.4 DISCUSSION	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which	  is	  more	  representative	  of	  in-­‐vivo	  conditions.	  Uniaxial	  tests	  also	  provide	  very	  limited	  information	  about	  tissue	  properties	  especially	  when	  attempting	  to	  characterize	  changes	  in	  mechanics	   during	   periods	   of	   remodeling	   [145].	   Therefore,	   for	   this	   work,	   we	   chose	   to	  perform	  equibiaxial	  mechanical	  tests	  to	  evaluate	  the	  role	  of	  smooth	  muscle	   in	  the	  vagina.	  This	   is	   particularly	   necessary	   here,	   as	   smooth	   muscle	   is	   oriented	   both	   axially	   and	  circumferentially	  within	  the	  vagina,	  and	  thus	  may	  have	  an	  individual	  impact	  on	  each	  axis,	  as	  well	  a	  combined	  or	  coupling	  effect.	  Additionally,	  with	  the	  focus	  being	  to	  investigate	  the	  mechanical	  role	  of	  smooth	  muscle,	  which	  to	  date	  has	  been	  poorly	  defined	  in	  the	  vagina;	  all	  tests	  were	  preformed	  on	  viable	  specimens.	  	  	  	   Stress-­‐strain	   curves	   generated	   following	   load-­‐control	   regimens	   were	   non-­‐linear	  and	  biphasic,	  exhibiting	  a	  low-­‐stiffness	  region	  and	  high-­‐stiffness	  region,	  most	  evidently	  in	  the	  circumferential	  direction.	  The	  results	  showed	  a	  three-­‐fold	  higher	  stiffness	   in	  the	  axial	  versus	   circumferential	   direction	   in	   the	   low	   stiffness	   region.	   However,	   there	   was	   no	  difference	  at	  the	  high	  stiffness	  region	  of	  the	  curve.	  Although	  it	  is	  assumed	  that	  strain	  in	  the	  circumferential	   direction	   must	   be	   larger	   than	   strains	   in	   the	   axial	   direction,	   especially	  during	  parturition,	  no	  previously	  published	  accounts	  were	  found.	  This	  degree	  of	  anisotropy	  was	  more	  evident	  when	  smooth	  muscle	  was	  at	  baseline	  level	  (ex-­‐vivo	  resting	  tension)	  and	  when	   passivated	   (relaxation),	   versus	  when	   activated	   (tonic	   contraction),	   suggesting	   that	  anisotropy	  may	  be	   influenced	  by	  smooth	  muscle	   function.	  The	   large	  degree	  of	  anisotropy	  was	  more	  evident	  at	  the	  toe	  or	  low-­‐stiffness	  region	  of	  the	  curve,	  than	  at	  the	  high-­‐stiffness	  region	  of	  the	  curve,	  suggesting	  that	  collagen	  fiber	  recruitment	  or	  the	  rotation	  of	  the	  fibers	  may	   be	   influencing	   the	   anisotropic	   behavior	   [105],	   [106],	   [146].	   This	   finding	   would	   be	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remiss	  during	  uniaxial	  testing.	  However,	  our	  data	  is	  consistent	  with	  that	  reported	  by	  Feola	  et	  al.	  for	  the	  modulus	  (2.1	  ±	  0.65	  MPa)	  following	  uniaxial	  testing	  of	  the	  axial	  direction	  [22].	  	  	  The	  ultimate	  influence	  of	  smooth	  muscle	  modulation	  on	  the	  high	  stiffness	  modulus	  was	  indeed	  variable,	  and	  minimal	  effects	  on	  the	  high-­‐stiffness	  modulus	  versus	  low-­‐stiffness	  modulus	  were	   observed.	   Similar	   findings	   of	   decreasing	   influence	   of	   smooth	  muscle	  with	  increasing	   strain	  were	   reported	  by	  Tremblay	   et	   al	   [143].	   Following	   smooth	  muscle	   tonic	  contraction,	   at	   the	   low-­‐stiffness	   or	   toe-­‐region	  of	   the	   stress–stain	   curves	   generated,	   there	  was	  a	  trend	  toward	  a	  decrease	  in	  stiffness	  in	  the	  axial	  direction	  and	  an	  increase	  in	  stiffness	  in	   the	   circumferential	   direction.	   This	   may	   perhaps	   be	   an	   attempt	   to	   redistribute	   stress	  along	  the	  loading	  axes,	  and/or	  a	  dampening	  effect	  by	  the	  smooth	  muscle.	  This	  dampening	  effect	   was	  most	   evident	   following	   the	   calculation	   of	   the	   percent	   contribution	   of	   smooth	  muscle,	  as	  there	  was	  a	  trend	  toward	  decreased	  stiffness	  in	  the	  high-­‐stiffness	  region	  in	  both	  the	   axial	   and	   circumferential	   direction.	   At	   the	   low-­‐stiffness	   region,	   smooth	   muscle	  decreased	  tonic	  contraction	  was	  associated	  with	  decreased	  stiffness	   in	  the	  axial	  direction	  and	  increased	  stiffness	  in	  the	  circumferential	  direction.	  As	  noted,	  the	  vagina	  is	  stiffer	  in	  the	  axial	  than	  circumferential	  direction,	  which	  further	  supports	  a	  protective	  dampening	  effect	  [147].	  	  Tremblay	  et	  al	  did	  not	  observe	  this	  dampening	  effect,	  but	  did	  observe	  less	  influence	  of	   smooth	   muscle	   when	   tested	   arteries	   were	   at	   high-­‐strains	   versus	   low-­‐strains	   [148].	  Although	  strain-­‐control	  regimens	  were	  not	  performed	  here,	  it	  can	  be	  inferred	  that	  at	  high	  strains,	   smooth	  muscle	   tonic	   contraction	  would	   reduce	  wall	   stresses.	  As	   strain	   increases,	  there	  is	  increased	  force	  generation	  until	  an	  optimal	  length	  for	  smooth	  muscle	  contraction	  (Lo)	  is	  attained,	  beyond	  which,	  smooth	  muscle	  force	  is	  known	  to	  rapidly	  decline	  [142].	  This	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phenomenon	   is	   commonly	   described	   as	   receptive	   relaxation,	   and	   is	   also	   evident	   in	   the	  bladder,	   as	   relaxation	   is	   required	   for	   adequate	   filling.	  Modeling	   by	  Rachev	   et	   al.	   showed	  that	  basal	  muscular	  tone	  also	  plays	  a	  role	  in	  maintaining	  more	  uniform	  stress	  distribution	  [149].	  The	  baseline	  tension,	  also	  observed	  as	  residual	  stress,	  is	  commonly	  measured	  by	  the	  opening	  angle	  of	  a	  vessel	  [150].	  It	  has	  been	  reported	  that	  smooth	  muscle	  contraction	  also	  affects	   the	   residual	   stress	   [149].	   Skalak	   et	   al	   showed	   that	   the	   elimination	   of	   elastin	   and	  collagen	  of	  zero-­‐stress	  slices,	  with	  elastase	  or	  collagenase,	  increased	  the	  opening	  angle	  by	  53	   and	   70%,	   respectively,	   suggesting	   that	   smooth	   muscle	   must	   interact	   with	   these	  components	   to	   alter	   residual	   stresses	   [151].	   At	   in-­‐vivo	   resting	   condition,	   collagen	   and	  elastin	  are	  under	  compression	  by	  the	  retractive	  forces	  of	  smooth	  muscle.	  In	  the	  vagina,	  this	  external	   force	   provided	   my	   smooth	   muscle	   is	   required	   to	   facilitate	   vaginal	   folding	   to	  restore	  the	  diameter	  of	  the	  vagina.	  However	  following	  opening,	  there	  was	  a	  release	  of	  this	  compression	  or	  residual	  stress	  resulting	  in	  a	  relaxation	  of	  the	  vaginal	  folds.	  This	  is	  further	  supported	  by	  our	  multiphoton	   images,	  which	  showed	  significant	   interaction	  between	   the	  smooth	  muscle	  bundles,	  and	  the	  elastin	  and	  collagen	  fibers.	  	  As	  noted	  in	  the	  results,	  the	  interaction	  between	  the	  smooth	  muscle	  and	  the	  elastin	  and	  collagen	  fibers	  proved	  most	  evident	  in	  the	  preload	  regimens,	  which	  interestingly,	  may	  represent	   the	   daily	   physiologic	   range.	   Smooth	   muscle	   tonic	   contraction	   was	   associated	  with	   a	   50%	   higher	   areal	   strain	   relative	   to	   smooth	   muscle	   at	   baseline,	   following	   a	   .1N	  preload.	   These	   finding	   are	   supported	   by	   reports,	   which	   indicate	   that	   smooth	   muscle	  exhibits	  a	  highly	  compliant	  series	  elastic	  component,	  support	  these	  findings	  [152].	  This	  is	  further	  supported	  by	  results	  from	  Gao	  et	  al	  which	  showed	  80%	  of	  collagen	  being	  recruited	  at	  average	  strains	  of	  1.61%	  in	  the	  duodunum	  of	  patients	  with	  systemic	  sclerosis,	  versus	  at	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average	  strains	  of	  2.97%	  for	  controls	  [106].	  Gao	  and	  colleagues	  concluded	  that	  the	  results	  were	  due	  to	  the	  differences	  in	  smooth	  muscle	  contraction,	  as	  the	  average	  force	  generated	  by	   the	   duodenum	   of	   patients	   with	   systemic	   sclerosis	   was	   45%	   less	   than	   controls;	   this	  assumption	  was	  validated	  by	  the	  replication	  of	  these	  findings	  in	  computational	  models	  for	  which	  the	  active	  smooth	  muscle	  component	  was	  modified.	  Further,	  Hill	  et	  al	  reported	  that	  the	   recruitment	   of	   collagen	   in	   passive	   tissues	   occurs	   at	   a	   finite	   strain	   [144],	   but	   in	   this	  study	  when	  smooth	  muscle	  was	   tonically	  contracted,	   the	  shape	  of	   the	  stress-­‐strain	  curve	  suggests	  a	  more	  gradual	  collagen	  recruitment.	  However,	  more	  work	  is	  needed	  to	  validate	  this	   observation.	   In	   addition,	   it	   still	   remains	   to	   be	   proven	   if	   there	   is	   indeed	   collagen	   in	  series	  and	  collagen	  in	  parallel	  as	  proposed	  by	  Bank	  et	  al,	  as	  Gao	  et	  al	  obtained	  adequate	  fits	  of	  their	  data	  utilizing	  a	  model	  of	  only	  collagen	  in	  series	  [105],	  [106].	  Our	  results	  could	  also	  likely	  be	  modeled	  with	  a	  single	  parallel	  component,	  as	  there	  may	  be	  no	  functional	  value	  of	  a	  less	   stiff	   collagen	   component	   in	   parallel	   with	   elastin.	   Smooth	   muscle	   contraction	   may	  simply	  be	  inducing	  increased	  crimp	  within	  the	  fibers,	  which	  may	  result	  in	  a	  more	  gradual	  recruitment	  or	  stiffening	  of	  the	  fibers	  when	  loaded	  (Figure	  16-­‐B).	  	  The	   current	   study	   provides	   the	   basis	   for	   future	   experimental	   techniques	   for	   the	  evaluation	  of	  smooth	  muscle	  mechanical	  role	  in	  the	  vagina,	  as	  well	  as	  sufficient	  premise	  for	  more	   studies	   aimed	   at	   further	   understanding	   how	   changes	   in	   smooth	   function	   could	  influence	   changes	   in	   the	   vagina.	  When	   combined	  with	   the	   preceding	   study	   in	   Chapter	   1,	  which	  showed	  that	  smooth	  muscle	  functionality	  is	  persistently	  altered	  in	  following	  VaBI,	  it	  becomes	  a	  highly	  significant	  finding,	  as	  it	  builds	  substantial	  evidence	  for	  the	  potential	  role	  of	  smooth	  muscle	  injury	  in	  the	  pathogenesis	  of	  POP.	  This	  is	  indeed	  the	  case,	  as	  the	  potential	  for	   increased	   wall	   stresses	   and	   increased	   anisotropy	   or	   distribution	   of	   wall	   stresses,	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following	   the	   loss	   of	   smooth	   muscle	   function	   could	   increase	   the	   propensity	   for	   vaginal	  remodeling.	  However,	  it	  is	  not	  without	  limitations,	  including	  the	  lack	  of	  significant	  findings,	  resulting	  from	  the	  relatively	  large	  pre-­‐load	  applied	  to	  the	  tissue.	  	  Additionally,	  since	  it	  has	  been	   postulated	   that	   smooth	   muscle	   may	   govern	   the	   recruitment	   of	   collagen,	   our	  significant	  findings	  observed	  in	  the	  pre-­‐load	  strains	  supports	  the	  lack	  of	  major	  significant	  findings	  as	  our	  baseline	  conditions	  may	  have	  surpassed	  the	  point	  at	  which	  smooth	  muscle	  is	   highly	   functional.	   Another	   limitation	   is	   that	   dynamic	   or	   simultaneous	   acquisition	   of	  collagen	   recruitment	   during	   loading	  was	   not	   obtained,	  which	   posed	   some	   disadvantages	  when	   attempting	   to	   associate	   collagen	   recruitment,	   tissue	   strain,	   and	   smooth	   muscle	  contraction.	  Future	  work	  could	  also	  involve	  evaluation	  of	  the	  intact	  organ.	  	  
4.0	   PROLAPSE	  MESHES	  NEGATIVELY	  IMPACT	  VaSM	  FUNCTION	  
4.1 BACKGROUND	  
As	   shown	   in	   the	   preceding	   chapter,	   smooth	  muscle	   function	   is	   essential	   for	  maintaining	  vaginal	  mechanical	   function.	  With	   POP,	   being	   associated	  with	   changes	   in	   smooth	  muscle	  function,	   treatment	   methods	   for	   POP	   should	   at	   the	   very	   least,	   maintain	   smooth	   muscle	  function,	  if	  unable	  to	  improve	  it.	  However,	  mesh-­‐related	  complications	  including	  exposure	  through	   the	   vaginal	   wall,	   erosion	   into	   an	   adjacent	   structure,	   and	   pain	   and	   infection	   are	  prevalent,	   and	  despite	   the	   introduction	  of	   light-­‐weight	   (<45	  g/m2),	   large	  pore	   (>1	  mm2),	  monofilament	  polypropylene	  meshes	  into	  the	  market,	  roughly	  10%	  of	  women	  who	  receive	  mesh	  have	  complications	  [15],	  [153],	  [154].	  The	  prevalence	  of	  these	  complications	  recently	  prompted	   warnings	   from	   the	   US	   Food	   and	   Drug	   Administration	   (FDA),	   with	   the	   most	  recent	   public	   health	   notification	   appearing	   in	   2011,	   warning	   that	   mesh-­‐associated	  complications	  are	  not	  rare	  events	  and	  that	  more	  thorough	  investigations	  into	  mechanisms	  by	  which	  mesh	  may	  negatively	  impact	  the	  vagina	  are	  warranted	  [15].	  Previous	   studies	   from	  our	   research	   group,	   have	   shown	   that	   implantation	  of	  mesh	  increases	  apoptosis,	   and	  decrease	   the	   thickness	  and	  contraction	  of	   smooth	  muscle	   in	   the	  underlying	  vaginal	  tissue	  [155].	  Interestingly,	  the	  degree	  of	  impact	  varied	  with	  the	  specific	  mesh	  implanted,	  but	  these	  widely	  used	  meshes	  are	  typically	  marketed	  similarly,	  and	  used	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interchangeably	   in	   clinical	   settings.	   These	   finding	  when	   paired	  with	   a	   previous	   study	   of	  ours	  which	   showed	   variability	   in	   the	   textile	   and	  mechanical	   properties	   of	   these	  meshes,	  suggest	  that	  the	  minor	  differences	  in	  mesh	  properties	  could	  be	  contributing	  to	  the	  different	  outcomes	   [19].	   For	   example,	   the	   gold	   standard	   mesh,	   Gynemesh™	   PS	   (Ethicon,	  Sommerville,	   NJ,	   USA),	   which	   exhibits	   the	   highest	   stiffness,	   highest	   weight	   and	   lowest	  porosity	  was	   associated	  with	   the	   greatest	   negative	   impact	   on	   smooth	  muscle	   relative	   to	  two	   lower	   stiffness	   meshes,	   UltraPro™	   (Ethicon,	   Sommerville,	   NJ,	   USA)	   and	   Restorelle®	  (Coloplast,	  Minneapolis,	  MN).	  We	  therefore	  theorized	  that	  a	  high	  stiffness	  mesh	  may	  shield	  the	   underlying	   soft	   tissues	   from	   experiencing	   normal	   physiologic	   stress,	   thus	   inducing	  atrophy	   and	   thinning	   of	   the	   smooth	   muscle	   layer.	   This	   phenomenon,	   termed	   stress	  shielding,	  which	   has	   been	  widely	   studied,	   is	   based	   on	   a	   biomechanical	   principle	   (Wolff’s	  Law)	   that	   the	   body	   undergoes	   structural	   remodeling	   in	   accordance	   to	   its	   functional	  demands,	   and	   in	   the	   absence	   of	   any	   mechanical	   demand,	   the	   tissues	   will	   begin	   to	  deteriorate	   [156][157].	   	  Additionally,	   the	   high	  weight	   and	   low	   porosity	   likely	   result	   in	   a	  greater	  mesh	  burden,	  and	  increased	  likelihood	  of	  a	  heightened	  foreign	  body	  response	  with	  impaired	  tissue	  ingrowth	  and	  a	  poor	  functional	  outcome.	  As	  vaginal	  smooth	  muscle	  (VaSM)	  plays	   an	   essential	   role	   in	  maintaining	  vaginal	   function	   (eg.	   tone),	   and	   is	   compromised	   in	  women	  with	   prolapse,	   it	   is	   essential	   that	   its	   structure	   and	   function,	   at	   the	   very	   least,	   be	  preserved	  if	  not	  improved	  following	  surgery.	  The	   results	   from	   the	   previously	   cited	   studies	   do	   suggest	   that	   lower	   stiffness	   and	  lighter	  weight	  meshes	  be	  used	  for	  prolapse	  procedures	  aiming	  to	  maintain	  VaSM	  structure	  and	   function,	   but	   the	   mechanism(s)	   remains	   unclear.	   Hence,	   to	   further	   investigate	   the	  mechanism	  and	  extent	  of	   the	   impact	  of	  mesh	  textile	  and	  mechanical	  properties	  on	  VaSM,	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we	  evaluated	   the	  effect	  of	  mesh	   implantation	  on	  VaSM	  contraction,	   innervation,	   receptor	  function,	  and	  innervation	  density	  in	  the	  underlying	  grafted	  tissues	  and	  tissues	  adjacent	  to	  the	  mesh	  (non-­‐grafted	  tissues).	  For	  the	  study	  design,	  the	  high	  stiffness	  mesh,	  Gynemesh™	  PS	  (Ethicon;	  27.5	  ±	  2.7	  N/mm),	  was	  evaluated	  relative	  to	  the	  two	  lower	  stiffness	  meshes,	  UltraPro™	   (Ethicon;	   0.01	   ±	   0.00	  N/mm)	   and	  Restorelle®	   (Coloplast;	   0.18	   ±	   0.03	  N/mm).	  Additionally,	  UltraPro™	  which	  is	  highly	  anisotropic,	  was	  implanted	  both	  with	  its	  blue	  line	  perpendicular	   (low	   stiffness	   direction,	   0.01	   ±	   0.00	   N/mm)	   and	   parallel	   (high	   stiffness	  direction,	  0.26	  ±	  0.09	  N/mm)	  to	  the	  long	  axis	  of	  the	  vagina.	  All	  meshes	  were	  implanted	  by	  abdominal	   sacrocolpopexy	   following	   hysterectomy,	   on	   cycling,	   parous	   Rhesus	  Macaques	  (macacca	   mulatta),	   without	   prolapse.	   This	   design	   ensured	   that	   the	   impact	   of	   mesh	   was	  being	   evaluated,	   independent	   of	   the	   degenerative	   effects	   of	   the	   disease	   (which	   could	   be	  variable),	  and	  following	  a	  procedure	  that	  has	  been	  shown	  with	  Level	  I	  clinical	  evidence	  to	  be	  associated	  with	  minimal	  complications	  [158].	  	  Evaluation	  of	  the	  outcomes	  measures	  incorporated	  both	  functional	  and	  histological	  assessments	  of	  the	  grafted	  and	  non-­‐grafted	  tissues.	  Specifically,	  smooth	  muscle	  contraction	  was	  measured	  by	  the	  force	  generated	  following	  muscle	  depolarization	  by	  a	  high	  potassium	  solution	  (KCl),	  innervation	  function	  was	  measured	  by	  the	  force	  generated	  following	  nerve	  stimulation,	  and	  receptor	  function	  was	  measured	  by	  the	  force	  generated	  following	  receptor	  depolarization	   by	   a	   non-­‐selective	   muscarinic	   receptor	   (MR)	   and	   α1-­‐adrenoceptor	   (AR)	  agonist.	  Innervation	  density	  was	  measured	  histologically	  as	  a	  percent	  of	  the	  fractional	  area	  of	  peripheral	  nerves	  labeled	  (cholinergic,	  adrenergic)	  within	  the	  smooth	  muscle	   layer.	  All	  outcome	   measures	   were	   analyzed	   as	   a	   function	   of	   mesh	   properties	   including	   porosity,	  weight,	  and	  stiffness.	  Results	  from	  the	  study	  will	  aid	  in	  determining	  whether	  the	  negative	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impact	  of	  mesh	  on	  vaginal	  smooth	  muscle	   is	   the	  result	  of	  a	   loss	  of	   the	  muscle	  contractile	  elements,	   a	   loss	  of	   innervation,	   or	   a	   loss	  of	   receptor	   function,	   and	   if	   these	   changes	   are	   a	  function	   of	   mesh	   textile	   and	  mechanical	   properties.	   Additionally,	   the	   evaluation	   of	   both	  adjacent	  grafted	  and	  non-­‐grafted	  tissues	  within	  the	  same	  animal	  will	  provide	  verification	  of	  the	  extent	  of	  the	  impact	  on	  the	  vagina.	  
4.2 PROTOCOLS	  
4.2.1 Animals	  
All	  animals	  (Rhesus	  macaques)	  used	  in	  this	  study	  were	  maintained	  and	  treated	  according	  to	  an	  experimental	  protocol	  approved	  by	  the	  Institutional	  Animal	  Care	  and	  Use	  Committee	  of	   the	   University	   of	   Pittsburgh	   (IACUC	   #1008675),	   and	   in	   adherence	   with	   the	   National	  Institutes	   of	   Health	   guidelines.	   Routine	   laboratory	   tests	   and	   regular	   examinations	   by	  veterinarians	   during	   a	   quarantine	   period	   were	   used	   to	   certify	   that	   these	   experimental	  animals	  were	  pathogen-­‐free	  and	   in	   good	  physical	   condition.	  Animals	  were	  maintained	   in	  standard	   cages	  with	  water	   (ad	   libitum),	   and	   scheduled	  monkey	   diet	   supplemented	  with	  fresh	  fruits,	  vegetables	  and	  multiple	  vitamins,	  daily.	  A	  12-­‐hour	  light/dark	  cycle	  (7	  AM	  –	  7	  PM)	  was	  used,	  and	  menstrual	   cycle	  patterns	  were	  recorded	  daily.	  Available	  demographic	  data	  of	  each	  NHP	  were	  collected	  prior	  to,	  and	  after	  surgery	  including	  age,	  weight,	  gravidity	  and	   parity.	   Researchers	   were	   blinded	   to	   all	   demographical	   data	   of	   each	   NHP	   until	   the	  completion	  of	  the	  study.	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4.2.2 Surgical	  Procedure	  
Following	  IACUC	  approval	  at	  the	  University	  of	  Pittsburgh,	  thirty-­‐eight	  (38)	  cycling	  parous	  NHP	   (Rhesus	   macaques)	   were	   selected	   for	   sham	   or	   mesh	   implantation	   with	   the	   stiffer	  mesh	  Gynemesh™	  PS	   (Ethicon;	  0.29	  ±	  0.015	  N/mm,	  N=8)	  vs	   two	   lower	   stiffness	  meshes,	  Restorelle®	  (Coloplast;	  0.18	  ±	  0.026	  N/mm;	  N=8)	  and	  UltraPro™	  (Ethicon;	  0.009	  ±	  0.0016	  N/mm,	   N=6).	   UltraPro™	   which	   is	   a	   highly	   anisotropic	   mesh,	   was	   implanted	   in	   two	  directions,	   with	   its	   blue	   orientation	   lines	   perpendicular	   (UltraPro™	   perpendicular	   –	   low	  stiffness	  direction,	   0.01	  ±	  0.00	  N/mm),	   and	  with	   its	   blue	  orientation	   lines	  parallel	   to	   the	  long	   axis	   of	   the	   vagina	   (UltraPro™	  parallel	   -­‐	   high	   stiffness	  direction,	   0.26	  ±	  0.09	  N/mm).	  Using	  a	  randomized	  procedure,	  each	  primate	  was	  assigned	  to	  a	  mesh	  group,	  or	  to	  the	  sham	  control	   group.	   All	   meshes	   were	   implanted	   via	   an	   abdominal	   sacrocolpopexy	   after	  hysterectomy,	  and	   the	  sham	  group	  (N=8)	  underwent	   the	   identical	  surgery	  without	  mesh.	  As	   previously	   published	   [155],	   [159],	   under	   general	   anesthesia,	   an	   abdominal	  hysterectomy	  was	  performed	   through	  a	  midline	   incision,	  without	  excision	  of	   the	  ovaries.	  The	   bladder	   was	   then	   dissected	   off	   the	   anterior	   vagina	   to	   the	   level	   of	   trigone,	   and	   the	  rectum	  dissected	   from	  the	  posterior	  vaginal	  wall	   to	   the	   level	  of	   the	  perineal	  body.	  A	  5cm	  incision	   was	   made	   over	   the	   sacral	   promontory	   and	   carried	   down	   to	   the	   longitudinal	  ligament	  of	  the	  spine.	  After	  completion	  of	  these	  dissections,	  the	  surgeon	  was	  then	  informed	  by	  the	  unblinded	  biotechnician	  that	  it	  would	  be	  a	  sham	  operation,	  or	  handed	  a	  sterile	  piece	  of	  mesh	  to	  be	  implanted.	  For	  mesh	  implantation,	  3	  cm	  wide	  by	  10	  cm	  long	  straps	  of	  mesh	  were	  laid	  flat	  on	  the	  anterior	  and	  posterior	  wall,	  respectively,	  and	  secured	  in	  place	  with	  a	  continuous	  suture	   (2-­‐0	  Biosyn™;	  Synovis,	   St.	  Paul,	  MN,	  USA)	  along	  each	   lateral	  edge.	  The	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two	   straps	   of	   mesh	   were	   then	   anchored	   into	   the	   sacral	   promontory	   with	   two	   delayed	  absorbable	  sutures,	  and	  any	  excess	  mesh	  was	  trimmed	  off	  prior	  to	  closing	  the	  peritoneum	  over	  the	  mesh.	  The	  abdominal	  muscle	  layer	  was	  closed	  with	  a	  single	  continuous	  suture,	  and	  three	   to	   five	   interrupted	   sutures	   were	   used	   to	   re-­‐approximate	   the	   subcutaneous	   fat,	  followed	  by	  a	  continuous	  subcutaneous	  closure	  (4-­‐0	  polysorb).	  Postsurgical	  care	  inclusive	  of	   pain	   medication,	   oral	   intake	   and	   activity	   was	   carried	   out	   according	   to	   a	   standard	  postoperative	   protocol.	   Twelve	   weeks	   after	   surgery,	   the	   vagina	   was	   dissected,	   and	  immediately	   following	   acquisition,	   tissue	   blocks	   were	   obtained	   from	   a	   region	   of	   the	  anterior	   vagina	   underlying	   the	  mesh	   (grafted),	   and	   a	   region	   adjacent	   to	   the	  mesh	   (non-­‐grafted).	  Additional	  steps	  were	  taken	  to	  ensure	  consistency	  of	  the	  biopsied	  site.	  
4.2.3 	  	  Functional	  Analysis	  (Organ	  Bath)	  
For	  the	  organ	  bath	  assay,	  grafted	  and	  non-­‐grafted	  tissues	  were	  subsequently	  divided	  into	  four	   2	  mm	  wide	   x	   7	  mm	   long	   circumferential	   strips,	   each.	   Each	   strip	  was	   then	   carefully	  suspended	  between	  two	  wires	  using	  stationary	  clips,	  and	  then	  immersed	  in	  an	  organ	  bath	  (20	   mL)	   containing	   oxygenated	   Krebs	   solution	   (95%	   O2-­‐5%	   CO2),	   maintained	   at	   37°C.	  Each	  segment	  was	  adjusted	  to	  a	  tension	  of	  1	  g	  and	  then	  allowed	  to	  equilibrate	  for	  60	  min.	  Contractile	  responses	  were	  monitored	  with	  a	  pressure	  transducer	  (Transbridge	  4M,	  World	  Precision	  Instruments)	  attached	  to	  a	  load	  cell	  (Honeywell,	  Morristown,	  NJ,	  USA),	  and	  force	  measurements	   were	   recorded	   using	   Chart	   software	   (version	   5)	   on	   a	   Power	   Lab	   system	  (sampling	  at	  40	  Hz,	  AD	  Instruments).	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To	   evaluate	   muscle	   contractile	   function	   or	   specifically,	   myofiber	   function,	   muscle	   force	  generation	  following	  administration	  of	  120	  mM	  KCl	  was	  measured.	  This	  concentration	  was	  chosen	  based	  on	  results	   from	  dose	  response	  curves	   in	  preliminary	  experiments,	   in	  which	  we	  found	  the	  maximum	  force	  generated,	  to	  plateau	  following	  the	  administration	  of	  120	  mM	  KCl.	  Once	  the	  response	  to	  the	  dose	  plateaued,	  the	  tissue	  was	  washed	  with	  Krebs	  solution	  3	  times	   (10	   minutes	   for	   each	   wash),	   prior	   to	   beginning	   the	   electrical	   stimulation	  experiments.	   To	   evaluate	   nerve	   function,	   muscle	   force	   generation	   to	   electrical	   field	  stimulation	  (EFS)	  at	  frequencies	  of	  1-­‐64	  Hz,	  intensity	  of	  20	  volts,	  and	  duration	  of	  2	  seconds	  was	   applied	   using	   a	   S88,	   Grass	   Telefactor	   stimulator.	   These	   settings	   were	   based	   on	  preliminary	  experiments	  to	  ensure	  that	  they	  were	   low	  enough	  to	  activate	  the	  nerves,	  but	  not	   significant	   enough	   to	   activate	   the	   attached	  muscle	   fibers,	   thereby	   ensuring	   that	   the	  force	   generated	   was	   a	   result	   of	   the	   activated	   nerves	   synaptically	   activating	   the	   muscle	  fibers.	   Tissue	   samples	   were	   washed	  with	   Krebs	   solution	   2	   times	   (5	  minutes	   per	   wash),	  between	   each	   stimulation.	   Contractile	   responses	   were	   recorded	   and	   normalized	   to	   the	  force	  generated	  following	  KCl	  (120mM)	  application,	  herein	  represented	  as	  a	  percentage	  of	  KCl	   response.	   For	   analysis	   of	   receptor-­‐mediated	   function,	   muscle	   force	   generation	   to	  increasing	   concentrations	   of	   carbachol	   and	   phenylephrine	   (10−8	   to	   10−4	   M,	   non-­‐cumulatively)	   were	   used	   to	   evaluate	   muscarinic	   receptor	   (MR)	   and	   α1-­‐adrenoreceptor	  (AR)	  function,	  which	  are	  present	  within	  the	  vagina.	  After	  the	  application	  of	  each	  dose,	  and	  after	   the	  observed	  response	  had	  plateaued,	   the	   tissue	  was	  washed	  with	  Krebs	  solution	  3	  times	   (10	  minutes	   for	   each	  wash),	   and	   the	   next	   dose	  was	   applied.	   Contractile	   responses	  were	   recorded	   and	   also	   normalized	   to	   the	   force	   generated	   following	   KCl	   (120mM)	  application.	   With	   120	   mM	   KCl	   proven	   to	   fully	   depolarize	   the	   smooth	   muscle,	   if	   only	   a	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fraction	   of	   the	   muscles	   present	   had	   functional	   neurons	   or	   functional	   receptors,	   nerve	  depolarization	  or	  receptor	  depolarization	  would	  only	  yield	  a	  percentage	  of	  the	  contractile	  force	   generated	   by	   KCl,	   thus	   providing	   an	   opportunity	   to	   capture	   functional	   changes.	  Additionally,	   to	  ensure	   that	   the	  changes	  observed	  were	  not	  a	  result	  of	  changes	   in	  muscle	  function,	  the	  normalization	  to	  KCl	  response	  was	  necessary.	  
4.2.4 	  	  Histochemical	  and	  Immunohistochemical	  Analysis	  (Nerve	  	  Labeling)	  
For	   the	   histochemical	   and	   immunohistochemical	   assays,	   grafted	   and	   non-­‐grafted	   tissues	  were	  fixed	  in	  4%	  paraformaldehyde	  overnight,	  and	  then	  exposed	  to	  graded	  concentrations	  of	  sucrose	  (cryoprotectant).	  The	  tissues	  were	  washed	  in	  phosphate	  buffered	  saline	  (PBS),	  embedded	   into	   optimal	   cooling	   temperature	   (O.C.T)	   medium	   (Sakura	   Finetek	   USA,	   Inc.,	  Torrance,	  CA,	  USA),	  and	  then	  cryosectioned	  at	  10µm	  thickness,	  at	  an	  angle	  perpendicular	  to	  the	   long	   axis	   of	   the	   vagina.	   The	   sections	   were	   then	   processed	   for	   Masson’s	   trichrome	  staining	  according	  to	  the	  methods	  of	  the	  Center	  for	  Biological	   Imaging	  (CBI,	  University	  of	  Pittsburgh).	  For	  immunohistochemical	  labeling,	  the	  sections	  were	  air-­‐dried	  for	  10	  minutes,	  submerged	   into	   cold	   acetone	   for	   20	   minutes,	   and	   then	   washed	   with	   buffer.	  Permeabilization	  in	  0.2%	  Triton	  X-­‐100	  for	  10	  min,	  followed	  by	  a	  wash	  in	  buffer,	  and	  then	  incubation	  for	  1.5	  hours	  in	  2%	  Bovine	  Serum	  Albumin	  (BSA)	  was	  performed.	  Sections	  were	  incubated	  overnight	  at	  4oC,	  with	  primary	  antibody	  diluted	   in	  PBDT	  (1xPBS,	   .2%	  BSA,	  2%	  Donkey	   Serum	   (Jackson	   Laboratories;	   no.	   017-­‐000-­‐00),	   and	   .03%	   Triton).	   Protein	   Gene	  Product	  (PGP	  9.5),	  a	  neuron-­‐specific	  ubiquitin	  which	  localizes	  to	  neuronal	  axons,	  was	  used	  to	   evaluate	   peripheral	   nerve	   density	   (1:10000;	   rabbit	   polyclonal	   antibody:	   Accurate	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Chemical,	   Westbury,	   NY	   YBG78630507).	   Vesicular	   Acetylcholine	   Transporter	   (VAChT),	  which	  is	  localized	  within	  the	  soma	  and	  the	  axons	  of	  cholinergic	  neurons,	  and	  plays	  a	  role	  in	  the	  packaging	  and	  transporting	  of	  acetylcholine	  (ACh)	   into	  synaptic	  vesicles	  was	  use	  as	  a	  marker	   to	  evaluate	  cholinergic	  nerve	  density	   (1:5000	  rabbit	  monoclonal	  antibody:	  Sigma	  V5387).	  Lastly,	  Tyrosine	  Hydroxylase	  (TH),	  a	  rate	  limiting	  enzyme	  that	  converts	  L-­‐tyrosine	  to	  L-­‐DOPA	  which	  is	  then	  converted	  to	  dopamine	  (a	  precursor	  of	  norepinephrine),	  was	  used	  to	   evaluate	   adrenergic	   nerve	   density	   (1:1000;	   rabbit	   polyclonal	   antibody:	   Sigma	  T8700).	  Following	  incubation	  with	  the	  primary	  antibodies,	  the	  sections	  were	  rinsed	  with	  PBS,	  and	  incubated	   for	   4	   hours	   at	   4oC	   with	   Cy3	   or	   FITC-­‐conjugated	   f(ab)	   donkey	   anti-­‐rabbit	   IgG	  (1:100;	   Jackson	  Laboratories	  no.	  711	  165	  152)	  diluted	   in	  PBDT.	  The	  sections	  were	  again	  washed	  in	  buffer	  and	  cover-­‐slipped	  with	  Fluoro-­‐Gel	  medium	  (EMS,	  Hatfield,	  PA	  	  17985-­‐10).	  In	  control	  experiments,	  no	  immunofluorescence	  staining	  was	  observed	  when	  the	  primary	  antiserum	  was	  omitted.	  
4.2.5 	  	  Morphometric	  Analysis	  	  
All	  images	  were	  captured	  using	  a	  Nikon	  microscope	  synced	  to	  a	  Nikon	  color	  digital	  camera,	  before	  being	  imported	  into	  the	  Elements	  software	  (NIS-­‐Elements	  AR	  3.2)	  for	  quantification.	  To	  evaluate	  fibers	  immunoreactive	  (IR)	  for	  PGP	  9.5,	  VAChT	  and	  TH	  in	  the	  three	  regions	  of	  the	  vagina,	   images	  were	  randomly	  captured	  at	  10x	  magnification.	  For	  analysis,	  all	   images	  were	   acquired,	   and	   the	   same	   threshold	   was	   applied.	   Pixels	   of	   binary	   images	   whose	  intensity	  did	  not	  exceed	  the	  threshold	  value	  were	  automatically	  removed	  and	  considered	  negative.	  The	  numbers	  of	  profiles	  per	  unit	   area	  of	   the	  vaginal	  wall	   for	   the	  vaginal	   layers	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was	  measured	  (fractional	  area)	  and	  averaged	   for	  each	  section.	  Nerves	   in	  all	   layers	  of	   the	  vaginal	  wall	  were	  quantified	  and	  evaluated	  separately,	  and	  vascular	  innervation	  shown	  by	  positive	  staining	  in	  the	  vascular	  structures	  was	  excluded.	  	  
4.2.6 	  	  Statistical	  Analysis	  
Statistical	  analysis	  of	  the	  functional	  (maximum	  force),	  and	  histological	  (%	  fractional	  area)	  parameters	  were	  performed	  using	   IBM	  SPSS	   statistical	   software	   (version	  17.0;	   SPSS	   Inc.,	  Armonk,	   NY).	   Differences	   between	   groups	  were	   evaluated	   using	   Kruskal	  Wallis	   one-­‐way	  analysis	   of	   variance	   (ANOVA),	   and	   Bonferonni	   post-­‐hoc	   tests.	   For	   additional	   analysis	   of	  UltraPro™	   Perpendicular	   vs	   UltraPro™	   Parallel,	   Mann	   Whitney	   U	   tests	   were	   used,	   and	  Regression	   and	   Correlation	   analysis	   were	   performed	   to	   evaluate	   the	   influence	   of	   mesh	  properties.	  For	  all	  measures,	  significance	  was	  set	  at	  P<0.05.	  
4.3 RESULTS	  
There	  was	  no	  significant	  difference	  in	  the	  age,	  weight	  and	  parity	  of	  the	  NHP	  groups	  (Table	  
8)	   prior	   to	   implantation	   with	   the	   three	   meshes,	   containing	   variable	   textile	   properties	  
(Table	  9).	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Table	  8.	  Macaques	  Demographics	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Mesh	  Groups	  	   Sham	  (n=7)	   Gynemesh™	  PS	  (n=7)	   Restorelle®	  (n=7)	   UltraPro™	  perpendicula	  (n=6)	   UltraPro™	  parallel	  (n=7)	   P-­‐value	  Age	  	  	  	  	  	  	  	  (year)	  	  Weight	  (gram)	  Parity	  
15.0	  (15.0,15.2)	  8.5	  	  	  	  	  	  	  	  (8.0,9.3)	  6.0	  	  	  	  	  	  	  	  (3.5,6.5)	  
13.5	  (11.0,14.0)	  7.9	  	  	  	  	  	  	  	  	  	  (7.1,9.0)	  4.0	  	  	  	  	  	  	  (2.0,5.2)	  
13.0	  	  	  	  	  	  	  	  (12.5,15.2)	  9.4	  	  	  	  	  	  	  	  	  	  	  	  (8.3,12.5)	  5.0	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (3.0,5.2)	  
13.0	  (12.0,15.0)	  7.3	  	  	  	  	  	  	  	  	  	  	  (6.4,8.8)	  3.0	  	  	  	  	  	  	  	  	  	  	  (2.2,6.5)	  
13.0	  (12.5,13.2)	  8.2	  	  	  	  (8.0,9.2)	  4.0	  	  	  	  	  	  	  	  (4.0,5.5)	  
	  ≥	  0.132	  
	  ≥	  0.426	  
	  ≥	  0.782	  
Values	  presented	  as	  Median	  (IQR)	  
Significance	  set	  a	  P	  <	  .05	  
	  	  	  	  	  	  	  	  	  	  	  	  	  However,	  upon	  explanation,	  the	  grafted	  region,	  shown	  as	  the	  boxed	  area	  in	  Figure	  18,	  was	  distinct	  from	  the	  non-­‐grafted	  region,	  and	  this	  grafted	  region	  was	  visually	  variable	  between	  groups.	  The	  mesh	   in	  the	  grafted	  region,	  had	  evidence	  of	  host	   tissue	   ingrowth	  (Figure	  18	  
[A-­‐D]),	   with	   the	   degree	   of	   incorporation	   varying	   according	   to	   the	   stiffness	   of	   the	   mesh	  implanted	   (Figure	   18.	   [E-­‐H]).	   Specifically,	   at	   the	   mesh-­‐tissue	   interface,	   UltraPro™	  perpendicular	   and	  Restorelle®	   had	   better	   tissue	   incorporation	  while	  Gynemesh™	  PS	   and	  UltraPro™	   parallel,	   in	   spite	   of	   having	   been	   implanted	   flat,	   appeared	   buckled,	   and	  surrounded	  by	  a	  connective	  tissue	  capsule	  (Figure	  1	  [A-­‐D]).	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4.3.2 Functional	  Results	  
Muscle	  Mediated	  Contractions	  
	   In	   the	   grafted	   region,	   evaluation	   of	   the	   contractile	   force	   generated	   following	   KCl	  administration	  showed	  that	  muscle	  function	  was	  significantly	  different	  between	  the	  groups	  (P	   <	   0.001)	   (Figure	   20).	   Specifically,	   the	   grafted	   region	   of	   Gynemesh™	   PS,	   UltraPro™	  parallel	  (high	  stiffness),	  and	  Restorelle®	  generated	  significantly	  less	  force	  relative	  to	  sham	  (P	   <	   0.001,	   P	   <	   0.001,	   P	   =	   0.015),	   while	   there	   was	   no	   difference	   between	   sham	   and	  UltraPro™	  perpendicular	  (P	  =	  0.155).	  As	  shown	  in	  Table	  3,	  the	  decrease	  in	  contractile	  force	  following	   implantation	  of	  Gynemesh™	  PS	  and	  UltraPro™	  parallel	  was	  the	  greatest	  at	  80%	  and	   65%,	   respectively.	   When	   the	   contractile	   force	   generated	   by	   UltraPro™	   parallel	   was	  compared	  to	  that	  of	  UltraPro™	  perpendicular,	  the	  stiffer	  UltraPro™	  parallel,	  generated	  less	  force,	  but	  this	  did	  not	  reach	  statistical	  significance	  (P	  =	  0.078).	   In	  the	  non-­‐grafted	  region,	  there	  was	  no	  significant	  difference	  in	  contractile	  force	  generation	  between	  the	  groups	  (P	  =	  0.085),	   but	   UltraPro™	   parallel	   again,	   in	   this	   region,	   generated	   less	   force	   than	   UltraPro™	  perpendicular	  (P	  =	  0.052).	  	  
Nerve	  Mediated	  Contractions	  	  
	   	  In	   the	   grafted	   region,	   the	   contractile	   force	   generated	   following	   electrical	  stimulation	  showed	  that	  nerve	  function	  was	  significantly	  different	  between	  the	  groups	  (P	  <	  0.002)	   (Figure	   20).	  Muscle	   contractile	   force	   following	   implantation	  with	  Gynemesh™	  PS	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was	  decreased	  by	  91%	  relative	  to	  sham-­‐operated	  controls	  (P	  =	  0.008).	  However,	  there	  no	  significant	   difference	   following	   implantation	   with	   the	   lower	   stiffness	   UltraPro™	  perpendicular	  and	  Restorelle®	  (P	  =	  0.187,	  P	  =	  0.155).	  When	  we	  compared	  the	  contractile	  force	   generated	   by	   UltraPro™	   parallel	   to	   that	   of	   UltraPro™	   perpendicular,	   there	   was	   no	  significant	   difference	   observed	   (P	   =	   0.143).	   In	   the	   non-­‐grafted	   region,	   there	  was	   also	   no	  significant	   difference	   in	   nerve	   function	   between	   the	   groups	   (P	   =	   0.361),	   and	   UltraPro™	  parallel	  and	  UltraPro™	  perpendicular	  were	  similar	  (P	  =	  0.247).	  	  
Receptor	  Mediated	  Contractions	  	   	  In	   the	   grafted	   region,	   contractile	   force	   generated	   following	   the	   application	   of	   the	  muscarinic	   receptor	   agonist,	   carbachol,	   showed	   that	   receptor	   function	   was	   significantly	  different	  between	  the	  groups	  (P	  =	  0.008,	  Figure	  20).	  Of	  note,	  there	  was	  a	  90%	  decline	  in	  the	  median	   contractile	   force	   generated	   following	   implantation	  with	   Gynemesh™	   PS	   (P	   =	  0.007),	   while	   there	   was	   a	   62%	   increase	   in	   the	   contractile	   force	   generated	   following	  implantation	   with	   Restorelle®	   (P	   =	   0.037).	   When	   the	   contractile	   force	   generated	   by	  UltraPro™	   parallel	   to	   that	   of	   UltraPro™	   perpendicular	   was	   compared,	   there	   was	   no	  significant	   difference	   observed	   (P	   ≥	   0.999).	   In	   the	   non-­‐grafted	   region,	   there	   was	   no	  significant	  difference	  in	  cholinergic	  receptor	  function	  between	  the	  groups	  (P	  =	  0.148),	  and	  UltraPro™	   parallel	   was	   not	   significantly	   different	   from	   UltraPro™	   perpendicular	   (P	   =	  0.647).	   Contractile	   force	   generated	   following	   the	   application	   of	   the	   adrenergic	   receptor	  agonist,	   phenylephrine	   (10−8	   to	   10−4	   M,	   non-­‐cumulatively),	   was	   not	   substantial	   while	   a	  robust	  response	  in	  our	  positive	  control	  (primate	  bladder)	  was	  observed.	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4.3.3 Immunohistochemical	  Results	  
Peripheral	  Nerve	  Density	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Table	  9.	  Peripheral	  Nerve	  Density	  (%Fractional	  Area)	  	   Peripheral	  Nerve	  Density	  	  
(%	  Area)	  	   	  	  	  	  	  	  	  	  	  	  	  Grafted	   Non-­‐grafted	  	  	  	  	  Sham	   	  	  	  	  	  	  	  	  	  	  	  	  	  0.53	  (0.47,	  0.58)	  Gynemesh™	  PS	   0.05	  (0.04,0.05)*	   0.41	  (0.13,0.42)	  Restorelle®	   0.28	  (0.19,0.30)	   0.42	  (0.33,0.50)	  UltraPro™	  	  perpendicular	  	   0.25	  (0.22,0.38)	   0.30	  (0.28,0.51)	  	  	  UltraPro™	  	  	  	  	  parallel	  	   0.16	  (0.15,0.17)*	   0.30	  (0.20,0.41)	  




Cholinergic	  Nerves	  Density	  	   In	   the	   grafted	   region,	   cholinergic	   nerve	   density	   as	   measure	   by	   labeling	   with	   an	  antibody	   for	   the	  acetylcholine	  transporter,	  VAChT,	  showed	  that	  cholinergic	  nerve	  density	  was	   not	   significantly	   different	   from	   sham-­‐operated	   animals	   (P	   <	   0.093).	   When	   we	  compared	  cholinergic	  nerve	  density	  following	  implantation	  with	  UltraPro™	  parallel	  to	  that	  of	  UltraPro™	  perpendicular,	  there	  was	  also	  no	  significant	  difference	  observed	  (P	  ≥	  0.146).	  Interestingly,	   in	   the	   non-­‐grafted	   region,	   there	   was	   a	   significant	   difference	   between	   the	  groups	   (P	   =	   0.009).	   Cholinergic	   nerve	   density	   declined	   following	   implantation	   with	  Gynemesh™	   PS,	   supporting	   the	   loss	   in	   nerve	   function,	   but	   the	   difference	   did	   not	   reach	  significance	   (P	   =	   0.077).	   Alternatively,	   an	   increase	   in	   cholinergic	   nerve	   density	   was	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observed	   following	   implantation	   with	   the	   less	   stiff	   UltraPro™	   perpendicular	   and	  Restorelle®,	   but	   again,	   the	   increase	  was	   not	   significant	   (P	   =	   0.055,	   P	   =	   0.099).	  However,	  when	  we	  compared	  the	  cholinergic	  nerve	  density	  in	  UltraPro™	  parallel	  to	  that	  of	  UltraPro™	  perpendicular,	   a	   significant	   difference	  was	   observed	   (P	   =	   0.028),	  which	  may	   explain	   the	  trend	  towards	  an	  increase	  in	  nerve	  density	  with	  the	  less	  stiff	  UltraPro™	  perpendicular	  and	  Restorelle®	  (Table	  10).	  
	  
Adrenergic	  Nerves	  Density	  
	   In	  the	  grafted	  region,	  adrenergic	  nerve	  density	  as	  measured	  by	  TH	  was	  significantly	  different	  between	   the	  groups	   (P	  <	  0.008).	   Specially,	   the	  grafted	   region	  of	  Gynemesh™	  PS	  and	  UltraPro™	  parallel	  had	  significantly	  less	  nerves	  relative	  to	  sham	  (P	  =	  0.004,	  P	  =	  0.013,	  
Table	   10),	   while	   Restorelle®	   and	   the	   less	   stiff	   UltraPro®	   perpendicular	   were	   not	  significantly	   different	   from	   sham	   (P	   =	   0.848,	   P	   =	   0.121).	   However,	   when	   we	   compared	  adrenergic	   nerve	   density	   in	   UltraPro™	   parallel	   to	   that	   of	   UltraPro™	   perpendicular,	   there	  was	   no	   significant	   difference	   (P	   <	   0.464).	   In	   the	   non-­‐grafted	   region,	   there	   was	   also	   a	  significant	  difference	  in	  adrenergic	  nerve	  density	  between	  the	  groups	  (P	  =	  0.005).	  Similar	  to	  the	  grafted	  region,	  nerve	  density	  decreased	  following	  Gynemesh™	  PS	  implantation	  and	  UltraPro™	   parallel	   implantation	   (P	   =	   0.004,	   P	   =	   0.011),	   but	   there	   was	   no	   significant	  difference	  following	  implantation	  with	  Restorelle®	  or	  UltraPro™	  perpendicular	  (P	  =	  0.848,	  P	  =	  0.121).	  Also,	  when	  we	  compared	  adrenergic	  nerve	  density	  in	  UltraPro™	  parallel	  to	  that	  of	  UltraPro™	  perpendicular,	  it	  was	  not	  significantly	  different	  (P	  <	  0.223).	  	  
	   	   101	  
Relationship	  Between	  Mesh	  Properties	  and	  Smooth	  Muscle	  Outcomes	  
	   To	  determine	  if	  there	  was	  any	  association	  between	  mesh	  properties	  and	  the	  smooth	  muscle	  outcome	  measures	   (muscle	  contraction,	   innervation,	   receptor	   function,	  and	  nerve	  density),	  a	  correlation	  analysis	  was	  performed.	  The	  results	  showed	  that	  mesh	  stiffness	  was	  negatively	   correlated	   with	   all	   smooth	   muscle	   functional	   outcome	  measures,	   in	   both	   the	  grafted	  and	  non-­‐grafted	  regions	  [Spearman	  ρ	  =	  -­‐0.567	  (P	  =	  0.001),	  ρ	  =	  -­‐0.718	  (P	  <	  0.001),	  ρ	  =	  -­‐0.444	  (P	  =	  0.018),	  Spearman	  ρ	  =	  -­‐0.398	  (P	  =	  0.029),	  ρ	  =	  -­‐0.398	  (P	  =	  0.029),	  ρ	  =	  -­‐0.398	  (P	  =	   0.029)],	   respectively.	   Similar	   to	   mesh	   stiffness,	   mesh	   weight	   was	   also	   negatively	  correlated	   to	   all	   the	   smooth	   muscle	   outcome	   measures,	   but	   only	   in	   the	   grafted	   region	  [Spearman	  ρ	   =	   -­‐0.427	   (P	  =	  0.019),	  ρ	   =	   -­‐0.711	   (P	  <	  0.001),	  ρ	   =	   -­‐0.605	   (P	  =	  0.001)],	  while	  mesh	   porosity	   was	   positively	   correlated	   with	   smooth	   muscle	   outcomes	   in	   the	   grafted	  region	  [Spearman	  ρ	  =	  0.427	  (P	  =	  0.019),	  ρ	  =	  0.711	  (P	  <	  0.001),	  ρ	  =	  0.606	  (P	  <	  0.001)].	  As	  shown,	   unlike	   mesh	   stiffness,	   the	   association	   with	   mesh	   weight	   and	   porosity	   on	   the	  functional	   outcomes	   was	   largely	   limited	   to	   the	   grafted	   region,	   and	   these	   trends	   were	  similar	  for	  the	  histological	  analysis.	  	  To	   determine	   if	  mesh	   textile	   properties	   could	   indeed	   serve	   as	   predictors	   of	   these	  surgical	   outcomes	   of	   interest,	   we	   performed	   multiple	   regression	   analyses	   using	   mesh	  stiffness,	   weight,	   and	   porosity	   as	   the	   independent	   variables,	   and	   the	   smooth	   muscle	  functional	   outcomes	   (muscle	   contraction,	   innervation,	   receptor	   function,	   and	   nerve	  density)	   as	   the	   dependent	   variables.	   Results	   from	   the	   regression	   analysis	   showed	   that	  changes	  in	  smooth	  muscle	  contraction,	  in	  both	  the	  grafted	  and	  non-­‐grafted	  regions,	  were	  a	  function	  of	  mesh	  stiffness	  (P	  =	  0.030,	  P	  =	  0.009,	  respectively),	  while	  changes	  in	  nerve	  and	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receptor	   function,	   evident	   in	  only	   the	   grafted	   region,	  were	   a	   function	  of	   the	   three	   textile	  properties	  combined	  (P	  =	  0.001,	  P	  =	  0.022,	  respectively).	  We	  were	  also	  able	  to	  determine	  that	  mesh	   stiffness,	   alone,	  was	   a	   significant	   predictor	   of	   peripheral	   nerve	   density	   in	   the	  grafted	  region	  (P	  =	  0.020).	  However	  analysis	  of	  the	  specific	  nerve	  types	  showed	  that	  only	  in	  the	  non-­‐grafted	  region	  was	  adrenergic	  [pore	  size,	  (P	  =	  0.008)]	  and	  cholinergic	  [stiffness,	  (P	  =	  0.010)]	  nerve	  density	  a	   function	  of	  mesh	  properties	  (mesh	  porosity	  and	  mesh	  stiffness,	  respectively).	  
	  	  	  	  	  
	  	  	  	  Table	  10.	  Cholinergic	  and	  Adrenergic	  Nerve	  Density	  (%Fractional	  Area)	  	   Cholinergic	  Nerve	  Density	  	  
(%	  Area)	   	  	  	  Adrenergic	  Nerve	  Density	  	  	  (%	  Area)	  	   	  	  	  	  	  Grafted	   Non-­‐grafted	  	   	  	  	  	  	  	  	  	  	  	  Grafted	   	  Non-­‐grafted	  	  	  	  Sham	   	  	  	  	  	  	  	  	  	  	  	  	  	  0.020	  (0.025,	  0.045)	   0.20	  (0.17,	  0.25)	  	  	  	  	  	  	  Gynemesh™	  PS	   0.011	  (0.010,0.020)	   0.007	  (0.005,0.012)*	   0.01	  (0.00,	  0.03)*	   0.08	  (0.07,	  0.11)*	  Restorelle®	   0.051	  (0.042,0.054)	   0.080	  (0.047,0.091)	   0.08	  (0.06,	  0.09)	   0.23	  (0.18,	  0.30)	  UltraPro™	  	  perpendicular	  	   0.052	  (0.057,0.065)	   0.096	  (0.067,0.129)	   0.14	  (0.04,	  0.17)	   0.14	  (0.13,	  0.14)	  	  	  UltraPro™	  	  	  	  	  parallel	  	   0.023	  (0.005,0.048)	   0.011	  (0.016,0.022)	   0.01	  (0.00,	  0.03)*	   0.13	  	  (0.09,	  0.13)*	  
	  	  	  	  	  	  Values	  represented	  as	  mean	  	  ±	  standard	  deviation	  	  	  	  	  	  	  	  	  	  	  *Indicates	  significance	  relative	  to	  sham	  (P	  <	  .05)	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4.4 DISCUSSION	  
Synthetic	  polypropylene	  mesh,	  use	  for	  prolapse	  surgeries,	  was	  originally	  adopted	  by	  clinicians	   because	   of	   the	   long	   term	   anatomical	   support	   that	   it	   provides	   to	   the	   prolapsed	  vagina	   following	   failure	   of	   its	   fibromuscular	   support	   [13],	   [160].	   As	   clinical	   successes	  associated	  with	  the	  use	  of	  mesh	  increased,	  widespread	  use	  of	  mesh	  ensued,	  as	  well	  as	  the	  advent	  of	  multiple	  mesh	  products	  onto	  the	  market.	  In	  2010,	  the	  number	  of	  surgeries	  being	  performed	   annually	   had	   reached	   an	   estimated	   100,000,	   and	   this	   figure	   is	   expected	   to	  double	   by	   2050	   [9].	   However,	   the	   increased	   use	   of	   mesh	   has	   been	   paralleled	   by	   rising	  complication	  rates,	  which	  has	  prompted	  the	  need	  for	  studies	  aimed	  at	  elucidating	  possible	  sources	  of	   complication	   [161],	   [162].	  	  Our	   initial	   studies	   investigating	   the	   impact	  of	  mesh	  implantation	   showed	   that	   mesh	   increases	   smooth	   muscle	   cell	   apoptosis,	   and	   decreases	  smooth	  muscle	   thickness	   and	   function	   in	   the	   underlying	   vagina	   and	   newly	   incorporated	  tissue	   [15],	   [155].	   This	   current	   study,	   which	   uses	   detailed	   functional	   and	   histological	  analysis,	  expands	  upon	  our	  previous	  findings	  to	  further	  show	  the	  negative	  impact	  of	  mesh	  on	   vaginal	   smooth	   muscle	   contraction,	   innervation,	   receptor	   function,	   and	   innervation	  density.	   In	  addition,	   this	  study	  shows	  that	  the	   impact	  extends	  beyond	  the	  grafted	  tissues,	  and	   that	   the	   degree	   of	   impact	   is	   a	   function	   of	   the	  mesh	   properties,	  most	   notably,	  mesh	  stiffness.	  The	  results	  are	  intriguing,	  but	  also	  highly	  relevant	  as	  the	  meshes	  evaluated	  are	  all	  currently	  being	  used	  clinically,	  including	  Restorelle®	  (Coloplast),	  UltraPro™	  (Ethicon),	  and	  the	  gold	  standard	  mesh,	  Gynemesh™	  PS	  (Ethicon).	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These	   meshes,	   which	   exhibit	   distinct	   textile	   and	   mechanical	   properties,	   are	   used	  interchangeably	  in	  clinical	  settings,	  but	  behaved	  very	  differently	  following	  implantation.	  As	  noted	   in	   the	   results,	   it	   was	   immediately	   apparent	   upon	   excision	   of	   the	  mesh	   implanted	  vaginas,	   that	   the	   less	   stiff	   UltraPro™	   perpendicular	   and	   Restorelle®	   were	   better	  incorporated	   into	   the	   tissue	   than	   the	  stiffer	  Gynemesh™	  PS,	  which	  appeared	  buckled	  and	  surrounded	  by	  a	  connective	  tissue	  capsule.	  This	  surprising	  finding	  is	  supported	  by	  recent	  studies,	  which	  show	  that	   less	  stiff	   implants	  do	  reduce	  macrophage	  activation,	  and	  elicit	  a	  less	   severe	   foreign	   body	   response	   (FBR),	   relative	   to	   their	   stiffer	   counterparts	   [163].	  	  	  	  Although	  in-­‐vivo	  studies	  are	  few,	  more	  data	  is	  available	  on	  in	  vitro	  models,	  which	  show	  that	  stiff	   substrates	   do	   indeed	   promote	   increased	   macrophage	   phagocytosis,	   migration,	  proliferation,	   differentiation,	   adhesion,	   and	   expression	   of	   the	   pro-­‐inflammatory	   cytokine,	  TNF-­‐α	   [164]–[166].	   	   This	   suggests,	   that	   the	   stiffest	   and	   heaviest	   mesh	   implanted,	  Gynemesh™	   PS,	   was	   the	   most	   vulnerable	   to	   eliciting	   an	   immense	   FBR,	   irrespective	   of	  surgical	   technique.	  These	   initial	   findings,	  although	  superficial,	  were	   in	  essence,	   indicators	  and	  possibly	  contributors	   to	   the	  more	  robust	  remodeling	  occurring	  within	   the	   tissues,	  as	  subsequent	   evaluations	   of	   the	   smooth	   muscle	   layer,	   also	   showed	   these	   mesh	   specific	  differences	  [167].	  Of	  note,	  implantation	  with	  Gynemesh™	  PS	  was	  shown	  to	  cause	  the	  most	  significant	  disruption	   of	   the	   smooth	   muscle	   bundles,	   and	   the	   greatest	   loss	   in	   muscle	   thickness,	  especially	  in	  the	  grafted	  region.	  This	  decline	  was	  also	  evident	  in	  the	  functional	  response	  to	  KCl,	   but	   again,	   to	   a	   greater	   degree	   in	   grafted	   region.	   UltraPro™	   parallel,	   which	   has	  comparable	  stiffness	   to	   that	  of	  Gynemesh™	  PS,	  had	  a	  similar	  degree	  of	   impact,	  while	   less	  stiff	  Restorelle®	  had	   less	  of	   an	   impact,	   and	   the	   least	   stiff	  mesh,	  UltraPro™	  perpendicular,	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had	  no	  negative	   impact.	   Interestingly,	   in	   the	  non-­‐grafted	  region,	  UltraPro™	  perpendicular	  exhibited	  the	  potential	  to	  cause	  an	  increase	  in	  the	  smooth	  muscle	  contractile	  response.	  As	  shown,	   the	   observed	   responses	  mirrored	   the	   stiffness	   profiles	   of	   the	  meshes,	   and	   upon	  statistical	  evaluation,	  mesh	  stiffness	  proved	  to	  be	  a	  significant	  predictor	  of	  smooth	  muscle	  function	   in	   both	   the	   grafted	   and	   non-­‐grafted	   regions.	   Based	   on	   the	   principle	   of	   stress	  shielding,	  it	  can	  be	  postulated	  that	  the	  high	  stiffness	  meshes	  Gynemesh™	  PS	  and	  UltraPro™	  parallel	  likely	  shielded	  vaginal	  smooth	  muscle	  from	  sensing	  their	  normal	  physiologic	  loads,	  thus	   leading	   to	   disuse,	   and	   in	   turn,	   atrophy.	   This	   is	   similar	   to	   the	   case	   where	   the	  implantation	  of	  very	  stiff	  stents,	  which	  off-­‐loaded	  the	  arterial	  wall,	  induced	  tortuosity,	  and	  in	  some	  cases,	  rapid	  and	  extensive	  atrophy	  of	  arterial	  smooth	  muscle,	  while	  less	  stiff	  stents	  caused	  increased	  proliferation	  and	  arterial	  occlusion	  [168]–[173].	  This	   observed	   decline	   in	  myogenic	   contraction	   is	   indicative	   of	   a	   loss	   of	  myofiber	  integrity,	   but	   additional	   steps	  were	   also	   taken	   to	   evaluate	   the	   impact	   of	  mesh	   on	   nerve	  function.	   Upon	   evaluation,	   the	   results	   showed	   that	   the	   greatest	   change	   in	   neurogenic	  contraction	  occurred	   in	   the	  grafted	  region,	   following	   implantation	  of	  Gynemesh™	  PS.	  The	  results	  also	  showed	  that	  the	  observed	  changes	  in	  neurogenic	  contraction	  were	  a	  function	  of	  not	  only	  mesh	  stiffness,	  but	  also	  of	  mesh	  weight	  and	  porosity.	  This	  is	  particularly	  important	  since	  women	  with	  POP	  have	  an	  overall	  paucity	  of	  peripheral	  nerves	  [174].	  	  The	  results	  from	  the	  evaluation	  of	  nerve	  function	  suggests	  that	  mesh	  implantation	  could	  either	  be	  inducing	  changes	  in	  the	  amount	  of	  neurotransmitter	  binding	  to	  the	  receptors,	  changes	  in	  the	  number	  of	   nerves	   being	   stimulated,	   or	   both.	   Our	   analysis	   of	   muscle	   receptor	   function	   showed	  changes	  in	  the	  number	  of	  receptors	  were	  also	  occurring,	  as	  there	  was	  a	  significant	  impact	  of	  mesh	  implantation	  on	  muscarinic	  receptors	  in	  both	  the	  grafted	  and	  non-­‐grafted	  regions.	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Corresponding	  to	   the	  trends	   in	  nerve	   function,	   the	  greatest	  decrease	   in	  receptor	   function	  was	  observed	  following	  implantation	  with	  Gynemesh™	  PS.	  As	  in	  the	  case	  of	  nerve	  function,	  the	   regression	  analysis	   also	   showed	   that	   changes	   in	   receptor	   function	  were	  governed	  by	  mesh	   stiffness,	   weight,	   and	   porosity,	   but	   only	   in	   the	   non-­‐grafted	   region.	   The	   results	   in	  essence,	   show	   that	   Gynemesh™	   PS,	   which	   has	   the	   greatest	   stiffness,	   weight,	   and	   least	  porosity	  was	  again	  more	  prone	  to	  eliciting	  the	  greatest	  negative	  impact	  on	  nerve	  function,	  and	   supports	   the	   likelihood	   that	   may	   have	   been	   via	   the	   upregulation	   of	   the	   muscarinic	  receptors.	  	  As	  previously	  mentioned,	  however,	  changes	  in	  nerve	  function	  could	  also	  have	  been	  influenced	   by	   changes	   in	   nerve	   density.	   Results	   from	   the	   quantification	   of	   PGP	   9.5-­‐IR	  nerves	   showed	   that	   peripheral	   nerve	   density	   in	   the	   grafted	   region	   significantly	   declined	  following	   implantation	   with	   Gynemesh™	   PS	   and	   UltraPro™	   parallel,	   but	   not	   following	  implantation	  with	  UltraPro™	  perpendicular	  and	  Restorelle®	  was	  significant.	  The	  regression	  analysis	   further	  showed	   that	   the	  decline	   in	  peripheral	  nerve	  density	  was	  a	   result	  of	  only	  mesh	  stiffness,	  and	  not	  mesh	  weight	  or	  porosity	  as	  was	  observed	  with	  nerve	  and	  receptor	  function.	   The	   results	   appear	   to	   be	   in	   support	   of	   the	   conclusion	   that	   the	   decline	   in	  peripheral	   nerve	   density	   may	   be	   the	   cause	   of,	   or	   the	   result	   of	   the	   previously	   reported	  decline	   in	  myofiber	   function,	   as	  myofiber	   function	  was	   also	   a	   function	   of	  mesh	   stiffness.	  Hence,	   more	   specific	   probing	   of	   dominant	   cholinergic	   showed	   that	   implantation	   with	  Gynemesh™	  PS	   significantly	   decreased	   cholinergic	   nerve	   density	   in	   both	   the	   grafted	   and	  non-­‐grafted	   regions,	   while	   implantation	   with	   UltraPro™	   perpendicular	   and	   Restorelle®	  caused	  an	  increase	  in	  cholinergic	  nerve	  density,	  albeit	  non-­‐significantly	  [175]–[178].	  Taken	  together,	  the	  results	  support	  the	  conclusion	  that	  high	  stiffness	  meshes	  can	  have	  a	  negative	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effect	   on	   cholinergic	   nerves,	   as	   in	   the	   case	   of	   Gynemesh™	   PS,	   but	   that	   lower	   stiffness	  meshes	  may	  have	  the	  potential	  to	  maintain	  or	  increase	  nerve	  density.	  The	   probing	   of	   cholinergic	   nerves	   were	   followed	   by	   subsequent	   analysis	   of	  adrenergic	   nerves,	   which	   showed	   that	   implantation	   with	   Gynemesh™	   PS	   and	   UltraPro™	  parallel	   significantly	   decreased	   adrenergic	   nerve	   density	   in	   both	   the	   grafted	   and	   non-­‐grafted	  regions.	  The	  presence	  of	  a	  significant	  difference	  in	  both	  the	  grafted	  and	  non-­‐grafted	  regions,	   suggest	   that	  adrenergic	  nerve	  density	  may	  be	   the	  most	  vulnerable	   to	   injury,	  and	  that	   it’s	   loss	  may	  precede,	   and	  possibly	   orchestrate	   changes	   in	   the	   other	   smooth	  muscle	  components.	   	   This	   is	   further	   supported	   by	   a	   recent	   study	   by	   Northington	   et	   al.,	   which	  showed	  that	  women	  with	  POP	  exhibit	  a	  complete	  loss	  of	  response	  to	  the	  α1-­‐adrenoreceptor	  agonist,	  phenylephrine,	  relative	  to	  non-­‐prolapse	  controls.	  Additionally,	  the	  study	  also	  found	  that	   the	   proportion	   of	   co-­‐localized	   α1-­‐adrenoreceptors	   and	   smooth	   muscle	   α	   actin	   was	  significantly	  less	  in	  women	  with	  POP	  compared	  to	  non-­‐prolapse	  controls	  [179].	  Therefore	  perseverance	   of	   adrenergic	   nerve	   density	   following	   implantation	   with	   UltraPro™	  perpendicular	  and	  Restorelle®,	  vs	  Gynemesh™	  PS	  and	  UltraPro™	  parallel,	  may	  explain	   the	  more	   favorable	  outcomes	   shown.	  Alternatively,	   the	  observed	  decline	   in	   adrenergic	  nerve	  density	   following	   Gynemesh™	   PS	   and	   UltraPro™	   parallel	   implantation	   may	   explain	   the	  gross	  negative	  impact	  on	  VaSM,	  by	  the	  influence	  of	  mesh	  stiffness.	  Overall	   this	   study	   shows	   that	  mesh	   stiffness	   and	  weight	   are	  negatively	   correlated	  with	   smooth	   muscle	   outcomes,	   while	   porosity	   is	   positively	   correlated	   with	   muscle	  outcomes,	   supporting	   the	   transition	   as	   seen	   clinically,	   to	   light-­‐weight	   and	   large	   pore	  meshes.	  It	  is	  possible	  that	  the	  impact	  of	  one	  of	  these	  negatively	  correlated	  mesh	  properties	  could	  prove	  tolerable,	  but	  a	  mesh	  exhibiting	  a	  combination	  of	  them,	  as	  shown	  in	  the	  case	  of	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Gynemesh™	  PS,	  could	   lead	  to	  a	  major	  negative	   impact	  on	  VaSM.	   It	   is	  unclear	  exactly	  how	  long	  this	  negative	  remodeling	  process	  takes	  place	  and	  complications	  like	  mesh	  exposures	  ensue.	   It	   is	   likely,	  however	   that	   for	  most	  meshes,	   it	  proceeds	   to	  a	  point	  where	   the	   forces	  equilibrate	   and	   the	   remodeling	   response	   reaches	   homeostasis,	   as	   most	   women	   do	   not	  experience	   a	   mesh	   exposure.	   However,	   this	   study’s	   utilization	   of	   a	   non-­‐human	   primate	  model,	  which	  is	  a	  highly	  acceptable	  model	  for	  pelvic	  floor	  disorders,	  findings	  can	  serve	  as	  a	  guide	  when	  designing	   future	  clinical	  studies	   to	   further	  evaluate	  sources	  of	  complications.	  Additionally,	   the	   results	   could	   prove	   useful	   when	   designing	   de	   novo	  meshes	   aiming	   to	  improve	  the	  occurrence	  of	  the	  post-­‐operative	  degenerative	  effects	  following	  surgical	  mesh	  placement.	   Future	   work	   will	   involve	   more	   studies	   to	   explore	   the	   mechanisms	   of	   mesh	  impact,	   and	  methods	   to	   reduce	   stress	   shielding,	   in	   an	   effort	   to	   improve	   smooth	  muscle	  outcomes.	  
5.0	   AFTERWORD	  
5.1 SYNOPSIS	  
Smooth	  muscle	  cells	   (SMCs)	   line	   the	  walls	  of	  hollow	  organs	   the	   like	  blood	  vessels,	  intestines,	  and	  remarkably,	  the	  vagina.	  These	  cells,	  which	  are	  modulated	  by	  environmental	  cues,	   involuntarily	  contract	  and	  are	  essential	   for	  maintaining	   the	   tone	  of	   the	  organs	   they	  occupy.	  Hence,	  their	  dysfunction	  has	  been	  linked	  to	  multiple	  pathologies	  [81],	  [127],	  [148],	  [180]–[182].	  Pelvic	  Organ	  Prolapse	  (POP),	  a	  dysfunction	  characterized	  by	  the	  decent	  of	  the	  pelvic	   organs	   into	   the	   unsupported	   vagina,	   has	   also	   been	   linked	   to	   changes	   in	   smooth	  muscle	   thickness,	   structure	  and	   function.	  The	  studies	  characterizing	   these	  changes	   in	   the	  vaginal	   wall	   of	   women	  with	   prolapse,	   were	   unable	   to	   determine	   their	   onset,	   hence	   it	   is	  unclear	  whether	  these	  changes	  play	  of	  role	  in	  the	  progression	  of	  the	  dysfunction,	  or	  are	  the	  result	  of	  its	  progression.	  With	  the	  anticipated	  increase	  in	  the	  number	  of	  women	  presenting	  with	   POP,	   due	   to	   a	   rise	   in	   the	   aging	   population	   in	   the	   US,	   coupled	   with	   the	   increased	  incidence	  of	  complications	  from	  surgically	  implanted	  mesh	  used	  to	  restore	  support	  to	  the	  pelvic	   organs	   that	   recently	   prompted	   FDA	  warnings,	   there	   is	   an	   increased	   need	   to	   fully	  understand	   the	   mechanisms	   of	   POP	   development.	   In	   this	   thesis	   work,	   using	   principles	  rooted	  in	  pharmacology,	  mechanobiology,	  and	  biomechanics,	  we	  explore	  how	  vaginal	  birth	  injury,	  a	  major	  risk	  factor	  the	  development	  of	  POP,	  could	  induce	  changes	  in	  smooth	  muscle	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function,	   and	   how	   these	   changes	   could	   play	   a	   role	   in	   the	   progression	   of	   the	   disorder.	  Additionally,	  we	  examined	  the	  ability	  of	  prolapse	  meshes	  currently	  being	  used	  clinically,	  to	  improve	  smooth	  muscle	  integrity.	  
Vaginal	  Delivery	  with	  Injury	  Alters	  VaSM	  Function	  
The	  goal	  of	  the	  Aim	  1	  was	  to	  pharmacologically	  and	  immunohistologically	  assess	  the	  recovery	  of	  vaginal	  smooth	  muscle	  (VaSM)	  innervation,	  contraction	  and	  receptor	  function	  following	  a	  simulated	  maternal	  birth	  injury	  in	  a	  rodent	  model.	  For	  the	  study,	  sixty	  female	  Long	   Evans	   rats	   underwent	   a	   simulated	  maternal	   birth	   injury.	   At	   4-­‐weeks	   and	   8-­‐weeks	  post-­‐injury	   vaginal	   tissues	  were	   harvested	   and	   divided	   into	   proximal,	  middle,	   and	   distal	  segments,	  and	  the	  force	  generated	  following	  KCl,	  phenylephrine	  (PE),	  carbachol	  (CCh),	  and	  electrical	   field	   stimulation	   (EFS)-­‐induced	   contractions	   were	   evaluated.	   Histological	  evaluations	  of	  muscle	  morphology	  and	  peripheral	  nerve	  fiber	  density	  were	  also	  performed.	  In	  the	  proximal	  vagina	  the	  thickness	  of	  the	  vaginal	  wall	  significantly	  increased	  (P	  =	  0.010)	  by	   4	  weeks,	   and	  marginally	   recovered	   by	   8	  weeks	   post	   injury	   (P	   <	   0.062),	   however	   the	  location	  along	  the	  vagina	  where	  gross	  laceration	  had	  occurred	  did	  not	  recover.	  Comparison	  of	   the	   functional	  parameters	  between	  the	  4	  and	  8-­‐week	  groups	  also	  showed	  a	  significant	  increase	   in	   EC50	   (P	   =	   0.001,	   P	   =	   0.069)	   in	   response	   to	   KCl	   in	   the	   proximal	   and	   middle	  vagina,	   a	  decrease	   in	  Emax	   (P	  =	  0.002,	  P	  =	  0.005)	   in	   response	   to	  CCh	   in	   the	  proximal	  and	  middle	  vagina,	  and	  a	  decline	  in	  the	  EC50	  in	  the	  distal	  vagina	  (P	  =	  0.011)	  in	  response	  to	  PE.	  The	  results	  also	  showed	  a	  corresponding	  decrease	  in	  Emax	  in	  the	  proximal	  and	  distal	  vagina	  (P	  =	  0.034,	  P	  =	  0.032),	  with	  a	  persistent	  decline	  in	  the	  middle	  vagina	  in	  response	  to	  EFS	  (P	  =	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0.758).	  The	  results	  show	  a	  trend	  of	  increasing	  increase	  muscle	  hypersensitivity,	  decreasing	  density	   of	   cholinergic	   receptors	   in	   the	   proximal	   and	   middle	   vagina,	   and	   increasing	  adrenergic	  receptor	  sensitivity,	  perhaps	  as	  a	  result	  of	  a	  persistent	  loss	  of	  nerve	  function.	  
VaSM	  Function	  Influences	  Vaginal	  Biaxial	  Mechanics	  
The	  next	  aim	  was	  to	  determine	  changes	  in	  the	  biaxial	  mechanical	  properties	  of	  the	  vaginal	  following	  a	  loss	  of	  VaSM	  function,	  as	  has	  been	  shown	  to	  be	  the	  case,	  following	  birth	  injury.	  For	  the	  study	  6	  virgin	  female	  Long	  Evans	  rats	  at	  3-­‐month	  old	  virgin	  were	  biaxially	  tested	  in	  the	  presence	  of	  a	  physiologic	  Krebs’-­‐bicarbonate	  buffer,	  a	  high	  potassium	  muscle	  depolarizing	   solution	   (KCl),	   and	   a	   Ca2+	   free	   Krebs’-­‐bicarbonate	   supplemented	   with	   a	  calcium	   chelating	   solution	   (1	  mM	  EGTA),	   to	   capture	   baseline	   (resting	   tension),	   activated	  (tonic	   contraction)	   and	   passivated	   (relaxed)	   smooth	   muscle	   states.	   For	   analysis,	   stress-­‐strain	   curves	  were	  generated	  based	  on	   the	  Green-­‐Lagrangian	   strains	   calculated	   from	   the	  marker	  displacements,	  for	  both	  the	  circumferential	  (εCirc)	  and	  axial	  (εAxial)	  direction.	  Multi-­‐photon	   imaging	   of	   collagen,	   elastin	   and	   smooth	  muscle	  were	   also	   done,	   and	   the	   percent	  collagen	   crimp	   determined.	   The	   outcomes	   were	   analyzed	   using	   a	   one-­‐way	   analysis	   of	  variance	   (ANOVA),	   with	   Bonferonni	   correction	   (P<0.05).	   The	   results	   showed	   that	   the	  vagina	  is	  hyperelastic	  and	  anisotropic,	  with	  the	  circumferential	  direction	  being	  significantly	  less	   stiff	   than	   the	   axial	   direction	   (P	   =	   0.020),	   and	   strained	   less	   (P	   =	   0.034).	   On	   average,	  there	  were	   differences	   in	   the	   shape	   of	   the	   stress	   strain	   curves,	  most	   impressively	   in	   the	  circumferential	   direction,	   where	   VaSM	   smooth	   muscle	   activation	   was	   associated	   with	   a	  36%	  decrease	  in	  tensile	  modulus	  in	  the	  axial	  direction	  (P	  =	  0.74),	  and	  a	  9%	  decrease	  in	  the	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modulus	   in	   the	   circumferential	  direction	   (P	  =	  0.87).	  There	  was	   also	  very	   little	  difference	  observe	   in	   the	   areal	   strain	   or	   the	   anisotropic	   index.	   However,	   there	  was	   a	   trend	   during	  non-­‐equibiaxial	   loading,	   toward	   increasing	   areal	   strain	   and	   decreasing	   anisotropy	  following	  smooth	  muscle	  contraction.	  The	  results	  also	  showed	  a	  governing	  role	  of	  strains	  in	  the	  circumferential	  direction	  on	  strains	  observed	  in	  the	  longitudinal	  direction,	  which	  may	  be	  indicative	  of	  the	  preferred	  orientation	  of	  the	  collagen	  and	  elastin.	  These	  findings	  show	  the	  potential	  of	   the	   loss	  of	  vaginal	  smooth	  muscle	   to	  cause	  an	   increase	   in	   tissue	  stress	  at	  low	  physiologic	   levels	  of	  strain,	  due	  to	  the	  absence	  of	   its	  protective	  ability	  to	  redistribute	  stress	   between	   the	   axes.	   These	   changes	   could	   cause	   resident	   cells	   to	   induce	   a	   catabolic	  response	  in	  an	  attempt	  to	  restore	  physiologic	  strains,	  resulting	  in	  tissue	  degeneration.	  	  
Prolapse	  Meshes	  Negatively	  Impact	  VaSM	  Function	  	  The	  final	  aim	  was	  to	  evaluate	  the	  impact	  of	  polypropylene	  mesh	  on	  vaginal	  smooth	  muscle	   structure	   and	   function,	   and	   to	   evaluate	   these	   outcomes	   in	   the	   context	   of	   mesh	  textile	  and	  mechanical	  properties.	  For	  the	  study,	  thirty-­‐eight	  parous	  Rhesus	  Macaques	  with	  similar	  age,	  parity	  and	  pelvic	  organ	  prolapse	  quantification	  (POP-­‐Q)	  scores	  were	  implanted	  with	   mesh	   via	   sacrocolpopexy.	   Three	   months	   following	   implantation	   of	   the	   3	  polypropylene	   prolapse	   meshes	   with	   distinct	   textile	   and	   mechanical	   properties,	   mesh	  tissue	   explants	   were	   evaluated	   for	   smooth	   muscle	   contraction,	   innervation,	   receptor	  function,	   and	   innervation	   density.	   The	   maximum	   contractile	   force	   generated	   following	  muscle,	  nerve,	  and	  receptor	  stimulation,	  and	  for	  peripheral	  nerve	  density	  for	  each	  explant	  was	  recorded.	  The	  impact	  of	  Gynemesh™	  PS	  (Ethicon;	  N=8),	  Restorelle®	  (Coloplast;	  N=8),	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UltraPro™	  parallel,	   and	  UltraPro™	  perpendicular	   (Ethicon;	  N=6,	  N=8),	  were	   compared	   to	  sham-­‐operated	   controls	   (N=8).	   The	   outcomes	   were	   analyzed	   by	   Kruskal-­‐Wallis	   ANOVA,	  Mann	  Whitney	  U	  tests,	  and	  multiple	  regression	  analysis	  (P<0.05).	  The	  results	  showed	  that	  muscle,	  nerve,	  and	  receptor	  mediated	  contractions	  were	  negatively	  impacted	  by	  mesh	  only	  in	  the	  grafted	  region	  (P<0.001,	  P=0.002,	  P=0.008),	  while	  cholinergic	  and	  adrenergic	  nerve	  density	   were	   impacted	   in	   the	   grafted	   (P=0.090,	   P=0.008)	   and	   non-­‐grafted	   (P=0.009,	  P=0.005)	  regions.	  The	  impact	  varied	  by	  mesh-­‐property,	  as	  mesh	  stiffness	  was	  a	  significant	  predictor	  of	  the	  negative	  impact	  on	  muscle	  function	  and	  nerve	  density	  (P=0.030,	  P=0.009),	  while	  mesh	  density,	  weight	  and	  porosity	  (combined)	  were	  predictive	  of	  nerve	  and	  receptor	  function	   (P=0.001,	   P=0.022).	  Overall,	   this	   aim	   showed	   that	  mesh	  has	   an	  overall	   negative	  impact	  on	  vaginal	   smooth	  muscle,	   and	   that	   the	  effects	  are	  a	   function	  of	  mesh	  properties,	  most	  notably,	  mesh	  stiffness.	  	  	  
5.2 IMPLICATIONS	  
Basic	  Science	  Implications	  
	   Stress	  is	  known	  to	  influence	  growth,	  adaptation	  and	  morphogenesis	  in	  many	  organs,	  and	   the	   vagina	   is	   no	   exception	   to	   this	   dogma.	   The	   vagina,	   a	   load	   bearing	   structure,	  suspends	   above	   the	   rectum	   and	   is	   kept	   in	   tension	   through	   its	   ability	   to	   dynamically	  contract	  against	  the	  levator	  ani	  muscles	  via	  its	  connective	  tissue	  attachments.	  In	  turn,	  the	  vagina	  provides	  support	  to	  the	  bladder,	  urethra,	  cervix	  and	  rectum.	  Hence,	  changes	  in	  the	  mechanical	   properties	   of	   the	   vagina	   or	   the	   vagina	   supportive	   connective	   tissues	   (VSTC),	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could	   hamper	   its	   ability	   to	   adequately	   support	   these	   organs,	   thus	   compromising	   pelvic	  organ	  support.	  As	  mentioned,	  VaBI,	  which	  is	  one	  of	  the	  major	  risk	  factors	  of	  POP,	  has	  the	  potential	  to	  impact	  multiple	  mechanical	  components	  of	  the	  vaginal	  and	  the	  VSTC.	  However	  our	   initial	   investigation	   of	   changes	   in	   the	   passive	   mechanical	   components	   of	   the	   VSTC	  
(Appendix	   I),	   showed	   that	   the	   effects	   of	   injury	   on	   the	   passive	   components	   does	   not	  worsen	  with	  time	  post-­‐injury,	  which	  may	  limit	  its	  effects	  as	  a	  pathogenic	  factor.	  However	  our	   investigation	   of	   VaBI	   on	   vaginal	   smooth	   muscle	   showed	   persistent	   loss	   of	   smooth	  muscle	   function	  with	  time-­‐post	   injury.	  Hence,	  we	  further	  aimed	  to	  evaluate	  the	   impact	  of	  changes	  in	  smooth	  muscle	  function,	  as	  these	  persistent	  changes	  in	  vaginal	  smooth	  muscle	  mechanics	   could	   be	   driving	   a	   degenerative	   remodeling	   process	   and	   the	   eventual	   loss	   of	  pelvic	  organ	  support.	  	  The	   results	   from	   chapter	   3	   indeed	   attest	   to	   the	   potential	   of	   changes	   in	   vaginal	  smooth	  muscle	  to	  alter	  vaginal	  wall	  mechanics,	  and	  the	  tension	  on	  connective	  tissues	  and	  ligamentous	  attachments.	  This	  is	  due	  to	  the	  ability	  of	  smooth	  muscle	  to	  dynamically	  sense	  and	  respond	  to	  changes	  in	  force,	  as	  exhibited	  in	  other	  mechanical	  organs	  like	  the	  bladder,	  duodenum	  and	  arteries	  [128],	  [183],	  [184].	  As	  noted,	  a	  loss	  of	  smooth	  muscle	  contraction	  is	  associated	  with	  decreased	   compliance	   in	   the	  bladder,	   increased	   stiffening	   and	  decreased	  motility	   in	   the	   duodenum,	   as	   well	   as	   increased	   stiffening	   of	   the	   arteries.	   Shown	   in	   this	  work,	   is	   that	   a	   loss	   of	   smooth	  muscle	   function	   in	   the	   vagina,	   as	   evident	   following	   VaBI,	  could	  also	  result	  in	  increased	  stiffening	  of	  the	  vaginal	  wall,	  due	  to	  more	  rapid	  recruitment	  of	  collagen	  and	  elastin	  fibers.	  This	  rapid	  recruitment	  of	  collagen	  fibers,	  would	  then	  subject	  fibroblast	  and	  smooth	  muscle	  cells	   localized	  within	  the	  matrix	   to	   increased	  strains	  under	  physiologic	   loads.	   These	   cells	   interact	   with	   their	   matrix	   through	   distinct	   patterns	   of	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signaling	  and	  migration,	  and	  can	  quickly	  detect	  changes	  in	  tensional	  homeostasis	  induced	  by	   changes	   in	   smooth	  muscle	   function	   [185]–[187].	   The	  mechanostat	   set	   point	   of	   these	  cells	   are	   calibrated	   to	   the	   physiologic	   tensional	   homeostasis	   of	   the	   tissue,	   and	   catabolic	  mechanisms	   are	   activated	   when	   strain	   induced	   signals	   are	   below	   the	   set	   point,	   while	  anabolic	   mechanism	   are	   activated	   when	   the	   signal	   is	   above	   the	   set	   point	   [188]–[190].	  These	   catabolic	   and	   anabolic	   mechanisms	   are	   highly	   regulated	   by	   the	   balance	   between	  matrix	   metalloproteinases	   (MMPs)	   and	   their	   inhibitors	   (TIMPs).	   It	   is	   also	   possible	   that	  anabolic	   and	   catabolic	   mechanisms	   could	   persist	   due	   to	   failure	   to	   restore	   homeostasis,	  which	   is	  highly	  probable	   following	  VaBI,	  as	  smooth	  muscle	  contractile	   function	  continues	  to	  decline.	  Not	   surprisingly,	   functional	   evaluation	   of	   the	   active	   mechanics	   of	   tissues	   from	  women	  show	  a	  decrease	  in	  smooth	  muscle	  contractility	  (when	  normalized	  to	  tissue	  area)	  in	  prolapse	   tissues	   relative	   to	   non-­‐prolapse	   tissues	   [179].	   Additionally,	   our	   finding	   that	  actinin,	  which	  aids	  in	  smooth	  muscle	  active	  tension	  development	  through	  binding	  of	  actin	  filaments	   and	   β-­‐integrins,	   declines,	   offers	   even	   more	   substantial	   evidence	   towards	   the	  association	   of	   VaBI	   and	   the	   development	   of	   POP	   [191].	   Also	   as	   previously	   mentioned,	  women	   with	   POP	   exhibit	   a	   decline	   in	   lysyl	   oxidase	   like-­‐1	   (LOXL1)	   expression.	   These	  changes	  in	  LOX	  expression,	  can	  alter	  the	  stiffness	  of	  the	  collagen	  fibers,	  hence	  it	  is	  another	  mechanism	   used	   by	   cells	   to	   restore	   mechanical	   homeostasis.	   Specifically,	   findings	   of	   a	  decline	   in	   LOX,	   supports	   the	   increased	   stress	   observed	   following	   smooth	   relaxation	   in	  chapter	  2,	  as	  a	  decline	  in	  LOX	  expression	  would	  aid	  in	  lowering	  the	  stress	  environment	  in	  women	  with	  POP	  following	  a	  loss	  of	  smooth	  muscle.	  Interestingly,	  however,	  the	  application	  of	  surgical	  mesh	  for	  repair,	  leads	  to	  a	  subsequent	  alteration	  of	  the	  vaginal	  wall.	  As	  shown	  in	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chapter	   3,	   mesh	   stiffness	   significantly	   influenced	   smooth	   muscle	   outcomes,	   as	   the	   high	  stiffness	  meshes	  were	  associated	  with	  a	  greater	  loss	  of	  smooth	  muscle	  contractile	  function.	  The	  findings	  were	  theorized	  to	  be	  attributed	  to	  a	  stress-­‐shielding	  phenomenon,	  similar	  to	  that	  observed	  in	  the	  cardiovascular	  literature	  [168]–[173].	  This	  is	  further	  substantiated	  by	  Holzapfel	  et	  al.	  report	  of	  varying	  mechanical	  properties	  of	  the	  intima,	  media	  and	  adventitia	  of	   the	   coronary	   artery,	   which	   is	   comparable	   to	   the	   subepithelium,	   muscularis,	   and	  adventitia	   of	   the	   vagina	   [192].	   The	   adventitia	   was	   found	   to	   be	   the	   least	   stiff,	   which	   is	  postulated	   to	  be	  essential	   as	   the	  adventitia	  engages	  under	   load,	  only	  after	   the	  media	  has	  been	  subjected	  to	  large	  strains,	  in	  order	  to	  prevent	  additional	  distention.	  Hence,	  it	  is	  likely	  that	   for	   the	  vagina,	   following	  the	   implantation	  of	  a	  stiff	  mesh	  onto	   the	  vaginal	  adventitia,	  the	   adventitia	   engages	   much	   earlier	   when	   subjected	   to	   loading	   thus	   shielding	   the	  muscularis	  from	  physiologic	  loads.	  	  Numerous	   studies	   have	   in	   the	   cardiovascular	   and	   orthopedic	   fields	   have	   revealed	  this	  thin	  line	  between	  degenerative	  and	  regenerative	  remodeling,	  as	  a	  result	  of	  physiologic	  versus	  non-­‐physiologic	  strain	  levels.	  An	  in	  vitro	  study	  on	  tendon	  cells	  by	  Yang	  et	  al.	  showed	  that	   for	   a	   load	   bearing	   structure	   like	   the	   tendon,	   strain	  magnitudes	   ≤	   6%	   can	   provide	   a	  protective	  effect,	  while	  strain	  magnitudes	  of	  ≥	  8%	  can	  prove	  detrimental	  with	  an	  increased	  expression	   of	  MMPs	   and	   other	   pro-­‐inflammatory	  markers	   in	   an	   attempt	   to	   reorient	   and	  remodel	   the	   matrix	   to	   reduce	   strains	   [193].	   Interestingly,	   a	   previous	   study	   from	   our	  laboratory	   also	   showed	   that	   vaginal	   fibroblast	   are	   mechanosensitive,	   with	   strain	  magnitudes	   of	   8%	   and	   16%,	   capable	   of	   increasing	   MMPs	   expression,	   relative	   to	   non-­‐stretched	   controls	   [194].	   Hence,	   a	   loss	   of	   smooth	  muscle	   function	   following	   VaBI,	   could	  indeed	  precede	   the	  eventual	  degenerative	   remodeling	  of	   the	  vagina	   leading	   to	  POP.	   	  The	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results	  from	  this	  work	  also	  suggest	  that	  VaBI,	  may	  increase	  the	  odds	  of	   incurring	  a	  strain	  induced	   injury	   during	   a	   subsequent	   vaginal	   delivery,	   as	   the	   stress	   dampening	   effect	  provided	   by	   the	   smooth	   muscle	   function	   would	   be	   lacking.	   Additionally,	   as	   shown	   in	  Appendix	   I,	   VaBI	   is	   also	   associated	   with	   delayed	   or	   inadequately	   healing	   of	   the	   vagina	  supportive	   connective	   tissue	   complex	   (VSTC),	   which	   can	   also	   increase	   the	   risk	   of	   a	  subsequent	   injury.	   This	   supports	   clinical	   data	   showing	   that	   the	   odds	   of	   developing	   POP,	  increases	  with	  each	  subsequent	  delivery	  [29].	  VaBI	  also	  did	  however;	  prevent	  post-­‐partum	  recovery	  of	  the	  VSTC,	  which	  may	  be	  an	  alternate	  mechanism	  through	  which	  the	  vagina	  may	  be	   subjected	   to	   stress	   shielding.	   This	   would	   also,	   in	   turn,	   result	   in	   a	   time-­‐dependent	  degenerative	  remodeling	  process	  that	  could	  manifest	  with	  time	  or	  hormonal	  withdrawal.	  	  Overall	   this	   work	   provides	   major	   insights	   into	   the	   role	   of	   smooth	   muscle	   in	   the	  pathogenesis	   of	   POP,	   which	   is	   seldom	   evaluated.	   More	   broadly,	   this	   work	   has	   major	  implications	   for	   field	  of	  mechanobiology.	  The	   theoretical	   basis	   for	   this	   is	   that	   changes	   in	  active	  mechanics	  (smooth	  muscle)	  following	  VaBI	  can	  also	  lead	  to	  alteration	  of	  the	  passive	  mechanics	   (collagen	   and	   elastin),	   promoting	   the	   upregulation	   of	  MMPs,	   and	   a	   decline	   in	  TIMPS	  and	  LOX	  leading	  to	  decreased	  mechanical	  properties	  [197].	  Additionally,	  with	  POP	  being	  significantly	  correlated	  with	  hormonal	  status,	  a	   factor,	  which	  can	  also	   influence	  the	  expression	  of	  these	  enzymes,	  it	  provides	  multiple	  avenues	  for	  which	  smooth	  muscle	  could	  influence	  tissue	  remodeling	  and	  the	  ultimate	  manifestation	  of	  POP.	  This	  theory	  also	  aligns	  well	  with	   our	   findings	   in	   Chapter	   3,	   that	   a	   loss	   of	   smooth	  muscle	   can	   increase	   stiffness,	  hence	  the	  disruption	  of	  the	  matrix	  by	  an	  upregulation	  of	  these	  matrix	  degrading	  enzymes,	  and	  decreased	  expression	  of	  the	  crosslinking	  enzyme	  could	  be	  mechanisms	  to	  reduce	  the	  stiffness	  of	  the	  matrix,	  in	  order	  to	  lessen	  load	  transfer	  to	  resident	  cells.	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Clinical	  Implications	  
	   Millions	  of	  women,	   in	   the	  United	  States	  and	  worldwide,	  presenting	  with	  POP	  have	  difficulty	   defecating	   and-­‐or	   urinating,	   in	   addition	   to	   some	   degree	   of	   sexual	   dysfunction,	  which	  can	  result	  in	  decreased	  quality	  of	  life	  and	  depression	  [4],	  [5].	  In	  the	  United	  States,	  the	  number	   of	   women	   who	   underwent	   surgery	   for	   POP	   was	   28.9%	   in	   2010,	   and	   with	   the	  expected	   increase	   in	   the	   elderly	   population;	   this	   figure	   is	   expected	   to	   double	  within	   the	  next	  30	  years	  [10]	  .	  As	  last	  reported	  in	  1997,	  the	  direct	  annual	  cost	  for	  those	  that	  do	  seek	  surgical	   intervention,	   is	  over	  a	  billion	  dollars,	  and	   this	   figure	   is	  also	  expected	   to	   increase	  [11].	   This	   rather	   exorbitant	   figure	   includes	   the	   cost	   of	   surgery	   performed	   for	   symptom	  management,	   and	  does	  not	   include	   strategies	  which	   address	   the	   underlying	   cause	   of	   the	  dysfunction,	   as	   it	   remains	  elusive.	   It	   is	  not	   surprising	   then,	   that	  within	  a	   few	  years,	   over	  10%	   of	   repairs	   requires	   a	   second	   procedure,	   and	   is	   associated	   with	   complications	   that	  recently	  prompted	  FDA	  warnings	  [6],	  [23]–[25].	  Hence,	  the	  studies	  which	  form	  the	  body	  of	  this	  thesis	  work	  is	  clinically	  relevant,	  as	  provide	  evidence	  to	  the	  support	  the	  role	  of	  smooth	  muscle	   as	   a	   pathogenic	   factor	   of	   POP,	   thus	   making	   it	   a	   potential	   target	   for	   clinical	  intervention	   for	   treatment	  and	  preventative	   strategies.	   Specifically,	   this	  work	   shows	   that	  vaginal	   injury	   during	   delivery,	   can	   lead	   to	   a	   steady	   decline	   in	   smooth	   muscle	   function,	  which	   can	   compromise	   vaginal	   support	   of	   the	   pelvic	   organs.	   In	   addition,	   it	   shows	   that	  surgically	   implanted	   meshes,	   designed	   to	   restore	   the	   unsupported	   organs	   to	   their	  anatomical	  position,	  have	  mechanical	  and	  textile	  properties	  that	  further	  promote	  a	  loss	  of	  VaSM.	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The	   basis	   for	   this	   investigation	   is	   rooted	   in	   findings	   of	   numerous	   clinical	   studies	  showing	   the	   high	   association	   between	   vaginal	   delivery,	   and	   pelvic	   organ	   support.	   The	  findings,	  which	  were	  recently	  summarized	  in	  a	  publication	  by	  the	  International	  Continence	  Society	  (ICS),	  showed	  with	  Level	   I	  and	  Level	   II	  clinical	  evidence	   that	  vaginal	  delivery	  can	  impact	   the	  alignment,	   tone,	   attachment,	   and	   innervation	  of	   the	  vagina	  and	   its	   supportive	  tissue	   complex	   (VSTC)	   [198].	   With	   only	   a	   percentage	   of	   women	   delivering	   vaginally,	  presenting	   with	   symptoms	   of	   prolapse,	   many	   clinical	   studies	   have	   focused	   on	  understanding	  the	  specific	  factors	  during	  delivery	  that	  may	  predispose	  a	  cohort	  of	  women	  to	  develop	  POP,	  especially	  with	  the	  rise	  in	  elective	  caesarian	  delivery	  to	  obviate	  the	  risk	  of	  POP	   [29],	   [32],	   [34],	   [47],	   [55],	   [199].	   Injury	  emerged	  as	  a	   relevant	  predictor	  of	   a	   loss	  of	  pelvic	  organ	  support	  postpartum,	  as	  characterized	  by	  increased	  mobility.	  More	  specifically,	  these	  studies	  showed	  that	  rates	  of	   injury	  are	   increased	  with	   forceps	  delivery,	  multiparty,	  longer	   second-­‐stage	   of	   labor,	   third-­‐degree	   perineal	   tear,	   and	  macrosomia,	   but	   the	   exact	  mechanism	  remains	  elusive,	  and	  individual	  study	  results	  are	  conflicting.	  Hence,	  this	  work	  is	  essential	  as	  it	  aids	  in	  bridging	  the	  gap	  between	  vaginal	  injury	  during	  delivery,	  and	  the	  loss	  of	   pelvic	   organ	   support.	   More	   importantly,	   it	   identifies	   smooth	   muscle	   injury	   occurring	  during	  delivery,	  as	  a	  key	  pathogenic	  factor,	  irrespective	  of	  vaginal	  injury	  mode.	  	  	   These	  findings	  paired	  with	  a	  study	  from	  Dietz	  et	  al.	  which	  showed	  that	  pelvic	  organ	  mobility	  antepartum	  was	  negatively	  associated	  with	  postpartum	  bladder	  (r	  =-­‐0.52),	  rectal	  (r	  =-­‐0.60),	  and	  cervical	  (r	  =-­‐0.54)	  descent,	  show	  the	  potential	  to	  design	  effective	  preventive	  measures	   [125].	   Women	   at	   risk	   of	   incurring	   an	   injury	   during	   delivery	   could	   be	   easily	  identified,	   and	   offered	   alternate	   delivery	   options.	   .	   The	   correlation	   for	   the	   study	   was	  analyzed	  from	  outcomes	  obtained	  from	  evaluations	  at	  the	  third	  trimester	  of	  pregnancy	  and	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2	  months	  postpartum.	  These	  findings	  are	  further	  supported	  a	  study	  showing	  that	  the	  risk	  of	   incurring	   a	   sulcus	   tears,	   similar	   to	   the	   tear	   evaluated	   in	   this	   thesis	  work,	   are	   present	  even	  before	  pregnancy	  [37].	  This	  is	  in	  contrast	  to,	  third	  and	  fourth-­‐degree	  tears	  which	  are	  also	   preventable	   as	   they	   are	   related	   to	   physician	   management.	   The	   subset	   of	   women	  undergoing	  sulcus	  tears	  were	  also	  reported	  to	  have	  a	  trend	  toward	  less	  weight	  gain	  during	  pregnancy,	   fewer	   episiotomies,	   and	   lack	   of	   employment,	   and	   perhaps	   a	   lower	  socioeconomic	   status	   as	   there	   also	   had	   a	   trend	   towards	   lower	   mother-­‐weight,	   mother-­‐height,	   and	  birth	  weight.	   These	   findings	  have	  been	   further	   substantiated	  by	  more	   recent	  studies	  showing	  that	  body	  mass	  index,	  socioeconomic	  status	  are	  independently	  associated	  with	   POP,	   at	   a	   95%	   confidence	   interval	   [200].	   The	   assertion	   by	   the	   authors	   that	   the	  inadequate	  maternal	   adaptation	  may	  be	   related	   to	   lower	   social	   economic	   status	   through	  nutrition	   is	   indeed	   merited	   as	   changes	   in	   nutrition	   can	   influence	   hormonal	   levels,	   with	  down-­‐stream	  effects.	  	  	   It	   is	  known	   that	  diabetic	  women	   (type	  1	  and	   type	  2),	   exhibiting	  high	  blood	  glucose	  levels	  have	   a	  1.7	   –	  6.20	  odds	   ratio	   of	   undergoing	   a	   c-­‐section	   compared	   to	  women	   in	   the	  general	  population	  [201].	  The	  elevated	  glucose	  levels	  have	  been	  shown	  to	  alter	  hormonal	  levels,	   which	   may	   increase	   in	   LOX	   and	   LOXL1	   (elastin	   &	   collagen	   crosslinkers)	   mRNA	  expression,	  which	  can	  result	  in	  decreased	  antepartum	  mobility	  in	  addition	  to	  the	  inhibition	  of	  other	  necessary	  maternal	  adaptations	  [202]–[205].	  This	  is	  further	  supported	  by	  studies,	  which	   show	   that	   the	   overexpression	   of	   LOX	   inhibits	   the	   phenotypic	   switch	   of	   smooth	  muscle	   from	   a	   contractile	   to	   a	   proliferative	   phenotype	   that	   is	   necessary	   for	   adaptations	  during	  pregnancy,	  as	  it	  allows	  for	  increased	  SMC	  proliferation	  and	  elastin	  synthesis	  [197].	  It	  is	  possible	  that	  in	  the	  absence	  of	  adequate	  vaginal	  smooth	  muscle	  adaptation,	  it	  becomes	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injured,	  initiating	  a	  cascade	  of	  degenerative	  events.	  The	  findings	  of	  this	  thesis	  suggest	  that	  these	   events	   could	   be	   a	   result	   of	   changes	   in	   the	   mechanical	   environment,	   nevertheless	  clinical	   analysis	   of	   antepartum	   pelvis	   organ	  mobility,	   nutrition,	   and	   increased	   physician	  training	  identified	  by	  Dietz	  and	  others,	  could	  serve	  as	  preventative	  measures	  (Figure	  22).	  In	  addition,	  the	  results	  from	  this	  work	  suggests	  that	  other	  preventative	  measure	  including	  lab	  tests	  similar	  to	  those	  utilized	  to	  predict	  cardiovascular	  risks,	  could	  prove	  beneficial	  for	  predicting	   the	   risk	   of	   birth	   injury,	   and	   hence	   prove	   beneficial	   for	   effectively	   selecting	  women	  who	  would	  benefit	   from	  a	  caesarean	  delivery.	  This	   lack	  of	  effective	  selection	  may	  be	   driving	   the	   conflicting	   results	   regarding	   the	   benefits	   of	   caesarean	   deliveries,	   as	   a	  caesarean	   may	   not	   be	   more	   beneficial	   relatives	   to	   a	   vaginal	   delivery	   with	   following	  adequate	  maternal	   adaptations.	   The	   predictive	   biomakers	   of	   interest	   could	   be	   similar	   to	  those	   being	   used	   to	   evaluate	   cardiovascular	   risk,	   as	   it	   is	   also	   characterized	   by	   increased	  smooth	  muscle	  proliferation	  and	  differentiation.	  	   	  The	  finding	  from	  this	  work	  also	  suggest	  that	  smooth	  muscle	  could	  serve	  a	  marker	  for	  the	  evaluation	  of	  the	  efficacy	  of	  treatments	  methods	  for	  POP,	  and	  thus	  steps	  were	  taken	  to	  evaluate	   the	   impact	   of	   currently	  used	  meshes	   for	  POP.	  The	   results	   in	  Chapter	  3,	   showed	  that	   meshes	   which	   were	   being	   used	   interchangeably,	   for	   POP	   repair,	   can	   compromise	  smooth	  muscle	  function,	  to	  varying	  degrees,	  with	  the	  single,	  most	  independent	  predictor	  of	  negative	   smooth	   muscle	   outcomes	   being	   increasing	   mesh	   stiffness.	   The	   results	   are	   not	  surprising,	   as	   the	  mechanical	   and	   textile	   requirements	   for	   gynecologic	   use	   have	   not	   yet	  been	   established,	   and	   to	   date,	   currently	   available	   meshes	   including	   the	   terminology	  “lightweight”,	  are	  all	  based	  on	  biomechanics	  parameters	  of	  the	  abdominal	  wall	  due	  to	  their	  class	  II	  classification	  so	  theses	  light-­‐weight	  meshes	  may	  indeed	  still	  be	  too	  heavy	  and	  stiff	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for	   the	   vagina.	   Synthetic	   polypropylene	   meshes	   for	   prolapse	   surgeries	   was	   originally	  adopted	  by	  urogynecologic	  clinicians	  because	  of	   the	   long-­‐term	  anatomical	  support	   that	   it	  provides	   to	   the	  prolapsed	  vagina	   following	   failure	  of	   its	   fibromuscular	   support	   [206].	  As	  clinical	   successes	   associated	   with	   the	   use	   of	   mesh	   increased,	   widespread	   use	   of	   mesh	  ensued,	   as	   well	   as	   the	   advent	   of	   multiple	   mesh	   products	   onto	   the	  market.	   In	   2010,	   the	  number	  of	  surgeries	  being	  performed	  annually	  had	  reached	  an	  estimated	  100,000,	  and	  this	  figure	  is	  expected	  to	  double	  by	  2050	  [9].	  However,	  recent	  reports	  indicate	  that	  the	  number	  of	   cases	   involving	   vaginal	  mesh	   erosion	   and	   or	   exposure	   ranges	   from	   7-­‐10%,	  with	   very	  little	   understanding	   as	   to	   the	   source	   of	   these	   complications	   [207].	   These	   findings	   along	  with	   increased	   incidence	   of	   pain,	   dyspareunia,	   and	   reoccurrence	   prompted	   the	   FDA	   to	  release	  a	  warning	   in	  2008,	  with	  a	   following	   in	  2011,	   stating	   that	  mesh	  complications	  are	  not	  rare	  events.	  	  	   	  Similar	  to	  mesh	  use	  for	  POP,	  at	  the	  onset,	  mesh	  use	  for	  hernia	  repair	  were	  published	  as	  having	  excellent	  outcomes,	   and	   so	   little	   emphasis	  was	  placed	  on	  mesh	  properties,	  but	  instead	   on	   surgical	   techniques.	   However,	   when	   synthetic	   mesh	   use	   for	   hernia	   repairs	  increased,	  as	  well	  as	  cases	  reporting	  complications	  following	  mesh	  procedures,	  numerous	  experimental	   studies	   and	   clinical	   observations	   began	   in	   1995	   to	   improve	   the	  understanding	   of	   the	   physiology	   and	   the	   mechanics	   of	   the	   abdominal	   wall	   in	   order	   to	  define	  the	  biomechanical	  requirements	  for	  successful	  integration	  into	  the	  host	  tissue	  [208].	  Therefore,	  the	  new	  generation	  of	  lightweight	  and	  large	  pore	  meshes	  introduced	  for	  hernia	  repairs,	   had	   design	   criteria	   based	   on	   biomechanical	   studies	   showing	   that	   under	   normal	  physiologic	  load	  of	  16	  N,	  the	  abdomen	  undergoes	  11-­‐32%	  strain	  (normalized	  deformation)	  [209].	  These	  mechano-­‐physical	  requirements	  set	   the	  design	  criteria	   for	  abdominal	  hernia	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meshes.	   Further,	   it	   was	   determined	   that	   the	   tensile	   strength	   of	   surgical	   meshes	   for	  abdominal	  wall	  placement	  for	  large	  vs	  small	  hernias	  be	  different,	  due	  to	  the	  differences	  in	  the	   support	   needed	   for	   each	   repair,	   as	   further	   surgical	   guidelines.	   Hence	  more	   work	   to	  understand	   the	   mechanics	   specific	   to	   the	   vagina,	   are	   needed	   to	   design	   optimally	  performing	   meshes,	   with	   design	   characteristics	   that	   can	   improve	   muscle	   outcomes.	   In	  2011,	   the	   FDA	  warnings	   were	   followed	   by	   orders	   to	   tentative	   reclassify	   urogynecologic	  meshes	  from	  class	  II	   to	  class	  III,	  medical	  devices	  requiring	  premarket	  approval	  (PMA),	  or	  notice	  a	  of	  completion	  of	  a	  product	  development	  protocol	  (PDP).	  Therefore,	  the	  findings	  of	  this	   study	   are	   also	   chronologically	   relevant,	   and	   could	   begin	   to	   offer	   some	   preliminary	  guidelines,	  in	  an	  effort	  to	  meet	  the	  FDA’s	  new	  requirements.	  
5.3 LIMITATIONS	  AND	  FUTURE	  DIRECTIONS	  
This	   thesis	   aided	   in	   answering	   lingering	   scientific	   and	   clinical	   questions	   regarding	   the	  pathogenesis	  and	  treatment	  of	  POP,	  but	  there	  were	  limitations	  and	  unanswered	  questions.	  	  Our	   investigation	  of	   the	   impact	  of	  birth	   injury	  on	  VaSM	  was	  evaluated	   following	  a	  simulated	  birth	   injury	   in	  non-­‐pregnant	   rodents,	  which	  may	  vary	   from	  humans,	   and	  does	  not	  capture	  the	  hormonally	  induced	  mechanical	  adaptations	  present	  during	  delivery.	  More	  research	   is	   needed	   to	   therefore	   evaluate	   these	   outcomes	   in	   the	   presence	   of	   these	  adaptations.	   Evaluations	   were	   also	   limited	   to	   vagina,	   exclusive	   of	   its	   fibromuscular	  structures	  (i.e	  the	  paravaginal	  attachments),	  but	  these	  structures	  may	  have	  also	  sustained	  injuries,	  and	  may	  directly	  influence	  changes	  in	  pelvic	  floor	  support	  or	  via	  changes	  in	  VaSM.	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Likewise,	  more	  studies	  are	  needed	  to	  evaluate	  the	  impact	  of	  injury	  on	  these	  structures,	  and	  to	   also	   determine	   the	   time-­‐dependent	   changes.	   This	   is	   particularly	   important,	   as	   out	  findings	   did	   show	   evidence	   of	   compensation	   mechanisms	   to	   maintain	   muscle	   function,	  hence	   it	   is	   unclear	   when	   these	   compensatory	   physiologic	  mechanisms	   fail	   and	   a	   loss	   of	  support	   ensues.	   Our	  model	   of	   a	   simulated	   injury	  was	   similar	   to	   a	   sulcus	   seen	   clinically,	  hence	  studies	  designed	  to	  evaluate	  the	  association	  between	  POP	  and	  sulcus	  tears	  would	  be	  worthwhile.	   Additionally,	   evaluation	   of	   biomarkers	   of	   smooth	   muscle	   remodeling	   on	  patients	   antepartum	   and	   postpartum	   patients	   could	   also	   provide	   insights.	   Future	   work	  could	  also	  include	  intervention	  strategies	  used	  to	  clinically	  induce	  the	  necessary	  adaptive	  mechanisms,	  needed	  to	  prevent	  vaginal	  injury	  related	  to	  inadequate	  adaptations.	  Our	  follow-­‐up	  study	  evaluated	  the	  impact	  of	  changes	  in	  smooth	  muscle	  function	  on	  vaginal	  mechanics,	  anticipated	  following	  vaginal	  birth	  injury,	  was	  also	  conducted	  in	  in	  vitro	  conditions,	   and	   may	   not	   represent	   in-­‐vivo	   conditions,	   although	   attempts	   were	   made	   to	  mimic	   in-­‐vivo	   physiology.	   Additionally,	   this	   study	   provides	   an	   evaluation	   of	   the	   effect	   of	  severe	   loss	   in	  muscle	   function	  which	  may	  not	   be	   clinically	   relevant,	   nevertheless	   it	   does	  provide	  insights	  into	  soft	  tissue	  mechanics	  that	  are	  applicable	  to	  not	  only	  the	  vaginal	  wall,	  but	  vascular,	  duodenal,	  esophageal,	  and	  bladder	  mechanics,	  from	  which	  experiments	  in	  this	  thesis	  have	  been	  adapted.	  The	  evidence	  of	  the	  role	  of	  smooth	  muscle	  in	  strain	  distribution	  between	   the	   axial	   vs	   circumferential	   direction	   are	   also	   intriguing,	   and	  may	   explain	   how	  changes	   in	   smooth	  muscle	  can	   influence	  changes	   in	   the	  vagina.	  More	  studies	  designed	   to	  evaluate	  the	  impact	  of	  varying	  degrees	  of	  smooth	  muscle	  loss	  will	  assist	  in	  understanding	  the	   progression	   of	   the	   potential	   degenerative	   effects.	   Animal	   models	   that	   allow	   for	   the	  evaluation	   of	   only	   the	   influence	   of	   the	   loss	   of	   VaSM	   in-­‐vivo,	   would	   be	   ideal.	   Such	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evaluations	  would	  be	  preferable	  in	  a	  large	  animal	  model,	  as	  the	  rat	  vaginal	  smooth	  muscle	  thickness	   is	   relatively	   thin	   compared	   to	   the	   human	   vagina.	   It	   is	   possible	   that	   a	   loss	   of	  smooth	  muscle	  could	  have	  more,	  or	  less	  significant	  effect	  when	  evaluated	  in	  another	  model.	  The	   clinically	   relevant	   degree	   of	   loss	   of	   also	   needed,	   hence	   clinical	   studies	   designed	   to	  evaluate	   VaSM	   function,	   similar	   to	   those	   used	   to	   evaluate	   lavator	   ani	   function	   are	   also	  warranted.	  	  Our	   concluding	   study,	   which	   evaluated	   the	   impact	   of	   currently	   used	   prolapse	  meshes	   on	   vaginal	   smooth	   muscle,	   was	   evaluated	   following	   implantation	   in	   a	   primate	  model.	  The	  primate	  model	  does	  have	  its	  advantages,	  but	  the	  loading	  condition	  of	  the	  mesh,	  in	   the	   pelvic	   floor,	   does	   differs	   from	   humans,	   although	   minimally.	   Our	   results,	   which	  showed	  that	  mesh	  stiffness	  was	  the	  primary	  factor	  driving	  smooth	  muscle	  outcomes,	  may	  have	   therefore	   been	   influenced	  by	   the	   loading	   conditions.	   Studies	   evaluating	   the	   loading	  and	  tensioning	  of	  meshes	  are	   therefore	  needed.	  Additionally,	   the	  results	  also	  showed	  the	  most	   significant	   impact	  of	  mesh	  occurred	   in	   the	  underlying	  grafted	   region,	  with	  minimal	  changes	   in	   non-­‐grafted	   region.	   It	   is	   also	   unclear	   if	   changes	   in	   nerve	   function	   precede	  changes	   in	  myofiber	   and	   receptor	   function,	   as	   there	   is	   literature	   in	   support	   of	   alternate	  mechanisms.	  More	  studies	  looking	  at	  the	  time-­‐dependent	  progression	  of	  the	  degenerative	  effects	  of	  mesh	   in	   the	  unsupported	  non-­‐grafted	   region,	  will	   help	   in	  better	  understanding	  mesh	   failure	   and	   reoccurrence.	  As	   is	   the	   limitation	   of	   all	   animals	  model,	   no	  measures	   of	  pain	  and	  discomfort	  were	  obtained	  following	  implantation,	  and	  clinical	  studies	  are	  indeed	  warranted.	   Findings	   of	   the	   influence	   of	   mesh	   stiffness	   on	   our	   smooth	   muscle	   outcomes	  suggest	  possible	  benefits	  of	  clinical	  standardization	  of	  mesh	  tensioning,	  and	  clinical	  studies	  designed	   to	   evaluating	   patient	   outcome	   should	   follow.	   However,	   not	   all	   processes	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associated	  with	  mesh	   implantation	   can	   be	   standardized,	   but	   rigorous	   studies	   evaluating	  best	  practices,	  could	  also	  provide	  further	  insight.	  More,	  importantly,	  studies	  designed	  to	  aid	  in	   determining	   ex-­‐vivo	   and	   in-­‐vivo	   characteristics	   of	  mesh	   needed	   to	   perform	   optimally	  irrespective	  of	  minor	  variances	  in	  implantation	  techniques	  are	  warranted.	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APPENDIX	  A	  
VAGINAL	  DELIVERY	  WITH	  INJURY	  IMPAIRS	  VSTC	  RECOVERY	  
A.1 INTRODUCTION	  
Maternal	   childbirth	   trauma	   has	   the	   greatest	   association	   with	   the	   development	   of	   pelvic	  floor	  dysfunctions	  (PFDs)	  later	  in	  life,	  which	  affect	  millions	  of	  women	  in	  the	  United	  States	  and	  worldwide	  [11],	  [119].	  The	  odds	  ratio	  (OR)	  of	  developing	  pelvic	  organ	  prolapse	  (POP)	  is	  reported	  to	  be	  ~5.6	   following	  a	  spontaneous	  vaginal	  delivery,	  and	  rising	  as	  high	  as	  7.5	  following	   operative	   vaginal	   delivery	   relative	   to	   a	   caesarean	   delivery.	   With	   only	   a	  percentage	  of	  women	  delivering	  vaginally	  presenting	  with	  symptoms	  of	  POP,	  many	  clinical	  studies	  have	  focused	  on	  elucidating	  specific	  factors	  that	  may	  predispose	  to	  developing	  POP,	  especially	  with	   the	   rise	   in	   elective	   caesarian	   deliveries	   in	   an	   attempt	   obviate	   the	   risk	   of	  developing	  PFDs	  [2],	  [6],	  [34],	  [210].	  Recently,	  increased	  effort	  has	  been	  directed	  towards	  injury	  of	  the	  levator	  ani	  muscles.	  However,	  studies,	  including	  a	  recent	  study	  by	  Peschers	  et	  al.,	   showed	   that	  76%	  of	  women	  presenting	  with	  POP	  do	  not	  have	   levator	   avulsions	   [52],	  [54].	  While	  vaginal	  delivery	  may	  be	  associated	  with	  POP,	  it	  may	  not	  be	  independently	  due	  to	  levator	  impairment,	  but	  perhaps	  levator	  impairment,	  concomitant	  with	  a	  loss	  of	  vaginal	  connective	   tissue	   support,	   allowing	   for	   visceral	   protrusion	   through	   the	   hiatus	   	   [211].
It	   is	   well	   established	   that	   mechanical	   failure	   of	   the	   vagina	   and	   supportive	   tissue-­‐	  complex	  (VSTC)	  results	  in	  a	  loss	  of	  support	  to	  the	  bladder,	  uterus,	  and	  rectum,	  though	  very	  few	  clinical	  studies	  have	  been	  able	  to	  capture	  the	  impact	  of	  childbirth	  trauma	  on	  this	  highly	  complex	  network	  of	  supportive	   tissues.	  As	  anatomically	  structured,	  vaginal	  suspension	   is	  maintained	  by	  the	  VSTC,	  which	  is	  contiguous	  with	  the	  vaginal	  adventitia	  layer	  and	  inserts	  posteriorly	   into	   the	   levator	   ani	   muscles.	   It	   could	   be	   inferred	   that	   the	   VSTC	   is	   likely	  subjected	  to	  grave	  insult	  during	  traumatic	  deliveries,	  due	  to	  extreme	  deformations,	  prior	  to	  transmission	   of	   forces	   to	   the	   mechanically	   more	   sturdy	   levator	   ani	   muscles.	   Indeed,	  previous	   work	   showing	   that	   changes	   in	   the	   mechanics	   of	   these	   structures,	   evident	   in	  women	  with	  POP	  and	  also	  during	  pregnancy,	  are	  associated	  with	  the	  descent	  and	  increased	  mobility	   of	   the	   pelvic	   organs	   [125].	   Unfortunately,	   limitations	   associated	   with	   tissue	  acquisition,	   as	   well	   as	   the	   level	   of	   control	   needed	   to	   make	   the	   association	   between	  childbirth	  trauma	  and	  altered	  VSTC	  support,	  precludes	  clinical	  associations.	  	  In	   order	   to	   rigorously	   evaluate	   the	   effects	   of	   birth	   trauma	   on	   the	   VSTC,	   this	   study	  utilizes	   a	   previously	   established	   birth	   injury	   rodent	   model	   [116].	   This	   model,	   which	  employs	   a	   balloon	   injury	   to	   the	   vagina,	   has	   been	  widely	   used	   for	  mechanistic	   studies	   of	  stress	   urinary	   incontinence	   (SUI),	   and	   has	   been	   shown	   to	   replicate	   many	   of	   the	  characteristics	  of	  SUI	  conditions	  in	  women	  [49].	  Simulation	  of	  birth	  injury	  in	  rodents	  is	  also	  quite	  standard,	  as	  they	  do	  not	  naturally	  sustain	  an	  injury	  during	  delivery,	  presumed	  to	  be	  due	  to	  the	  small	  size	  of	  the	  fetal	  head	  relative	  to	  the	  vaginal	  diameter.	  This	  model	  further	  excels	  as	  the	  rodent	  levator	  ani	  muscles	  primarily	  function	  to	  control	  the	  tail,	  allowing	  for	  the	   investigation	   of	   the	   VSTC	   independent	   of	   contributions	   of	   the	   levator	   ani	   [212].	   To	  quantify	   the	   impact	   of	   birth	   injury	   on	   the	   VSTC,	   we	   utilized	   an	   established	   mechanical	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testing	  protocol,	  previously	  used	   to	   characterize	   changes	   in	   the	  mechanical	  properties	  of	  the	  VSTC	  during	  pregnancy	  and	  following	  hormonal	  withdrawal	  [196],	  [213].	  Hence,	   the	   objective	   of	   this	   study	   was	   to	   evaluate	   the	   time-­‐dependent	   impact	   of	  simulated	  maternal	   childbirth	   trauma	  on	   the	  vagina	   and	   supportive	   tissues	   complex	   in	   a	  rodent	   model	   (VSTC),	   as	   trauma-­‐induced	   alteration	   of	   the	   VSTC	   could	   be	   a	   mechanism	  whereby	  childbirth	  leads	  to	  the	  eventual	  loss	  of	  pelvic	  organ	  support.	  	  
A.2 PROTOCOLS	  
A.2.1 Animals	  
Approval	  for	  this	  study	  was	  received	  from	  the	  Institutional	  Animal	  Care	  and	  Use	  Committee	  (IACUC)	   at	   the	  University	   of	   Pittsburgh.	  A	   total	   of	   44	   three-­‐month-­‐old	   female	   Lewis	   rats	  were	  used.	  32	  pregnant	  animals	  arrived	  at	  gestation	  day	  21	  and	  were	  randomly	  assigned	  to	  injured	   postpartum	   and	   control	   postpartum	   (n=8	   for	   each	   of	   Control	   4-­‐week,	   Injured	   4-­‐week,	  Injured	  8-­‐week,	  Control	  8-­‐week)	  groups.	  To	  isolate	  the	  role	  of	  maternal	  adaptations,	  three-­‐month	  old	  virgin	  female	  Lewis	  rats	  were	  also	  divided	  into	  control	  and	  injured	  groups	  (n	   =	   6	   for	   each	   Virgin	   group).	   Injured	   groups	   underwent	   a	   simulated	   maternal	   birth	  trauma,	   as	   described	   below,	   and	   each	   group	   was	   sacrificed	   at	   the	   corresponding	   time-­‐points.	  All	  rats	  were	  housed	  in	  a	  temperature	  and	  light-­‐controlled	  room	  with	  free	  access	  to	  food.	   Variables	   that	   could	   be	   influence	   by	   injury,	   including	   weight,	   pups/litter,	   genital	  hiatus	   (GH:	  measured	   from	   the	  middle	   of	   the	   external	   urethral	   meatus	   to	   the	   posterior	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midline	   introitus),	   and	   total	   vaginal	   length	   (TVL:	  measured	   from	   posterior	   fornix	   to	   the	  introitus)	  were	  obtained	  prior	  to	  injury,	  and	  post-­‐injury	  at	  the	  time	  of	  sacrifice	  of	  each	  rat.	  	  
A.2.2 Simulated	  Birth	  Injury	  
A	   simulated	   birth	   injury	   was	   inflicted,	   using	   a	   previously	   established	   model,	   which	   is	  known	  to	  mimic	  the	  vaginal	  trauma	  that	  typically	  occurs	  during	  a	  prolonged	  second	  stage	  of	  labor.	  Within	  2	  hours	  of	  delivery	  (in	  the	  pregnant	  groups),	  each	  animal	  was	  anesthetized	  and	  a	  16	  Fr	  catheter	  was	  inserted	  and	  inflated	  with	  10ccs	  of	  water.	  The	  catheter	  was	  placed	  in	   the	  vagina	  but	  not	   inflated	   in	   the	  control	  groups.	  This	  volume	  of	  water	  had	  previously	  been	  shown	  by	  our	  group	  to	  induce	  a	  grossly	  observable	  sulcus	  tear.	  While	  maintaining	  the	  volume,	  the	  rats	  were	  placed	  supine	  with	  their	  pubic	  symphysis	  at	  the	  edge	  of	  the	  table.	  A	  130gm	  weight	  was	  then	  attached	  to	  the	  end	  of	  the	  catheter	  and	  allowed	  to	  hang	  freely	  for	  3	  hours.	   At	   the	   end	   of	   the	   3-­‐hour	   period,	   the	   balloon	   was	   deflated	   and	   the	   catheter	   was	  removed.	   Post-­‐injury	   care	   including	   oral	   intake	   of	   pain	   medication	   was	   carried	   out	  according	  to	  a	  standard	  protocol.	  	  
A.2.3 Uniaxial	  Mechanical	  Tests	  
Biomechanical	  Testing	  was	  preformed	  as	  previously	   reported.	  Briefly,	   the	  vagina	  of	   each	  rat	  was	  dissected	  along	  the	  perineal	  body	  to	  isolate	  the	  distal	  5	  mm	  of	  the	  vagina	  from	  the	  rectum	  and	   adjacent	   tissues.	   The	  hind	   limbs	  were	   then	  disarticulated	   at	   the	   acetabulum,	  and	   the	   spine	   was	   disarticulated	   above	   the	   L1	   vertebra,	   leaving	   the	   pelvis	   intact.	   To	  produce	   suitable	   rigidity	   for	   clamping,	   the	   spine	   was	   potted	   in	   polymethylmethacrylate	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(PMMA),	   such	   that	   the	   spine	   and	   the	   pelvis	  were	   aligned.	   The	  PMMA	   secured	   spine	  was	  then	  mounted	  in	  a	  cylindrical	  clamp	  and	  a	  customized	  soft-­‐tissue	  clamp	  was	  used	  to	  secure	  the	   distal	   5	   mm	   of	   the	   vagina.	   The	   cylindrical	   clamp	   was	   then	   fixed	   to	   the	   base	   of	   the	  materials	   testing	   machine	   (SmartTest	   EMS,	   Enduratec,	   Minnetonka,	   Minnesota;	  displacement	  resolution	  .025	  mm),	  while	  the	  soft	  tissue	  clamp	  was	  attached	  to	  a	  load-­‐cell	  (M-­‐1000N,	   Interface,	   Scottsdale,	   Arizona;	   resolution	   0.015	   N)	   and	   fixed	   to	   the	   linear	  actuator.	  Before	  each	  test,	  specimens	  were	  preloaded	  to	  0.15	  N,	  and	  then	  preconditioned	  at	  an	   elongation	   rate	   of	   25	   mm/min	   between	   0	   and	   2	   mm	   for	   10	   cycles.	   Following	  preconditioning,	  the	  specimen	  was	  loaded	  until	  failure	  at	  25	  mm/min.	  Failure	   modes	   were	   recorded	   and	   load-­‐elongation	   data	   sampled	   at	   50	   Hz	   was	  imported	   into	   Excel	   for	   analysis	   (Excel,	   Microsoft	   Corp,	   Redmond,	   Wash).	   All	   load–elongation	  curves	  in	  this	  study	  were	  shaped	  similarly,	  with	  a	  defined	  toe,	  linear,	  and	  failure	  regions,	  corresponding	  to	  when	  the	  vagina	  and	  paravaginal	  attachments	  become	  engaged,	  distended	   and	   when	   one	   or	   more	   of	   these	   structures	   fail	   (Figure	   23).	   The	   structural	  properties	   of	   the	   vagina	   supportive	   tissue	   complex	   (VSTC)	   were	   represented	   by	   the	  following	   parameters:	   linear	   stiffness	   (N/mm),	   ultimate	   load	   at	   failure	   (N),	   ultimate	  elongation	  (mm),	  and	  energy	  absorbed	  to	  failure	  (N*mm).	  Linear	  stiffness,	  a	  measure	  of	  a	  specimen’s	  ability	  to	  resist	  deformation	  with	  tension,	  was	  defined	  as	  the	  steepest	  positive	  slope	  measured	   over	   a	  moving	  1	  mm	  window	  of	   elongation	   for	   each	   specimen.	  Ultimate	  load	  at	  failure	  is	  a	  measure	  of	  the	  maximal	  sustainable	  force	  of	  the	  VSTC	  and	  was	  defined	  as	  the	  highest	  load	  on	  the	  load–elongation	  curve.	  Maximal	  elongation	  was	  the	  elongation	  that	  corresponded	  with	  the	  ultimate	  load	  and	  describes	  the	  maximum	  distance	  achieved	  before	  failing.	  Energy	  absorbed	  to	  failure	  was	  defined	  as	  the	  area	  under	  the	  load–elongation	  curve	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up	  to	  the	  point	  of	  failure;	  this	  parameter	  is	  also	  influenced	  by	  the	  degree	  of	  crosslinking	  in	  collagen	   and	  elastin.	  The	   yield	  point,	   the	  point	  which	  marks	   the	   end	   linear	   region	  of	   the	  curve,	  was	  also	  compared	  between	  groups,	  as	  this	  point	  is	  usually	  indicative	  of	  permanent	  deformation	  of	  the	  tissue.	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A.2.4 Microanatomy	  and	  Histological	  Analysis	  
To	   analyze	   the	   microanatomy	   of	   the	   vaginal	   wall	   and	   its	   connective	   tissue	  attachments	   to	   the	   pelvic	   sidewall,	   the	   pelvises	   of	   10	   rats	   were	   further	   dissected	   by	  dividing	  the	  pelvises	  along	  the	  horizontal	  axis.	  One	  half	  of	  the	  specimen	  was	  placed	  in	  10%	  neutral	  buffered	  formalin	  for	  24	  hours.	  The	  pelvises	  were	  then	  cut	  in	  proximal,	  middle,	  and	  distal	  sections	  and	  placed	  in	  a	  decalcifying	  fixative	  (Cal-­‐Ex™	  II	  Fixative/Decalcifier,	  Fisher	  Chemical)	  for	  48	  hours.	  Following	  decalcification,	  the	  sections	  were	  embedded	  in	  paraffin	  blocks	   and	   sections	   were	   obtained	   at	   thicknesses	   of	   5-­‐7µm,	   followed	   by	   Masson’s	  trichrome	  staining.	  	  
A.2.5 Statistical	  Methods	  
Statistical	   analyses	   were	   performed	   using	   SAS	   Version	   9.4	   (SAS	   Institute,	   Cary,	   NC).	   All	  parameters	   are	   described	   as	   mean	   ±	   SD.	   Normality	   was	   assessed	   using	   skewness	   and	  kurtosis	   statistics	   as	  well	   as	   histograms.	  No	   significant	  departures	   from	  normality	   in	   the	  pre-­‐test	  parameters	   (pups	  per	   litter,	  weight,	  GH,	  and	  TVL)	  or	   the	  mechanical	  parameters	  (load,	   stiffness,	   elongation,	   and	   energy	   absorbed),	   allowed	   for	   evaluation	   of	   differences	  between	   injured	  rats	  and	  control	  rats	   in	  each	  of	   the	  groups	  (4-­‐week	  postpartum,	  8-­‐week	  postpartum,	  and	  virgin)	  using	  pairwise	  t-­‐tests.	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A.3 RESULTS	  
	  
Table	   11	   displays	   characteristics	   of	   control	   rats	   vs.	   injured	   rats	   in	   each	   group	   (4-­‐week	  postpartum,	  8-­‐week	  postpartum,	  and	  virgin)	  prior	   to	   conducting	   the	  mechanical	   tests.	   In	  the	   4-­‐week	   postpartum	   group,	   the	   injured	   rats	   trended	   towards	   lower	   weight	   (P=0.06),	  larger	  GH	  (P=0.06),	  and	  smaller	  TVL	  (P=0.08).	  The	  8-­‐week	  postpartum	  group	  had	  slightly	  different	   trends,	   with	   the	   injured	   group	   trending	   toward	   higher	  weight	   (P=0.04),	   with	   a	  smaller	  GH	  (P=0.07).	  In	  the	  virgin	  group,	  the	  injured	  rats	  were	  significantly	  lighter	  (P<0.01)	  with	  larger	  GH	  (P=0.04)	  than	  the	  control	  rats.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Table	  11.	  Data	  Demonstrating	  the	  Baseline	  Number	  of	  Fetuses,	  Weight,	  GH,	  and	  TVL	  Group	   N	   	  	  Pups/Litter	  	   	  	  Weight	  (g)	   GH	  (cm)	   TVL	  (cm)	  4-­‐Week	  PP	  Injured	  	   8	   	  	  5.88	  ±	  3.64	   	  223.7	  ±	  9.90	   	  0.84	  ±	  0.19a	   1.81	  ±	  0.26	  4-­‐Week	  PP	  Control	  	   8	   	  	  7.38	  ±	  3.38	   	  234.6	  	  ±	  11.6	   0.69	  ±	  0.12	   2.00	  ±	  0.00	  8-­‐Week	  PP	  Injured	  	   8	   	  	  8.25	  ±	  3.24	   	  249.2	  ±	  19.0	   0.66	  ±	  0.40	   1.94	  ±	  0.18	  8-­‐Week	  PP	  Control	  	   8	   	  	  6.29	  ±	  2.36	   	  221.8	  ±	  14.8	   0.50	  ±	  0.00	   2.00	  ±	  0.00	  Virgin	  Injured	  	   6	   N/A	   198.9	  ±	  10.5	   	  0.75	  ±	  0.22a	   2.00	  ±	  0.00	  Virgin	  Control	   6	   N/A	   221.8	  ±	  14.81	   0.50	  ±	  0.00	   2.00	  ±	  0.00	  
Values	  presented	  as	  Median	  (IQR)-­‐	  Significance	  set	  a	  P	  <	  .05	  
a	  Relative	  to	  control	  matched	  controls	   	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   Evaluation	  of	   the	  mechanical	  parameters	   in	   the	  4-­‐week	  postpartum	   injured	  group	  showed	   no	   difference	   in	   load	   bearing	   capacity	   (P=0.11),	   stiffness	   (P=0.52),	   elongation	  (P=0.39),	  or	  the	  amount	  of	  energy	  absorbed	  (P=0.53)	  by	  the	  VSTC	  before	  failure,	  relative	  to	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the	   postpartum	   control	   group	   (Table	   12).	   	   However,	   subsequent	   evaluation	   at	   8	  weeks	  injured	  group	  showed	  that	  the	  VSTC	  had	  23%	  lower	  load-­‐bearing	  capacity	  (P=0.03),	  a	  32%	  lower	  stiffness	  (P=0.02),	  and	  a	  40%	  greater	  elongation	  (P=0.02)	  of	  the	  VSTC,	  relative	  to	  the	  postpartum	  control	  group	  (difference	  in	  load-­‐bearing	  capacity	  shown	  in	  Figure	  24).	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Table	  12.	  Comparison	  of	  the	  Mechanical	  Properties	  of	  the	  VSTC	  	   N	   Load	  	  (N)	   Stiffness	  	  	  	  	  (N/mm)	   Elongation	  	  (mm)	   Energy	  Absorbed	  	  (N*mm)	  	  4-­‐Week	  PP	  Injured	   	  8	   	  	  	  16.24	  ±	  1.89	   	  3.49	  ±	  0.60	   	  10.88	  ±	  1.96	   	  93.06	  ±	  19.70	  4-­‐Week	  PP	  Control	   8	   	  	  17.73	  ±	  1.66	   3.81	  ±	  1.26	   9.86	  ±	  2.65	   86.06	  ±	  24.10	  8-­‐Week	  PP	  Injured	   8	   	  	  14.59	  ±	  3.26	   3.30	  ±	  1.19	   10.68	  ±	  3.24	   85.06	  ±	  37.58	  8-­‐Week	  PP	  Control	   8	   	  	  19.12	  ±	  3.06	   4.87	  ±	  1.02	   7.58	  ±	  0.92	   68.85	  ±	  20.74	  Virgin	  4-­‐Week	  Injured	   6	   	  	  16.51	  ±	  1.61	   	  3.54.	  ±	  0.90	   9.70	  ±	  2.94	   	  76.99	  ±	  29.87	  Virgin	  Control	   6	   	  	  13.55	  ±	  1.50	   	  2.95	  ±	  0.71	   8.24	  ±	  1.08	   51.51	  ±	  10.76	  4-­‐Week	  PP	  Injured	  vs	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4-­‐Week	  PP	  Control	   	   P =	  0.116	   P	  =	  0.521	   P	  	  =	  0.394	   P	  =	  0.535	  8-­‐Week	  PP	  Injured	  vs	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  8-­‐Week	  PP	  Control	   	   P =	  0.032	   P	  ≥	  0.015	   P	  	  =	  0.015	   P	  	  =	  0.196	  4-­‐Week	  PP	  Injured	  vs	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  8-­‐Week	  PP	  Injured	  	  	   	   P ≥	  0.197	   P	  ≥	  0.230	   P	  ≥	  0.814	   P	  ≥	  0.776	  4-­‐Week	  PP	  Control	  vs	  	  	  8-­‐Week	  PP	  Control	   	   P	  ≥	  0.276	   P	  ≥	  0.083	   P	  ≥	  0.038	   P	  ≥	  0.148	  Virgin	  vs	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Virgin	  4	  Week	  Injured	   	   P	  ≥	  0.008	   P	  ≥	  0.236	   P	  ≥	  0.280	   P	  ≥	  0.078	  
Nomenclature	  -­‐	  PP:	  Post	  Partum,	  Load:	  Maximum	  Load,	  Stiffness:	  Maximum	  Linear	  Stiffness,	  	  	  	  
Elongation:	  Maximum	  Elongation	  –values	  represented	  as	  mean	  	  ±	  	  standard	  deviation	  	  
Significance	  set	  a	  P	  <	  .05	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To	   determine	   if	   the	   significant	   decline	   of	   the	   mechanical	   properties	   of	   the	   VSTC	  observed	   in	   the	   postpartum	   injured	   vs.	   control	   group	   at	   8	  weeks	   following	   injury	  was	   a	  result	   of	   a	   time-­‐dependent	  worsening	  of	   the	   injury	  or	  due	   to	   continuous	   recovery	  of	   the	  control	  group,	  comparison	  of	  the	  4-­‐week	  vs	  8-­‐week	  postpartum	  time-­‐points	  for	  injured	  and	  control	  groups	  was	  performed.	  Although	  the	  results	  showed	  no	  significant	  difference	  in	  the	  4	   vs.	   8	  weeks	  postpartum	   injured	   group	   for	   any	   of	   the	   outcome	  measures,	   indicating	  no	  time-­‐dependent	   worsening	   of	   the	   effects	   of	   injury,	   there	   was	   a	   27%	   lower	   stiffness	  (P=0.010)	  and	  43%	  greater	  elongation	  (P=0.038)	  in	  the	  4	  vs.	  8	  weeks	  postpartum	  control	  group.	   	  The	  results	  suggest	   that	   the	  time-­‐dependent	  recovery	  occurring	   in	  the	  absence	  of	  injury	  maybe	  be	  prevented	  or	  delayed	  when	  significant	  injury	  is	  present	  (Table	  12).	  To	   further	   determine	   if	   the	   adaptive	   mechanisms	   occurring	   during	   pregnancy	   to	  afford	  vaginal	  distension	  at	  the	  time	  of	  delivery	  place	  the	  tissues	  at	  increased	  risk	  for	  injury	  if	   those	   adaptations	   are	   exceeded,	   we	   compared	   the	   impact	   of	   injury	   in	   the	   virgin	   vs	  postpartum	  group	  at	  4	  weeks	  post	  injury.	  Results	  from	  the	  evaluation	  showed	  that	  indeed	  the	  negative	  impact	  of	  injury	  in	  the	  postpartum	  group	  exceeded	  that	  observed	  in	  the	  virgin	  group	  (Figure	  3).	  In	  the	  virgin	  group,	  the	  injured	  rats	  had	  significantly	  greater	  load-­‐bearing	  capacity	  (P<0.01),	  in	  contrast	  to	  the	  results	  showing	  no	  difference	  in	  load-­‐bearing	  capacity	  in	  the	  4-­‐week	  postpartum	  group	  and	  significantly	   lower	  load-­‐bearing	  capacity	  for	   injured	  rates	   in	   the	   8-­‐week	  postpartum	  group.	   In	   the	   virgin	   group,	   the	   increase	   in	   load	  was	   not	  accompanied	  by	   any	  decline	   in	   the	   stiffness	   (P=0.23),	   elongation	   (P=0.29),	   or	   the	   energy	  absorbed	  (P=0.09).	  	  	   	   Previous	  studies	  have	  shown	  that	  rodents	  do	  not	   typically	  sustain	  an	   injury	  to	  the	  VSTC	  during	  delivery.	  Not	  surprisingly,	  our	  results	  corroborate	  these	  findings	  showing	  no	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significant	  correlations	  between	  the	  number	  of	  fetuses	  delivered	  and	  any	  of	  the	  mechanical	  outcomes	   in	   the	   absence	   of	   a	   simulated	   injury	   (load,	   stiffness,	   elongation	   and	   energy	  absorbed;	  correlation	  coefficients	  ranging	  from	  r=0.02	  to	  r=0.3).	  However,	  in	  the	  presence	  of	   injury,	   there	   was	   a	   significant	   negative	   correlation	   between	   the	   number	   of	   pups	   and	  VSTC	   elongation	   (r=-­‐0.59)	   at	   4	   weeks	   and	   load-­‐bearing	   capacity	   (r=-­‐0.52)	   at	   8	   weeks.	  Histological	  analysis	  also	  confirmed	  that	  the	  VSTC	  in	  the	  rat	  is	  indeed	  contiguous	  with	  the	  vagina,	   at	   level	   I,	   level	   II,	   and	   level	   III	   (Figure	   25),	   suggesting	   that	   our	  mechanical	   tests	  which	  were	  performed	  by	  uniaxial	  pulling	  along	  the	  distal	  end	  of	  the	  vagina,	  did	  evaluate	  the	  integrity	  of	  these	  structures.	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A.4 DISCUSSION	  
In	  women,	  observational	  data	  supports	  an	  association	  between	  traumatic	  vaginal	  delivery	  and	  POP.	  In	  this	  chapter,	  we	  aimed	  to	  evaluate	  the	  impact	  of	  simulated	  maternal	  childbirth	  trauma	  on	  the	  VSTC,	  in	  order	  to	  define	  the	  role	  of	  birth-­‐related	  trauma	  in	  deterioration	  of	  the	  mechanical	  properties	  of	  the	  VSTC.	  In	  the	  absence	  of	  trauma,	  we	  observed	  a	  significant	  time-­‐dependent	   postpartum	   recovery	   of	   the	  VSTC,	  with	   full	   recovery	   evident	   at	   8	  weeks	  postpartum.	   However,	   following	   simulated	   trauma,	   this	   time-­‐dependent	   postpartum	  recovery	  was	  impeded	  as	  results	  showed	  that	  the	  load	  bearing	  capacity	  and	  stiffness	  of	  the	  injured	  group	  was	  significantly	  inferior	  to	  that	  of	  the	  control	  group	  at	  8	  weeks,	  in	  addition	  to	  exhibiting	   increased	  elongation.	   Injury	  was	  also	  associated	  with	  changes	   in	   the	   size	  of	  the	  genital	  hiatus	  and	  animal	  weight,	  although	  the	  significance	   is	  unknown.	  Nevertheless,	  the	  result	  suggests	  that	  injury	  impedes	  mechanical	  recovery	  of	  the	  VSTC,	  thus	  more	  easily	  deforming	  under	  a	  given	  load,	  presumably	  increasing	  susceptibility	  to	  failure	  over	  time	  and	  the	  development	  of	  POP.	  	  	   	   During	   pregnancy,	   collagen	   (types	   I,	   II,	   V),	   which	   is	   a	   dominant	   biomechanical	  constituent	   of	   the	   VSTC,	   is	   known	   to	   increase	   in	   content,	   but	   the	   number	   of	   crosslinks	  within	   these	   fibers	   declines.	   This	   decrease	   in	   crosslinked	   fibers	   reduces	   the	  mechanical	  strength,	   allowing	   the	   fibers	   to	   undergo	   high	   degrees	   of	   deformation	   during	   delivery	  without	  fracturing,	  and	  ensuring	  rapid	  postpartum	  recovery[214].	  The	  decline	  in	  crosslink	  density,	   is	  known	  to	  be	  due	  to	  a	  decline	  in	  the	  expression	  of	   lysyl	  oxidases	  (LOX),	  a	  cross	  linking	   enzyme.	   A	   robust	   study	   by	   Drewes	   et	   al.	   showed	   up	   to	   80%	   decline	   in	   the	  expression	  of	  LOX	  during	  pregnancy	   in	   rodents	   [215].	  LOX	  expression	  however	  began	   to	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increase	  during	  labor,	  peaking	  at	  24	  hours	  after	  delivery,	  but	  rapidly	  declining	  by	  48	  hours	  postpartum	  below	  antepartum	  levels	  (remaining	  low	  for	  weeks	  postpartum).	  In	  this	  study,	  the	  significantly	  inferior	  mechanical	  response	  of	  the	  postpartum	  injured	  groups	  at	  8	  weeks	  after	  injury,	  characterized	  by	  increased	  deformation,	  elongation,	  and	  energy	  absorbed	  with	  loading,	   suggests	   inadequate	   LOX-­‐induced	   crosslinking,	   as	  Alperin	   et	   al.	   reported	   similar	  mechanical	  properties	  in	  LOX	  -­‐/-­‐	  mice	  [195].	  	  	   	   Such	  inadequate	  crosslinking	  may	  also	  provide	  a	  possible	  explanation	  as	  to	  why	  the	  impact	  of	  injury	  on	  the	  mechanical	  integrity	  of	  the	  postpartum	  group	  was	  more	  severe	  than	  the	   virgin	   group,	   following	   injury.	   It	   is	   likely	   that	   injury	   in	   the	   virgin	   group	   induced	   an	  elevated	  expression	  of	  LOX	  for	  weeks	  following	  injury,	  to	  facilitate	  wound	  contraction	  and	  scar	   formation	   [216].	   In	   contrast,	   in	   the	   postpartum	   group,	   where	   LOX	   expression	   was	  below	   antepartum	   levels,	   the	   wound	   healing	   response	   may	   have	   been	   delayed,	   thus	  resulting	   in	   inferior	  mechanics	  of	   the	  VSTC	   [217].	   If	   this	   is	   indeed	   the	   case,	   the	   lack	  of	   a	  significant	   difference	   between	   the	   4-­‐week	   postpartum	   control	   and	   4-­‐week	   postpartum	  injured	   group,	   suggests	   that	   LOX	   expression	   at	   4	   weeks	   postpartum	  may	   still	   be	   below	  antepartum	  levels,	  thus	  resulting	  in	  comparably	  inferior	  mechanics	  in	  both	  the	  postpartum	  injured	  and	  postpartum	  control	  groups.	  Following	  this	  progression,	  in	  thought,	  it	  could	  be	  inferred	   that	   a	   resurgence	   of	   LOX	   expression	   to,	   or	   above	   antepartum	   levels	   occurs	   at	   8	  weeks	  postpartum,	  explaining	  the	  superior	  mechanics	  of	  the	  VSTC	  in	  the	  8-­‐week	  versus	  4-­‐week	  postpartum	  control	  group.	  	  	  	   	   Although	   more	   long-­‐term	   data	   is	   needed	   to	   determine	   whether	   the	   postpartum	  injured	   group	   eventually	   recovers,	   our	   finding	   that	   healing	   of	   the	   VSTC	   is	   delayed	   is	  meaningful	  as	  it	  would	  render	  the	  VSTC	  more	  susceptible	  to	  damage	  and	  improper	  loading	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during	   the	   early	   postpartum	   period.	   Indeed,	   we	   showed	   that	   the	   VSTC	   in	   the	   8-­‐week	  postpartum	  injured	  group	  began	  permanently	  deforming	  under	  20-­‐30%	  less	  load	  than	  the	  postpartum	   control	   group.	   Histological	   analysis	   also	   suggests	   that	   such	   a	   change	   in	   the	  mechanics	  of	  the	  VSTC	  could	  have	  a	  significant	  impact	  on	  vaginal	  suspension.	  Interestingly,	  Dietz	  et	  al.	  have	  shown	  that	  the	  odds	  of	  incurring	  a	  loss	  of	  postpartum	  pelvic	  organ	  support	  increases,	   with	   inadequate	   maternal	   adaptation	   [125].	   Our	   results,	   which	   showed	   a	  negative	   correlation	   between	   number	   of	   pups/litter	   size	   and	   the	   resulting	   mechanical	  integrity	  following	  injury,	  support	  this	  mechanism,	  as	  more	  pups	  are	  likely	  associated	  with	  increased	  mechanical	  adaptation.	  This	   theory	   is	   further	  supported	  by	  studies	  showing	  an	  association	  of	  sulcus	  tears,	  similar	  to	  that	  imposed	  in	  this	  study,	  with	  inadequate	  maternal	  adaptation	   [37].	  More	  data	  on	   the	   impact	  of	  mode	  of	   trauma	  on	   the	  development	  of	  POP	  are,	  however,	  warranted	  although	  the	  risk	  factors	  for	  sulcus	  tears	  and	  POP	  do	  align.	  	  	   	   As	   reported,	   the	   findings	   of	   this	   study	   are	   noteworthy,	   however	   they	   should	   be	  interpreted	  in	   light	  of	  their	   limitations.	  One	  such	  limitation	  is	  the	  use	  of	  an	  animal	  model	  (rodent),	  whose	  recovery	  mechanism	  may	  be	  distinctively	  different	  from	  humans,	  although	  similar	  connective	  tissue	  supports	  were	  histologically	  observed.	  Postpartum	  injury-­‐care,	  as	  well	  as	  postpartum	  exercise	  regimens	  may	  further	  result	  in	  distinct	  outcomes.	  In	  addition,	  our	   injury	  model	  was	   limited	   to	  sulcus	   tears,	   the	  effects	  of	  which	  may	  not	  apply	   to	  other	  types	  of	  lacerations.	  Further,	  as	  the	  trauma	  was	  simulated,	  tissue	  damage	  may	  be	  under	  or	  over	   exaggerated,	   Nevertheless	   this	   model	   is	   highly	   useful	   for	   the	   future	   evaluation	   of	  multiple	  modes	  of	  birth	  trauma,	  independently	  or	  combined	  with	  hormonal	  withdrawal	  for	  the	   elucidation	   of	   postpartum	   induced	   onset	   of	   POP.	   Future	  work	  will	   also	   evaluate	   the	  impact	  of	  a	  subsequent	  delivery	  (s)	  on	  the	  VSTC.	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Figure	   26.	   Maximum	   Axial	   	   (E11)	   &	   Circumferential	   (E22)	   Strain.	   Strains	   in	   the	  circumferential	   direction	   were,	   on	   average,	   greater	   than	   strains	   in	   the	   axial	   direction.	  Strains	  in	  the	  axial	  direction	  did	  not	  appear	  to	  be	  a	  function	  of	  the	  stress,	  but	  a	  function	  of	  circumferential	   strains.	   Increased	   strain	   in	   the	   circumferential	   direction	   was	   associated	  with	   decreased	   strain	   (or	   a	   shortening)	   in	   the	   axial	   direction	   (Poisson	   effect).	   Smooth	  muscle	  contraction	  enables	   the	  axial	  direction	   to	  maintain	   its	  geometry,	   thus	   limiting	   the	  




























Figure	   27.	   Areal	   Strain.	   Areal	   strain	   exhibited	   an	   increasing	   trend	   following	   smooth	  muscle	   contraction,	   relative	   to	   baseline	   and	   relaxed	   conditions.	   This	   trend	   is	   even	  more	  evident	  during	  .75:1	  and	  .5:1	  loading	  regimens,	  where	  smooth	  muscle	  contraction	  resulted	  in	  a	  greater	   increase	   in	  areal	   strain,	   likely	  due	   to	   the	   increase	   in	   the	  axial	   strain	  (Figure	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